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Summary
The reabsorption and secretion of electrolytes and fluids by the kidney critically de-
pends on the activity of renal ion and water transport proteins and channels in the
apical and basolateral plasma membrane of the renal epithelial cells. In the last two
decades, many of the renal ion and water transporting proteins have been identified,
but the molecular mechanisms underlying the regulation of their activity remains
elusive. Interestingly, the activity of many of the renal ion and water transport-
ing proteins is controlled by the regulation of the trafficking of these proteins to or
from the plasma membrane. Previous in vitro studies on various cell culture models
suggested that the Rab GTPase-activating protein (Rab GAP) TBC1D4 partici-
pates in the control of the intracellular trafficking of the epithelial sodium channel
(ENaC), the water channel aquaporin 2 (AQP2), and the Na+-K+-ATPase localized
in the apical and basolateral plasma membrane of certain renal epithelia, respec-
tively. TBC1D4 is thought to retain ENaC, AQP2, and Na+-K+-ATPase-bearing
vesicles in the cytoplasm and thereby to reduce the cell surface abundance of these
proteins similar to the well known and previously reported effects of TBC1D4 on the
glucose transporter GLUT4 in fat and skeletal muscle cells. The goal of this thesis
was to define the in vivo role of TBC1D4 in the kidney and to test the hypothesis
that TBC1D4 controls the intracellular trafficking of renal ion and water transport-
ing proteins. To reach this end, wildtype and TBC1D4 knockout (KO) mice were
studied by functional, morphological, biochemical, and molecular-biological tech-
niques.
TBC1D4 is highly abundant in the renal tubular system
First, I contributed to studies that localized TBC1D4 along the renal tubular sys-
tem (Lier et al., 2012). Using co-immunostainings for a variety of nephron-specific
marker molecules, immunohistochemistry revealed high levels of TBC1D4 abun-
dance in parietal epithelial cells (PEC) of Bowman’s capsule, in descending and
ascending thin limbs, the thick ascending limb (TAL), the distal convoluted tubule
(DCT), the connecting tubule (CNT) and the collecting duct (CD). This distribution
pattern matches well with the expression of TBC1D4 mRNA levels as determined
later by qRT-PCR on mouse microdissected nephron segments.
TBC1D4 deficiency does not affect renal sodium and water handling
First, TBC1D4 KO mice were grossly phenotyped. Mice were normal in terms of
organ morphology, physical appearance and survival. Urinary ion excretion, osmo-
larity and plasma ion concentrations, as well as blood pressure levels were similar for
wildtype (WT) and TBC1D4 KO mice. Likewise urinary and plasma aldosterone
levels were not different between genotypes. Even when challenged by 2 weeks feed-
ing of a low Na+ and high K+ diet or by 24 hours of water restriction, TBC1D4 KO
mice did not show any phenotype different from the one of WT mice. Consistently,
immunoblotting did not reveal any difference in the abundance of renal ion and
water transporting proteins including ENaC, AQP2, and Na+-K+-ATPase between
genotypes under each condition.
TBC1D4 deficiency improves glucose tolerance
On standard diet and after overnight fasting, TBC1D4 KO mice had lower plasma
glucose and insulin levels than WT mice. The glucose tolerance was slightly im-
proved, whereas the insulin sensitivity was impaired in TBC1D4 KO mice compared
with WT mice. Furthermore, TBC1D4 KO mice gained less bodyweight under a
high fat diet than their WT littermates.
TBC1D4 co-localizes with and appears to regulate GLUT4 in the kidney
As we did not find any evidence that TBC1D4 controls ENaC, AQP2 and Na+-
K+-ATPase in the kidney, we next addressed the question whether TBC1D4 may
also regulate GLUT4 in the kidney. First, we showed by qRT-PCR on microdis-
sected nephron portions and by immunohistochemistry that the distribution pat-
tern of TBC1D4 and GLUT4 mRNA and protein matches very well along the TAL,
DCT, CNT, and CD of WT mice, while TBC1D4 expression in the PEC matched
with the glucose transporter (GLUT1). Interestingly, in TBC1D4 KO mice, renal
GLUT4 and GLUT1 levels were significantly reduced as assessed by immunohisto-
chemistry and immunoblotting. In primary TAL cells isolated from the kidneys of
WT and TBC1D4 KO mice, basal glucose uptake was increased and could not be
anymore stimulated by insulin in TAL cells of TBC1D4 KO mice, consistent with
the metabolic data.
Microarray analysis did not provide evidence for compensatory up-/down-
regulation of proteins involved in regulation of membrane trafficking
To test for potentially up- and/or down-regulated trafficking genes that may com-
pensate for the loss of TBC1D4 in renal epithelia, we isolated by COPAS (complex
object parametric analysis and sorting technique) green fluorescent DCTs from WT
and TBC1D4 KO mice. Microarray analyses revealed no differential regulation of
Rab GAPs and Rab guanine exchange factors (Rab GEFs), other family members
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of the TBC1 family, or other genes involved in membrane trafficking and in salt
and water homeostasis. However, stearoyl-CoA desaturase-1 (Scd1), which is cru-
cial in in fatty acid metabolism, was significantly down-regulated in DCT cells of
TBC1D4 KO mice and warrants future studies. In the context of this thesis, I also
established a human embryonic kidney (HEK293) cell line stably transfected with
the DCT-specific NaCl cotransporter (NCC) in order to have a cell-based assay in
which to study the possible role of TBC1D4 for NCC. However, although functional
assays demonstrated the utility of the cells to study the phosphorylation of NCC,
the project was abandoned as NCC was not targeted to the cell surface in these cells
and as the in vivo studies did not reveal any evidence that TBC1D4 may regulate
renal Na+ transporting proteins.
Summary and Conclusion
In sum, this thesis provides evidence that in contrast to previous findings in vitro,
TBC1D4 does not control ENaC, AQP2 and the Na+-K+-ATPase in the kidney in
vivo. However, TBC1D4 plays a role in whole body glucose homeostasis and appears
not only to control, as previously shown by others, GLUT4 in fat and skeletal muscle
cells, but also in the kidney. In the kidney TBC1D4-regulated and GLUT4-mediated
glucose uptake might supply distal tubule with substrates for anaerobic glycolysis,
which may contribute to the higher ischemic tolerance of distal tubules compared
with proximal tubules. Moreover, TBC1D4-dependent regulation of GLUT4 might
be important in the post-prandial state, where glucose availability and insulin levels
in the blood rise and renal tubular working load increases.
iii
Zusammenfassung
Die Resorption sowie Sekretion von Elektrolyten und Flu¨ssigkeit durch die Nieren
ha¨ngt entscheidend von der Aktivita¨t renaler Ionen- und Wassertransportproteine
an der apikalen und basolateralen Membran in renalen Epithelzellen ab. In den letz-
ten zwei Jahrzehnten konnten mehrere renale Ionen- und Wassertransportproteine
identifiziert werden, jedoch sind die molekularen Mechanismen zur Regulierung der
Aktivita¨t dieser renalen Transportproteine noch weitgehend unbekannt. Interessan-
terweise unterliegt die Kontrolle der Aktivita¨t vieler dieser Ionen- und Wassertrans-
portproteine der Regulierung des Transports zu oder weg von der Plasmamembran.
Fru¨here in vitro Studien in verschiedenen Zellkulturmodellen legten nahe, dass das
Rab GTPase-aktivierende Protein (Rab GAP) TBC1D4 an der Kontrolle des in-
trazellula¨ren Transports des epithelialen Natriumkanals (ENaC), des Wasserkanals
Aquaporin 2 (AQP2), jeweils in der apikalen Membran, und der Na+-K+-ATPase in
der basolateralen Membran in bestimmten Nierenepithelzellen beteiligt ist. TBC1D4
wird vermutet ENaC-, AQP2- und Na+-K+-ATPase-enthaltende Vesikel im Zyto-
plasma zuru¨ckzuhalten und dadurch die Proteinmenge an der Zelloberfla¨chen zu
reduzieren, a¨hnlich wie beim bereits beschriebenen Effekt von TBC1D4 auf den
Glukosetransporter GLUT4 in Fett- und Muskelzellen. Das Ziel dieser Doktorarbeit
war es, die in vivo Rolle von TBC1D4 in den Nieren zu erforschen und die Hypothe-
se zu besta¨tigen, dass TBC1D4 den intrazellula¨ren Transports renaler Ionen- und
Wassertransportproteine kontrolliert. Um dieses Ziel zu erreichen, wurden funktio-
nale, morphologische, biochemische und molekular-biologische Studien an Wildtyp
(WT)- und TBC1D4-Knockout (KO)-Ma¨usen durchgefu¨hrt.
TBC1D4 kommt vermehrt im renalen Tubulussystem vor
Zu Beginn dieser Arbeit habe ich an der Studie zur Lokalisierung von TBC1D4
im renalen Tubulussystem beigetragen (Lier, Gresko, Di Chiara, Loffing-Cueni, &
Loffing, 2012). Durch Ko-Immunofa¨rbung fu¨r verschiedene nephron-spezifische Mar-
kermoleku¨le zeigten immunhistochemische Analysen eine hohe TBC1D4-Expression
in den parietalen Epithelzellen der Bowman-Kapsel, dem absteigenden und aufstei-
genden du¨nnen und dem dicken aufsteigenden Ast der Henleschen Schleife (TAL),
der Pars convoluta des distalen Tubulus (DCT), dem Verbindungstubulus (CNT)
und im Sammelrohr (CD) auf. Das Verteilungsmuster stimmte mit dem TBC1D4
mRNA Expressionsniveau, das spa¨ter durch qRT-PCR in mikrodissektierten Maus-
Nephronsegmente bestimmt wurde, u¨berein.
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Der Verlust von TBC1D4 hat keinen Effekt auf den Salz- und Wasser-
haushalt
Zu Beginn wurden TBC1D4 KO-Ma¨use bezu¨glich augenscheinlicher Abnormalita¨ten
untersucht. TBC1D4 KO-Ma¨use waren hinsichtlich Organmorphologie, physischer
Erscheinung und Lebensdauer unauffa¨llig. Die Ionenausscheidung im Urin sowie die
Osmolarita¨t, die Plasmaionenkonzentration und der Blutdruck waren a¨hnlich zwi-
schen WT- und TBC1D4 KO-Ma¨usen. Zusa¨tzlich waren die Aldosteronspiegel im
Urin und Plasma zwischen den Genotypen unvera¨ndert. Selbst durch Fu¨tterung
einer stimulierenden niedrig Na+-hoch K+-Dia¨t oder durch einen 24-stu¨ndigen Was-
serentzugs zeigten die TBC1D4 KO-Ma¨use keinen vera¨nderten Pha¨notyp im Ver-
gleich zu den WT-Ma¨usen. Damit u¨bereinstimmend waren im Immunoblot keine
Unterschiede in der Proteinmenge renaler Ionen- und Wassertransportproteine, ein-
schliesslich ENaC, AQP und Na+-K+-ATPase, zwischen den Genotypen und unter
verschiedenen Konditionen zu erkennen.
TBC1D4 ko-lokalisiert mit GLUT4 und scheint GLUT4 in der Niere zu
regulieren
Da wir keine Hinweise darauf, dass TBC1D4 ENaC, AQP2 und die Na+-K+-ATPase
in der Niere kontrolliert, gefunden haben, stellten wir uns die Frage, ob TBC1D4
auch GLUT4 in der Niere reguliert. Wir konnten durch qRT-PCR an mikrodissek-
tierten Nephronsegmenten und durch immunohistochemische Analysen eine hohe
U¨bereinstimmung der Gen- und Proteinexpression von TBC1D4 und GLUT4 im
TAL, DCT, CNT und CD zeigen, wa¨hrend die Expression von TBC1D4 in den
parietalen Epithelzellen mit der des GLUT1-Glukosetransporters u¨bereinstimmte.
Interessanterweise zeigten immunohistochemische Analysen und Immunoblotting
in TBC1D4 Ma¨usen reduzierte GLUT4- und GLUT1-Proteinmengen. In prima¨ren
TAL-Zellen, isoliert aus Nieren von WT- und TBC1D4 KO-Ma¨usen, war die basa-
le Glukoseaufnahme erho¨ht und konnte in TAL Zellen von TBC1D4 KO-Ma¨usen
nicht weiter durch Insulin stimuliert werden, was mit den metabolischen Daten
u¨bereinstimmt.
Micoarray-Analysen ergaben keinen Hinweis auf eine kompensatorische
Herauf- oder Herunterregulierung mo¨glicher Proteine beteiligt an der
Membrantransport-Regulierung
Um mo¨gliche herauf- oder herunterregulierte Transport-Gene zu testen, die den Ver-
lust von TBC1D4 in renalen Epithelien kompensieren ko¨nnten, isolierten wir mit
Hilfe der
”
fluoreszenz-aktivierten Sortierung mehrzelliger Objekte“-Technik (CO-
PAS), gru¨n-fluoreszierende DCTs von WT- und TBC1D4 KO-Ma¨usen. Microarray-
Analysen ergaben keine vera¨nderte Regulierung der Rab GAPs und Rab Guanin-
v
Austauschfaktoren (Rab GEFs), Familienmitglieder der TBC1 Familie, sowie ande-
rer Gene beteiligt im Membrantransport und an der Salz- und Wasserhomo¨ostase.
Jedoch war die Expression von Stearoyl-CoA Desaturase-1 (Scd1), ein Gen von
entscheidender Bedeutung im Fettsa¨urestoffwechsel, signifikant in DCT Zellen von
TBC1D4 KO-Ma¨usen herunterreguliert. Dieser Befund garantiert weitere Studien.
Im Zusammenhang mit dieser Dissertation habe ich eine Zellline (HEK293 Zellen)
mit einer stabil-transfektierten Expression des DCT-spezifischen NaCl-Kotranspor-
ters (NCC) entwickelt, welche zur Aufka¨rung einer mo¨glichen Rolle von TBC1D4
auf den NCC dienen sollte. Obwohl funktionale Assays die Nu¨tzlichkeit dieser Zel-
len zur Erforschung der Phosphorylierung von NCC besta¨tigten, wurde das Pro-
jekt eingestellt, da NCC nicht an der Zelloberfla¨che detektiert werden konnte und
in vivo Studien keinen Anhaltspunkt dafu¨r gaben, dass TBC1D4 bei der Regulie-
rung renaler, Na+-transportierender Proteine eine Rolle spielt. Zusammenfassend
belegt diese Dissertation, dass TBC1D4 nicht wie vermutet ENaC, AQP2 und die
Na+-K+-ATPase in der Niere in vivo reguliert. TBC1D4 spielt jedoch eine Rol-
le in der systemischen Glukosehomo¨ostase und scheint nicht nur, wie zuvor durch
andere Gruppen beschrieben GLUT4 im Fett- und Skelettmuskelzellen zu regulie-
ren, sondern auch in der Niere. In der Niere, ko¨nnte die TBC1D4-regulierte und
durch GLUT4-vermittelte Glukoseaufnahme die distalen Tubuli mit Substraten fu¨r
die anaerobe Glykolyse versorgen. Diese erho¨hte Zufuhr von Glukose ko¨nnte zu
einer verbesserten ischa¨mischen Toleranz der distalen Tubuli gegenu¨ber der proxi-
malen Tubuli beitragen. Des Weiteren ko¨nnte die TBC1D4-abha¨ngige Regulation
von GLUT4 nach Aufnahme einer Mahlzeit (postprandial) von Bedeutung sein, da
in dieser Phase die Glukoseverfu¨gbarkeit und die Insulinspiegel im Blut steigen und
sich die Arbeitsbelastung des renalen Tubulus erho¨ht.
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1 Introduction
1.1 The mammalian kidney
The mammalian kidneys are paired, bean-shaped organs lying on each side of the
vertebral column behind the abdominal cavity. A thin renal capsule covers the
kidney and provides stability and protection. The so-called hilus is the only opening
of the capsule and the entry site for the renal artery and nerves. The hilus is also
the exit site for the renal vein, ureter and lymphatics. Although the kidneys only
represent 0.5% of the total body weight, they receive 20 % of the cardiac output
[Boron and Boulpaep, 2009]. This seemingly disproportional distribution of blood
is in fact crucial to maintain salt and water homeostasis, as will be covered in the
following sections. The kidneys consist of two regions, a granular outer region (the
cortex) and inner region (the medulla), the latter comprising an outer and an inner
portion (Figure 1). The kidneys serve several whole body-homeostatic functions,
such as the regulation of electrolytes and water, blood pressure and the maintenance
of acid-base balance.
Furthermore, the kidneys filtrate and excrete toxic metabolites and waste products
(e.g. urea, ammonium, K+, organic acids and bases) from the blood, reabsorb impor-
tant nutrients (glucose, amino acids) and produce hormones (renin, erythropoetin,
calcitriol). The nephron is the functional unit of the kidney where fluid filtration,
secretion and reabsorption takes place (Figure 1). The number of nephrons is lin-
early correlated with body weight. The kidney of a mouse contains around 15.000
nephrons, whereas that of a rat possess 30.000-40.000, a human 1 - 1.4 million and
an elephant around 7.5 million [Alpern et al., 2013].
Each nephron consists of vascular loops in the Bowman’s capsule, called the glomeru-
lus, and a tubular system, which forms urine from the primary filtrate in the tubular
lumen. Upon entering the vascular pole from afferent arterioles, blood is drained
through the glomerular filtration barrier formed by fenestrated endothelial cells,
the glomerular basement membrane (GBM) and slit diaphragms of interdigitating
foot processes of podocytes [Boron and Boulpaep, 2009] (Figure 2). The resultant
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Figure 1: The functional unit of the kidneys: the nephron One nephron con-
sists of a filtration unit, the glomerulus, and a tubular system divided
into proximal tubule (PT), thin limbs of Henle’s loop (TL), the thick as-
cending limb of Henle’s loop (TAL), the early and late distal convoluted
tubule (DCT1 and DCT2) and the connecting tubule (CNT). Around 5-8
nephrons end in one common collecting duct (CD). The transition from
the cortex to the outer medulla is marked by the PT leading into the TL
and the transition from outer to inner medulla is marked by the TL leading
into the TAL. (Picture kindly provided by J. Loffing and B. Kaissling.)
ultrafiltrate [liquids, small solutes (< 5 nm) and proteins < 65 kDa] enters the
Bowmans space and is further processed as it moves along the tubule. The tubular
segment includes the proximal tubule (PT) divided into the proximal convoluted
tubule (PCT), the proximal straight tubule (PST) or S1, S2, and S3 segment, the
thin limbs of Henle’s loop (TL) divided into descending and ascending thin limps
(DTL and ATL), and the distal nephron. The distal nephron is especially important
for the fine-tuning of ion excretion (e.g. Na+, K+, HCO3
−), for the regulation of
pH, and for the reabsorption of water. Within this distal part are five distinguish-
able segments, namely; the thick ascending limb of Henle’s loop (TAL), the early
and late distal convoluted tubule (DCT1 and DCT2, respectively), the connecting
tubule (CNT), and the collecting duct (CD). Each segment fulfills specific task(s)
and underlies definite regulatory mechanisms, which are discussed in detail in the
next chapters.
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Figure 2: The filtration unit of a nephron: the glomerulus The formation of
urine starts with blood entering from afferent arterioles at the vascular
pole into the Bowman’s capsule and being filtrated through fenestrations
in the endothelial layer, the glomerular basement membrane (GBM) and
slit diaphragms of podocytes. This pre-urine formed in the Bowman’s
space is further process as it leaves the glomerulus at the urinary pole.
(Picture modified from Wikipedia glomerulus)
1.2 Na+ reabsorption along the nephron
One important function of the kidney is to maintain ion- and water homeostasis in
the body. Na+ reabsorption is of particular interest as it regulates extracellular fluid
osmolality and volume. Above 99 % of Na+ is reabsorbed via transepithelial trans-
port along the nephron [Boron and Boulpaep, 2009]. The major driving-force for this
transepithelial Na+ transport and basically all transport processes in the kidney is
generated through the Na+-K+-ATPase; a pump expressed at the basolateral mem-
brane of each nephron segment. Through ATP consumption, the Na+-K+-ATPase
takes up two K+ and extrudes three Na+ ions against its concentration gradient out
of the cell creating a low [Na+]i and a negative cell voltage [reviewed in Curthoys
and Moe [2014]]. This gradient allows for Na+-uptake by co- or counter-transport
of various substrates (e.g. glucose, amino acids, phosphate, and sulfate) (Figure 3).
In the PT, most of the Na+ (around 60 %) in the ultrafiltrate is taken up through
the apical membrane by Na+-coupled or -exchange secondary active transport pro-
cesses, e.g. by the Na+-glucose co-transporter 1 (SGLT1; Slc5a1) or 2 (SGLT2;
Slc5a2), which co-transports one glucose molecule together with two or one Na+,
respectively. Phosphate is primarily taken up by the type IIa Na+-coupled phos-
3
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Figure 3: Schematic overview of sodium-dependent transcellular transport
processes in PT cells A transport gradient for Na+ from the luminal
(urine) side to the blood side is generated via the ATP-consuming Na+-K+-
ATPase leading to a low intracellular Na+ concentration and a negative
cell potential used for Na+-mediated uptake (Y) and excretion (X) of
various substrates (e.g. glucose, phosphate, sulfate). (Picture modified
from Curthoys and Moe [2014].)
phate co-transporter (NaPi-IIa; Slc34a1) [Bacic et al., 2004; Hernando et al., 2000;
Villa-Bellosta et al., 2009]. Next to the Na+-coupled co-transport, Na+ entry is
also achieved by e.g. the electroneutral Na+-hydrogen-exchanger 3 (NHE3; Slc9a3).
A modest increase in Na+-hydrogen-exchange has been described during increased
glomerular filtration rate (GFR) accompanied by volume expansion [Zhou et al.,
2006]. In addition, different neurohormonal and dietary influences can modify
Na+ reabsorption in the PT. The two catecholamines, namely norepinephrine and
epinephrine, low angiotensin II levels and a low Na+ intake all have stimulatory
effects on Na+ uptake [Hall et al., 1998; McDonough, 2010; Riquier-Brison et al.,
2010], whereas dopamine, high angiotensin II levels and a high Na+ diet have in-
hibitory effects on Na+ uptake [Hegde et al., 1989; McDonough, 2010; Wang et al.,
1993]. In the TAL, about 30 % of the filtered Na+ is reabsorbed by the Na+-K+-
2Cl− co-transporter (NKCC2; Slc12a2). Crucial for the functioning of NKCC2 is the
lumen-positive, transepithelial potential difference generated by the potassium in-
wardly rectifying channel (ROMK; Kcjn1). Gene mutations in NKCC2, ROMK, the
chloride channel Kb (ClCKb; CLCNKB), barttin (barttin; BSND) and the calcium
ion-sensing receptor (CaR; Casr) cause Bartter syndrome I-V, respectively. Pa-
tients with Bartter syndrome present symptoms of renal salt wasting, hypokalemic
metabolic alkalosis, hypercalciuria, and lowered blood pressure (reviewed in Rossier
et al. [2013]). NKCC2 activity can be antagonized with pharmacological agents
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known collectively as loop diuretics (e.g. furosemide and bumetanide), which pre-
vent NaCl reabsorption in this nephron section. The TAL is also an important
segment for paracellular uptake of Na+, Ca2+ and Mg2+. The final adjustment of
urinary [Na+] occurs in the distal segments. In the DCT, 8 % of Na+ is reabsorbed
by the thiazide-sensitive NaCl co-transporter (NCC; Slc12a3), which is expressed at
the apical membrane. The late DCT (DCT2) can be distinguished from the early
DCT (DCT1) by the co-expression of the amiloride-sensitive epithelial Na+ chan-
nel (ENaC; Scnn1) [Loffing et al., 2001]. Loss-of-function mutations in the human
NCC gene cause Gitelman’s syndrome (familial hypokalemia-hypomagnesemia) with
symptomes such as hypokalemic metabolic alkalosis, hypomagnesima and hypercal-
cemia [Mastroianni et al., 1996; Monkawa et al., 2000]. In addition, the DCT is
crucial for Mg2+ homeostasis mediating active magnesium uptake by the transient
receptor cation potential channel (TRPM6; Trpm6), which colocalizes with the cy-
toplasmic Mg2+- and Ca2+-binding protein parvalbumin (PV; Pvalb) in the DCT1
[Voets et al., 2004] Furthermore, the DCT regulates around 15 % of the filtered load
of Ca2+ by transcellular Ca2+ transport through the apical Ca2+ channel (ECaC1;
Trpv5), the cytosolic calcium-binding protein calbindin D28K (CBP-D28k; Calb1)
and the basolateral Na+-Ca2+-exchanger (NCX1; Scl8a1), from the late DCT con-
tinuing on to the CNT [Hoenderop et al., 2001; Loffing et al., 2001; Loffing and
Kaissling, 2003; Reilly et al., 1993]. In the CNT and CD, ENaC takes up most of
the remaining Na+ (1-2%). The major hormone regulating ENaC function is al-
dosterone; thus the nephron segments expressing ENaC are also referred to as the
aldosterone-sensitive distal nephron (ASDN), which includes the DCT2, CNT and
CD. Alongside ENaC expression, hallmarks of the ASDN are the expression of the
mineralocorticoid receptor (MR; Nr3c2) and the 11β-hydroxysteroid dehydrogenase-
2 enzyme (11β-HSD2; hsd11b2), which counteracts inappropriate MR activation via
glucocorticoids, whose plasma levels exceed 100-1000 times the levels of plasma min-
eralocorticoids [Bostanjoglo et al., 1998; Loffing and Kaissling, 2003]. Detailed pro-
cesses in the regulation of distal Na+ transporting proteins (NKCC2, NCC, ENaC
and the Na+-K+-ATPase) are described in the upcoming sections.
1.3 Regulation of NKCC2, NCC, ENaC and the
Na+-K+-ATPase
Na+ reabsorption in the TAL is increased by an augmentation of intracellular cAMP
levels through various hormones, particularly vasopressin, but also parathyroid hor-
mone (PTH), glucagon and calcitonin [Bailly, 1998]. The responsiveness to vaso-
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pressin in the TAL underlines the synergism of H2O conservation with i) its effects
upon the TAL, the main diluting segment modulating medullary osmolality, and ii)
its major target, the CD, where the adjustment of final urine volume occurs [Bren-
ner and Rector, 2004]. Through binding of the peptide hormone to its receptor, the
vasopressin receptor V2, the G-stimulatory protein (Gs) activates the adenyl cy-
lase (AC), which leads to an increase in the intracellular second messenger (cAMP)
concentration. In turn, enhanced concentrations of cAMP lead to i) augmented ex-
ocytosis and phosphorylation of NKCC2 at the apical membrane, via protein kinase
A (PKA) at position serine 126 (Ser126) [Knepper et al., 1999; Rieg et al., 2013]
and/or ii) increased transcription of NKCC2 (as suggested by the cAMP response
element in the 5’-promoter region of this gene) [Knepper et al., 1999; Mount, 2006].
In the last few years, studies on the regulatory mechanisms of NCC function and salt
reabsorption in the DCT have focused on the WNK-SPAK/ORS1 pathway [reviewed
in [Gamba, 2012]] (Figure 4). WNK [with no lysine (K) protein kinase] proteins are
serine/threonine kinases lacking a highly conserved lysine in their catalytic domain
[Wilson et al., 2001; Xu et al., 2005]. The WNK family contains four members,
named WNK1-4 [McCormick and Ellison, 2011].
Figure 4: Regulatory mechanisms of NCC phosphorylation via the WNK-
SPAK/ORS1 pathway NCC phosphorylation and thus activity is reg-
ulated via Ser/Thr kinases such as WNK1 (stimulatory; in green) and
WNK4 (inhibitory; in red) and the STE20/SPS1-related proline/alanine-
rich kinase (SPAK) and the oxidative stress response kinase-1 (OSR1)
(both stimulatory) [Kahle et al., 2010]. Hormones and mutations in the
WNK4 gene causing familial hyperkalemic hypertension (FHHt) can con-
vert WNK4 to an activator of NCC. WNK4 is further regulated via two
splice variants of WNK1, the long isoform (L-WNK1) suppressing WNK4
activity thus activating NCC and the kidney specific isoform (KS-WNK1)
suppressing L-WNK1. (Kindly provided by J. Loffing)
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So far, WNK1, WNK3 and WNK4 have been identified as being involved in re-
nal NCC-regulation [reviewed in Gamba [2012]]. WNK proteins can also regulate
the activity of other WNK kinases. For example, the ubiquitously expressed full-
length WNK1 with kinase activity (L-WNK1) suppresses WNK4, what leads to
up-regulation of NCC activity [Yang et al., 2005]. The kidney-specific short isoform
(KS-WNK1), whose expression is restricted to the distal nephron, inhibits L-WNK1
[Subramanya et al., 2006]. KS-WNK1 is hypothesized to be a negative regulator of
L-WNK1 catalytic domain, as it itself bears no kinase activity [Kroiher et al., 2001]
(Figure 4). Gene mutations in WNK1 (Wnk1) and WNK4 (Wnk4) are causative
for pseudohypoaldosteronism type II (PHAII), also known as familial hyperkalemic
hypertension (FHHt) or Gordon’s syndrome with symptoms including hyperten-
sion, hyperkalemia, hyperchloremic metabolic acidosis and hypercalciuria [Wilson
et al., 2001; Yang et al., 2007]. The phenotype of this disease, which resembles an
NCC-gain-of-function mutation, mirrors the phenotype of Gitelman’s syndrome and
can be normalized via thiazide-treatment [Mayan et al., 2002]. Thiazides, or more
precisely hydrochlorothiazides, are a class of diuretic drugs known to specifically
inhibit NCC. Moreover, hormones such as aldosterone, angiotensin II and insulin
can alter NCC activity via their effects upon WNK4-signalling [Lai et al., 2012;
San-Cristobal et al., 2009; Sohara et al., 2011; Susa et al., 2012]. The interaction of
WNK-activation and NCC-phosphorylation is not direct, but is rather mediated via
the protein kinase of the STE20 family termed STE20/SPS1-related proline/alanine-
rich kinase (SPAK) and the oxidative stress response kinase-1 (OSR1) (Figure 5)
[Vitari et al., 2005]. WNK1 and WNK4 activate SPAK/ORS1 by phosphorylation
of a conserved threonine residue in the T-loop of the kinase domain (Thr233 for
SPAK and Thr185 for ORS1) [Vitari et al., 2005] (Figure 5).
Activated SPAK/ORS1 have been shown to phosphorylate NKCC1, NKCC2 and
NCC on serine/threonine residues in the cytosolic N-terminus (Figure 5) [Mercier-
Zuber and O’Shaughnessy, 2011]. An important phosphorylation site for SPAK/-
ORS1 is Thr60 in the human NCC (Thr58 in murine NCC). In patients with Gitel-
man syndrome, defective phosphorylation at Thr60 abolishes NCC activity and
also reduces adjacent phosporylation at Thr46 and Thr55 [Pacheco-Alvarez et al.,
2006; Richardson et al., 2008]. On the other hand, in WNK48D561A/+ knock-in
mice Thr53, Thr58 and serine 71 (Ser71) (human Thr55, Thr60 and Ser73) are
constitutively phosphorylated resulting in PHAII [Yang et al., 2007]. Moreover,
SPAK-mediated regulation of NKCC2 and NCC has been suggested to be inversely
regulated: while deletion of SPAK increases NKCC2, it diminishes NCC activity.
Moreover, the kidney-specific SPAK isoform (KS-SPAK), preferentially expressed
in the TAL, is suggested to be a putative inhibitor of NKCC2, whereas full-length
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Figure 5: Phosphorylation of SPAK/ORS1 by WNK and NKCC1, NKCC2
and NCC by SPAK/ORS1 WNKs regulate SPAK/ORS1 via phospho-
rylation at Thr233 (SPAK) and Thr185 (ORS1) in their kinase domain.
On the other hand, SPAK and ORS1 phosphorylate NKCC1, NKCC2
and NCC at conserved Ser/Thr residues in the N-terminus (adapted from
Vitari et al. [2005])
.
SPAK, preferentially expressed in the DCT, primarily activates NCC [McCormick
et al., 2011]. Recently, another inactive SPAK isoform (SPAK2) has been discov-
ered in the kidney; this kinase has also been shown to inhibit NKCC2 function, but
to a lesser extent than KS-SPAK [Park et al., 2013]. Further regulatory proteins
in the DCT affecting renal salt homeostasis and blood pressure control are the co-
factor y-adducin, which modulates NCC activity in its dephosphorylated state in
a dose-dependent manner [Dimke et al., 2011]; the protein phosphatase 4 (PP4),
which inhibits NCC activity through the interference with the Thr58 phosphoryla-
tion site (pT58) [Glover et al., 2010]; and the hormone vasopressin [Mutig et al.,
2010] [Pedersen et al., 2010; Saritas et al., 2013]. However, it is still unclear whether
the vasopressin-mediated regulation of NCC is a direct or indirect effect. In fact,
previous ex vivo data on isolated mouse DCTs did not show any increase in intra-
cellular cAMP levels in response to the synthetic analogue of vasopressin, dDAVP
(1-desamino-8-D-arginine vasopressin) [Imbert et al., 1975]. Recently, the protein
phosphatase 1 inhibitor 1 (I1) and the protein kinase D1 (PKD1) have been shown
to modulate the phosphorylation status of NCC [Picard et al., 2014; Trompf, 2013].
In addition, the aldosterone-induced protein serum- and glucocorticoid-inducible
kinase 1 (SGK1) and ubiquitylation might play a role in the control of the thiazide-
sensitive co-transporter [Vallon et al., 2009] (see section below). In the ASDN, ENaC
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is crucial for extracellular fluid maintenance, Na+ and K+ homeostasis and blood
pressure control. Hormones, posttranslational modifications (e.g. phosphorylation,
ubiquitylation), trafficking, and proteolytic cleavage can all influence the activity
of the channel. The mineralocorticosteroid aldosterone, the main hormone activat-
ing ENaC, passes the cell membrane unrestricted and causes different intracellular
events. I) Aldosterone is thought to bind to the MR. The MR is then translocated to
the nucleus, where it acts as transcription factor initiating the transcription through
cis-elements in the 5’ flanking region of the Scnn1a gene-promoter [Mick et al., 2001].
ENaC consists of three subunits, namely α, β, and γ with each subunit possessing
two transmembrane domains (M1 and M2) connected by a long extracellular loop.
Transcriptional activation of α-ENaC with subsequent assembling of the cytoplasmic
β- and γ-subunits is thought to be one of the determining steps for the processing
and trafficking of functional Na+ channels to the cell surface. II) Aldosterone is
thought to induce SGK1 expression. SGK1 decreases the ability of Nedd4-2, an E3
ubiquitin-protein ligase, to degrade ENaC via ubiquitylation. As shown from ex-
periments in human embryonic kidney 293 cells (HEK293), SGK1-phosphorylation
at position Thr246 in the conserved tryptophan domain (WW domain) of the hu-
man Nedd4-2 leads to sequestration of Nedd4-2 to the scaffolding proteins 14-3-3
[Wiemuth et al., 2010]. Under non-stimulated conditions, Nedd4-2 interacts via its
WW domain with a proline- and tyrosine-rich PPXY (PY) motif in the C-terminus
of ENaC resulting in increased ubiquitylation, decreased membrane abundance and
proteasomal degradation [Staub et al., 1996]. In addition to the Nedd4-2-ENaC regu-
lation, the ligase has also been shown to downregulate apical NCC expression [Arroyo
et al., 2011]. Here again, the interaction between Nedd4-2 and NCC is abrogated
through SGK1, although in contrast to ENaC, Nedd4-2-mediated NCC-inhibition
does not occur via a PY motif. Furthermore, Vallon and coworkers demonstrated
that SGK1 affects NCC expression and phosphorylation by using an SGK1-knockout
(KO) mouse line [Vallon et al., 2009]. Interestingly, SGK1 has also been shown to
be involved in the WNK4-signaling pathway [Rozansky et al., 2009]. In the Xenopus
leavis oocyte expression system, the kinase phosphorylates WNK4 at pS1169 and
pS1196 and thus attenuates the inhibitory effect of WNK4 on NCC activity. Other
volume regulating hormones are known to increase (e.g. vasopressin, insulin) or to
decrease [(e.g. atrial natriuretic peptide (ANP), endothelin-1 (ET-1)] [Pandit et al.,
2012; Wang et al., 2006] ENaC-dependent Na+ reabsorption. Ergonul and collabo-
rators showed a proteolytic cleavage in the α- and γ-ENaC subunits in the kidneys
of rats restricted from Na+ or treated with aldosterone. This cleavage resulted via
ENaC-activation proteases, such as furin, elastase, and prostasin [also called channel
activating protease 1 (CAP1)] through the excision of an inhibitory peptide within
the extracellular loop. α-ENaC increased in a 85 kDa and a cleaved 30 kDa protein,
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whereas γ-ENaC showed an increase of an excised 70 kDa protein and a decrease
in the 90 kDa γ-subunit [Ergonul et al., 2006]. The relevance for this plethora of
ENaC regulatory mechanisms becomes apparent in pathophysiologcial states. Loss-
of-function mutations in either MR or ENaC cause salt wasting, dehydration, growth
retardation, hyperkalemia and metabolic acidosis. This clinical picture is also re-
ferred as pseudohypoaldosteronism type I (PHAI). Most prominently, mutations in
the PY domain in one of the three ENaC subunits prevents Nedd4-2 ubiquitylation
resulting in a gain-of-function mutation referred as Liddle’s syndrome. Some charac-
teristic symptoms are salt-sensitive hypertension, hypokalemia, metabolic alkalosis,
low plasma renin levels, and suppressed aldosterone secretion. Spironolactone and
eplerenone, two pharmaceutical MR antagonists, can inhibit MR-dependent ENaC
activity [Brown et al., 2003], whereas diuretics such as amiloride, benzamil and
phenamil act directly on ENaC [Benos, 1982; Canessa et al., 1994; Kleyman and
Cragoe, 1988].
Summa and coworkers have shown that aldosterone can also regulate the Na+-K+-
ATPase [Summa et al., 2001]. The Na+-K+-ATPase consists of a heterotrimeric
complex formed by a “catalytic” α-subunit, a β-subunit (important for the mat-
uration and insertion of the Na+-K+-ATPase) and an additional γ-subunit, which
is only expressed in certain tissues and not required for normal protein function
[Geering, 1990; Gottardi and Caplan, 1993]. The Na+-K+-ATPase has been shown
in intracellular pools [Barlet-Bas et al., 1990; Horisberger and Rossier, 1992], which
can be rapidly recruited to the plasma membrane by hormonal and intracellular
stimuli (e.g. aldosterone and cAMP). This rapid effect is known as short-term con-
trol [Gonin et al., 2001; Kiroytcheva et al., 1999; Summa et al., 2001]. On the other
hand, long-term regulation relies on de novo synthesis and transcriptional regula-
tion of the Na+-K+-ATPase [Barlet-Bas et al., 1990]. Furthermore, several other
hormones have been shown to regulate the translocation and cell surface abundance
of the Na+-K+-ATPase, such as dopamine [Chibalin et al., 1999], promoting its en-
docytosis, or vasopressin [Fe´raille et al., 2003], mediating a rapid translocation of
intracellular pools similar to aldosterone. In addition, insulin has also been demon-
strated to control the Na+-K+-ATPase [Comellas et al., 2010], what will be described
in the upcoming sections.
1.4 Water reabsorption along the nephron
Maintaining the body’s H2O homeostasis, blood pressure, volume, and osmolarity
are some of the most crucial physiological tasks of the kidneys. The glomeruli fil-
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trate around 180 l of fluid per day, yet only 1-1.5 l are excreted as urine. Therefore,
the excretion of urine accounts for less than 1 % of total filtrate. Distribution-wise,
67 % of the filtered water is reabsorbed in the PT, 15 % in the DTL and the final
urinary volume concentration is determined via regulated water reabsorption in the
CNT and CD, explained in detail in the next sections. Although water can diffuse
through lipid bilayers, insertion of water channels, so-called aquaporins (AQPs), can
greatly increase the permeability. 13 mammalian AQPs are known so far (AQP0-
12), all small proteins of around 30 kDa and of which eight are expressed in the
kidney [Nielsen et al., 2002]. The most important AQPs involved in renal water
reabsorption are AQP1-4 (Figure 6). AQP1 is expressed at both the apical and
basolateral side of PT and DLT cells and reabsorbs water in a transcellular and
active, near iso-osmolar, manner. In AQP1-deficient mice, Ma and coworkers have
shown a marked decrease in urinary osmolarity, which might be due to a defect in
the formation of a hypertonic medullary interstitium [Ma et al., 1998]. In humans, a
loss-of-function mutation in AQP1 leads to a urinary concentrating inability during
water restriction (WR) [King et al., 2001]. Starting from the CNT, expression of
AQP3 and AQP4 is found at the basolateral membrane, whereas AQP2 is primarily
found in the apical membrane, although a weak expression has been observed in
the basolateral membrane [Christensen et al., 2003]. AQP2 expression and localiza-
tion is tightly regulated via different mechanisms (e.g. hormones, phosphorylation,
ubiquitylation, trafficking). The main AQP2-controlling hormone is vasopressin,
also known as arginine vasopressin (AVP) or antidiuretic hormone (ADH). Under
conditions such as hypernatremia or hypovolemia, vasopressin is secreted from the
posterior pituitary into the blood stream and transported to the kidneys where
it binds to the basolateral V2 receptor, starting an intracellular signaling cascade
leading to increased intracellular cAMP levels (see also 1.3, regulation of NKCC2).
Further on, phosphorylation of AQP2 at pS256 via PKA has been demonstrated to
be involved in the trafficking of AQP2 from intracellular vesicles to the apical mem-
brane [Kamsteeg et al., 2000; Katsura et al., 1997]. Endocytosis with intracellular
storage and/or lysosomal degradation of AQP2 is mediated via ubiquitylation at
lysine 270 (Lys270) [Kamsteeg et al., 1999, 2006].
Moreover, several other factors are important for AQP2 regulation, e.g. angiotensin
II [Stegbauer et al., 2011], extracellular tonicity [Hasler et al., 2005], long-term
aldosterone treatment [Hasler et al., 2003] and insulin[Bustamante et al., 2005].
Furthermore, different mouse models show evidence for the essential function of
AQP2: CD-specific AQP2 deletion causes polyuria with a decrease in urine osmo-
larity [Rojek et al., 2006]. Similarly, this could be observed in a CD-inducible AQP2
gene deletion mouse model and in CNT-specific AQP2 knockout mice [Korteno-
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Figure 6: Distribution of AQPs along the human nephron AQP1 (light blue)
is expressed at the apical and basolateral side of the PT and DLT, AQP2
at the apical side and AQP3 at the basolateral side from the CNT on to
the CD. AQP4 can be found at the basolateral side of the inner medulla
CD (IMCD) (AQP2-4: dark blue). OMCD = outer medulla CD. [Hasler
et al., 2009]
even et al., 2013; Yang et al., 2006]. Nevertheless, CNT-AQP2 knockout mice are
able to decrease urine volume when circulating plasma vasopressin levels are high
[Kortenoeven et al., 2013]. Whereas mice bearing a total AQP2 gene deletion die
within days after birth [Rojek et al., 2006], a loss-of-function mutation of AQP2 in
humans is not known to be lethal (reviewed in [Robben et al., 2006]). However,
these patients do represent a disability in concentrating urine. This syndrome is
known as nephrogenic diabetes insipidus (NDI) (reviewed in Robben et al. [2006]).
Not only loss-of-function mutation in AQP2, but also in the V2 receptors or in one
of the proteins involved in the signaling cascade can cause NDI. In the case of cen-
tral diabetes insipidus (CDI), where vasopressin production and/or secretion in the
brain is impaired, patients show polyuria and polydipsia [Saito et al., 1997, 1999].
Administration of dDAVP rescues the phenotype in these patients, whereas in NDI
patients, administration of dDAVP has no effect and hence cannot prevent polyuria
and polydipsia. Overall, APQs in the kidney, especially AQP1 in the proximal and
AQP2 in the distal nephron, fulfill important roles in renal water handling.
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1.5 Rab-GTPases
As described above, a key aspect in the regulation of many renal transporters and
channels (e.g. NKCC2, NCC, ENaC, AQP2 and the Na+-K+-ATPase) is their tem-
poral and spatial localization. Especially in polarized cells, as it is primarily the case
in the kidney, a determined positioning between intracellular membrane compart-
ments is indispensable. Mediating the budding of vesicles from donor membranes
and the transport, fusion and docking of these cargo-vesicles to specific acceptor
membranes is carried out by so-called Rab GTPases (simplified Rab proteins), which
are part of the small GTPases Ras superfamily. Rab GTPases form the largest group
of the > 100 members of the Ras superfamily with 66 Rab GTPases known in hu-
mans and around 11 known in yeast, named Yptp/Sec4p [Pereira-Leal and Seabra,
2000; Schwartz et al., 2007]. Rab GTPases function as molecular switches, changing
between two conformational states: the GDP-bound, “off” and the GTP-bound,
“on” state. The conversion between the GDP- and GTP-bound form occurs in spe-
cific regions of the Rab protein, termed switch I, switch II and interswitch. These
regions are known to interact with Rab effector proteins. GTP-binding is facilitated
through guanine exchange factors (GEFs) as GDP is bound very tightly and cy-
tosolic GTP levels are relatively high (1 mM). Although Rab GTPases are able to
hydrolyze GTP to GDP at a low intrinsic rate, hydrolysis is enhanced via GTPase
activating proteins (GAPs), which terminate the active, GTP-bound state of Rab
GTPases (see 1.6). Beyond this simplicity, there are further proteins involved in
the circuitry, e.g. the Rab escort protein (REP), geranylgeranyl transferase (GGT),
the Rab GDP dissociation inhibitor (GDI) and the GDI displacement factor (GDF)
(Figure 7). However, the functional description of these proteins goes beyond the
scope of this thesis.
In his review “Rab GTPases as coordinators of vesicle transport”, Stenmark de-
scribes the faith of Rab proteins from vesicle sorting over to vesicle uncoating, motil-
ity, tethering and fusion/docking [Stenmark, 2009]. During vesicle motility, Rab GT-
Pases, as exemplified for Rab27, together with motor proteins (e.g. myosin Va) pro-
pel cargo-vesicles along microtubules and actin filaments [Wu et al., 2002]. In neu-
ronal exocytosis, membrane fusion with v (vesicle)-SNAREs (soluble N-ethylmalei-
mide sensitive factor attachment protein receptor) such as the VAMP2 (vesicle-
membrane associated protein) on cargo-vesicles and the t (target)-SNAREs [e.g.
syntaxin, synaptosomal protein 25 (SNAP25)] on plasma membranes is mediated
via Rab27A and Rab3A and their effector protein, rabphilin [Tsuboi and Fukuda,
2005]. In summary, Rab proteins are master regulators of secretory and endocytotic
pathways. The finding of distinct Rab GTPases being expressed solely in certain
13
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Figure 7: Rab GTPase-regulated vesicular trafficking (I/II) Rab GTPases
activating proteins (GAPs) hydrolyze GTP to GDP, inactivating RabGT-
Pases whereas guanine exchange factors (GEFs) catalyze GDP to GTP,
activating Rab proteins. Other factors for the regulation and stabilization
of RabGTPases to GDP are the Rab escort protein (REP), geranylgeranyl
transferase (GGT), the Rab GDP dissociation inhibitor (GDI) and the
GDI displacement factor (GDF). In the active state, RabGTPases bind to
their effector proteins [Stenmark, 2009].
membranes makes them suitable molecular markers for different membrane compart-
ments. As exemplified, Rab13 represents tight junctions, whereas Rab10 has been
found in GLUT4 storage vesicles (GSV). Rab14 is used as a marker for GLUT4
containing-endosomes, and Rab4A, 4B and 8A are used to stain early endosomes
[Chen and Lippincott-Schwartz, 2013a,b]. Furthermore, some Rab proteins are cell-
type or cell specific, e.g. Rab17 is only expressed in epithelial cells and Rab3 is
specifically found in neurons [Stenmark, 2009].
1.6 Rab GEFs and GAPs
The key switch for Rab GTPases activation is the exchange of GDP to GTP, re-
alized by the GEFs (see 1.6.1, Figure 8). The counter-acting part, leading to the
inactivation of Rab proteins and thus to a hold in trafficking are the Rab GAPs (see
1.6.2, Figure 8).
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Figure 8: Rab GTPase-regulated vesicular trafficking (II/II) Activating en-
zymes, so-called guanine exchange factors (GEFs), lead to the binding
of Rab proteins to GTP and their specific effector proteins in order to
direct the transport of vesicles and organelles. Rab GTPases activating
proteins (GAPs) of the TBC- and Rab3GAP-family hydrolyze GTP to
GDP, inactivating Rab proteins [Fukuda, 2011].
1.6.1 Rab GEFs
Many efforts have been undertaken to analyze the interaction between Rab GT-
Pases and GEFs. Yoshimura and coworkers described 17 GEFs of the DENN
(DENN/MADD domain containing)/connecdenn family and their specificity to-
wards Rab GTPases in humans [Yoshimura et al., 2010]. The GEF DENND1A
activates Rab35 and binds to clathrin and clathrin adaptor protein 2 (AP2) of early
endosomes. DENND2 helps recycling mannose-6-phosphate receptor from late endo-
somes back to the trans-Gogli network (TGN) together with Rab9 [Lombardi et al.,
1993; Riederer et al., 1994]. Moreover, Rab8 and Rab10 have been found to be
key players in apical and basolateral trafficking, respectively, with Rab8 functioning
primarily in the transport of actin-rich membrane protrusions [Pera¨nen et al., 1996]
and in the primary cilium [Yoshimura et al., 2007]. Mutations in the fly homolog of
DENND4, CRAG, showed defects in polarized sorting similar to inactivation of Rab8
and Rab10 in Madin-Darby canine kidney cells (MDCK) [Denef et al., 2008; Schuck
et al., 2007]. Recently, Sano and collaborators showed that DENND4c, known as a
Rab10-GEF, is part of the GLUT4 trafficking-cascade upon insulin-stimulation in
adipocytes [Sano et al., 2011]. GEFs are very important for intracellular traffick-
ing and regulation of Rab proteins, and research on DENN proteins just is in the
fledgling states.
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1.6.2 Rab GAPs
A key and one of the best-characterized members of the family of Rab GAPs con-
tains the Tre2-Bub2-Cdc16 (TBC)-domain, which facilitates Rab protein inactiva-
tion. The TBC-domain was first described as a conserved domain among the tre-2
oncogene and yeast cell cycle regulators Bub2 and Cdc16 and consists of around
200 amino acids. So far, more than 40 proteins possessing the TBC-domain, also
termed GAP domain, are known in humans and mice. Furthermore, GAPs are char-
acterized through two amino acids in their TBC domain, forming the catalytic site
responsible for GTP hydrolysis: arginine (R) and glutamine (Q) or the RQ finger
[Albert et al., 1999]. Only 29 GAPs have been shown to possess the RQ finger,
whereas other TBC-domain containing GAPs have a replacement of either R or Q
with another amino acid or neither R nor Q. It is suggested that these GAPs might
be inactive, but this has still to be clarified.
1.7 TBC1D4
1.7.1 Expression and structure
One Rab GAP that received increasing attention in the last couple of years because
of its implication in the regulation of glucose homeostasis is TBC1D4. TBC1D4
is highly conserved among mammalian species. The GAP enzyme is expressed on
chromosome 13 and 14 in humans and mice, respectively. The murine protein con-
sists of around 1300 amino acids with a molecular weight of approximately 160 kDa
(Figure 9). In the literature, TBC1D4 is also referred to as Akt substrate of 160
kDa (AS160). Indeed, TBC1D4 was found after a screen for novel substrates of
the seronine/threonine kinase Akt (or protein kinase B: PKB) [Kane et al., 2002].
TBC1D4 is further build up by two phosphotyrosine interaction domains (PTB)
near the N-terminus and, close to the TBC or GAP-domain at the C-terminus, by
a calmodulin-binding domain (CBD). In addition, seven Akt-phosphorylation sites
are known, which are important for the regulation of TBC1D4 (see later section).
TBC1D4 expression can be found at low levels in liver, testis, pancreas, and at high
levels in kidney, brain, lung, muscle and fat tissue [Chen et al., 2011; Lansey et al.,
2012].
Spliced and shorter isoforms are known, but their role is yet less clear. A close ho-
mologue of TBC1D4 is the family member TBC1D1 (TBC1 domain family, member
1) (Figure 10). This GAP-enzyme is similarly structured with minor differences in
16
1.7. TBC1D4
Figure 9: Protein structure of human TBC1D4 with important domains
and Akt phosphorylation sites Human TBC1D4 consists of 1299 aa,
within two phosphotyrosine interaction domains (PTB) at the N-terminus,
and at the C-terminus a calmodulin-binding domain (CBD) and the GT-
Pase activating protein GAP/TBC domain. The second PTB domain is
flanked by seven Akt phosphorylation residues [Cartee and Funai, 2009].
length and phosphorylation sites. Besides Akt phosphorylation, TBC1D1 is as well
phoshorylated by the AMP-kinase (AMPK), an important kinase in the metabolism
of skeletal muscles (Winder, 2001). Next to TBC1D4, TBC1D1 is thought to be the
major GAP in muscle tissue [Cartee and Funai, 2009; Dokas et al., 2013].
Figure 10: Protein structure of human TBC1D1 Human TBC1D1 consists
of 1168 aa, with a high similarity in structure to its close homologue
TBC1D4. TBC1D1 contains an AMPK phosphorylation site at Ser237
and an Akt phosphorylation site at Thr596 (modified from Cartee and
Funai [2009]).
1.7.2 Function
In addition, many studies have now shown that TBC1D4 and TBC1D1 are primarily
involved in the intracellular trafficking of the insulin-regulated GLUT4-transport in
fat and muscle cells [Cartee and Wojtaszewski, 2007; Kane et al., 2002]. The GAP at-
taches to small Rab GTPases, which keeps them inactive during basal states. In vitro
assays demonstrated TBC1D4 GAP activity versus Rab2A, Rab4, Rab8A, Rab10,
17
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and Rab11 [Larance et al., 2005; Mendes et al., 2010; Mıˆinea et al., 2005; Randhawa
et al., 2008; Sano et al., 2007, 2008]. Rab GTPases promote translocation of GLUT4-
containing/storage vesicles (GSVs). This occurs through PKBβ/Akt2 phosphoryla-
tion of TBC1D4 in response to insulin, after which TBC1D4 is sequestered by 14-3-3
proteins, leading to the conversion of Rab proteins into their active (GTP-bound)
state. At this stage, GSVs are transported and GLUT4 transporters are inserted
into the cell surface promoting glucose uptake.
1.7.3 Regulation
TBC1D4 is regulated through phosphorylation at seven known serine/threonine
phosphorylation sites (Ser318, Ser341, Ser570, Ser588, Thr642, Ser666 and Ser751,
equivalent in mice: Ser325, Ser348, Ser577, Ser595, Thr649, Ser673 and Ser758
[Chen et al., 2011; Geraghty et al., 2007; Sano et al., 2003]). In vitro as well
as in vivo studies have demonstrated that next to the insulin stimulus other fac-
tors such as IGF-1 (insulin-like growth factor-1), EGF (epidermal growth factor),
PDGF (platelet-derived growth factor), the phorbol 12-myristate 13-acetate (PMA)
(a strong activator of the protein kinase C), leptin (an appetite-inhibiting hormone)
and AICAR (5-aminoimidazole-4-caarboxamide-1-β-D-ribofuranoside) can inacti-
vate TBC1D4 through a distinctive phosphorylation pattern [Geraghty et al., 2007;
Sa´inz et al., 2012; Thong et al., 2007]. The effect is mediated via different kinases;
for example RSK1 (p90 ribosomal S6 kinase-1), which is activated via PMA; AMKP,
which is activated via AICAR; and SGK1, which shares a high substrate specificity
with Akt and itself is activated via aldosterone. Moreover, insulin and IGF-1 lead to
TBC1D4-phosphorylation of Ser341 and Thr642, promoting the binding to 14-3-3
proteins [Geraghty et al., 2007]. On the other hand, AMPK phosphorylates TBC1D1
at Ser237 and Thr596 (paralog to TBC1D4 Thr642) to induce 14-3-3 binding [Chen
et al., 2008]. Ramm and coworkers suggested that binding to 14-3-3 of Rab GAPs
is important for insulin-stimulated GLUT4 translocation [Ramm et al., 2006]. Fur-
thermore, the specificity of some protein isoforms is determining the interaction of
TBC1D4 with other proteins, e.g. Akt2 is thought to be the major isoform required
for insulin action within the Akt isoforms (Akt1-3) [Cho et al., 2001; Kempe et al.,
2010; Ng et al., 2008; Schultze et al., 2012]. Likewise, binding of TBC1D4 to the
14-3-3 protein is stronger towards the β, , and σ isoforms, and rather weak towards
the γ and θ isoforms [Liang et al., 2010].
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1.8 TBC1D4 in vitro and in vivo
The role of TBC1D4 is well characterized from in vitro and in vivo studies in so-called
classical insulin-responsive tissues, namely fat and skeletal muscle tissue. The two
tissue types together take up 80-90 % of the ingested glucose, with skeletal muscle
tissue having the greater glucose disposal capacities.
1.8.1 TBC1D4 in vitro
In 3T3-L1 adipocytes, knockdown of TBC1D4 results in increased cell surface expres-
sion of GLUT4 at the basal state [Eguez et al., 2005; Larance et al., 2005]. Moreover,
when mutating four main phosphorylation sites (Ser318, Ser588, Thr642 and Ser751)
to non-phosphorylatable alanine (TBC1D4-4P mutant), insulin-stimulated GLUT4
translocation as well as membrane docking and insertion are impaired in 3T3-L1
adipocytes [Bai et al., 2007; Jiang et al., 2008; Sano et al., 2003] and L6 myocytes
[Thong et al., 2007]. In addition, overexpression of the 4P-mutant affects GLUT4
exocytosis, but not its endocytosis in 3T3-L1 adipocytes [Zeigerer et al., 2004]. Be-
yond the analysis of TBC1D4 in classical insulin-responsive tissues, several groups
described its GAP function in non-classical insulin responsive tissues, for example
the pancreas [Bouzakri et al., 2008], lung [Comellas et al., 2010], brain [Grillo et al.,
2009], and kidney [Alves et al., 2010; de Baaij et al., 2013; Jung and Kwon, 2010;
Kim et al., 2011; Liang et al., 2010]. Bouzakri and coworkers showed that TBC1D4
deletion causes an increased basal insulin excretion whereas glucose-stimulated in-
sulin secretion is impaired in sorted human pancreatic β-cells and murine MIN6B1
cells. Interestingly, loss of TBC1D4 leads to increased apoptosis and caspase-3 ac-
tivation, pointing to a prosurvival role of pancreatic TBC1D4. In the lung, insulin
stimulates Na+-K+-ATPase translocation through Akt phosphorylation of TBC1D4
and Rab10 activity [Comellas et al., 2010]. Interestingly, Akt-dependent GLUT4
translocation was shown in rat hippocampus after intra-cranial insulin injection,
although without a direct proof of TBC1D4 involvement [Grillo et al., 2009]. In
the kidney, TBC1D4 has been described to be involved in the trafficking regulation
of AQP2, ENaC, and Na+-K+-ATPase (discussed in greater detail in the following
sections) [Alves et al., 2010; Kim et al., 2011; Liang et al., 2010].
19
Chapter 1. Introduction
1.8.2 TBC1D4 in vivo
Recently, different genetically modified mice models with altered TBC1D4 expres-
sion and phosphorylation patterns have been created, primarily demonstrating the
GAP-impact on whole-body glucose homeostasis [Chen et al., 2011; Ducommun
et al., 2012; Lansey et al., 2012; Wang et al., 2013]. The group of Lansey et al. gen-
erated a TBC1D4-deficient mouse line (D4−/−) by the excision of exon 1, including
the transcription start and part of the downstream intron. Further, another group
analyzed the phenotype of TBC1D4-deficient mice with an excision of the tenth exon
harboring the T649A mutation site [Chen et al., 2011; Ducommun et al., 2012; Wang
et al., 2013]. Furthermore, a TBC1D4 T649A knockin mouse line (D4 T649 KI) has
been generated in order to investigate the effect of the crucial Thr649 binding site
to 14-3-3 proteins, when mutated to a non-phosphorylatable alanine [Chen et al.,
2011]. In contrast to the other mouse lines, the GAP domain in the TBC1D4 T649A
knockin mice is still functional. Further models such as a TBC1D4−/− mouse model
(similar to our model, see 3.2.13), a knockout model of the close homologue TBC1D1
(D1−/−) an a double knockout of TBC1D4 and TBC1D1 (TBC1D4/TBC1D1 knock-
out: D4/D1−/−) have been designed by Chadt and coworkers [Chadt et al., 2015,
2008]]. In Table 1 the phenotype in regard to glucose homeostasis of these models is
summarized. For body weight gain, fasted plasma glucose levels, insulin sensitivity
and glucose uptake in adipocytes, the TBC1D4−/− model of Chadt et al. behave dif-
ferently compared to the other two TBC1D4−/− models [Lansey et al., 2012; Wang
et al., 2013]. In terms of BW gain, plasma glucose and insulin levels as well as
glucose uptake in muscle, the TBC1D4 KI mouse line reveals a similar phenotype as
the TBC1D4 KOs. Since the KI mouse model overexpresses the dominant negative
regulator, whereas the KOs have lost this molecular break, these similarities are sur-
prising. But in fact, the KI mice have increased GLUT4 abundances in adipocytes
and soleus muscle as well as an increased ex vivo insulin-stimulated glucose uptake
in adipocytes, which is opposite to what is observed in the TBC1D4−/− mice (Table
1).
As previously mentioned, TBC1D4 is a close homologue of TBC1D1 and both have
been shown to regulate GLUT4 trafficking [Chadt et al., 2008; Dokas et al., 2013;
Szekeres et al., 2012]. Interestingly however, TBC1D4 and TBC1D1 reveal fairly
different expression patterns. Whereas TBC1D4 is mainly expressed in adipocytes
and oxidative muscles (e.g. soleus, vastus lateralis muscles, etc.), TBC1D1 shows
almost no abundance in adipocytes, but is instead mainly expressed in glycolytic
muscles [e.g. extensor digitorum longus (EDL), tibialis anterior (TA) and quadri-
ceps]. As expected, GLUT4 expression in TBC1D1 and TBC1D4 KOs is specifically
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BW PGlc Plns GT IS GLUT4 GU GU
fasted fasted Adip Soleus
~ | ~ | ~ | ~ | ~ | Adip Sol EDL - ins ins - ins ins
| | | | | | |
D4−/− (ex1)1 ↔ ↔ ↓ ↓ ↓ ↔ ↔ ↓ ↓ ↓ ↓ ↓ ↔ ↑ ↓ ↔ ↓
D4−/− (ex10)2 ↔ ↔ ↓ - ↔ - ↔ - ↓ - ↓ ↓ ↔ ↑ ↓ ↔ ↓
D4−/− (ex1)3 ↓ - ↔ - - - ↔ - ↔ - ↓ ↓ ↔ ↔ ↓ ↔ ↓
D4/D1−/− 3 ↓ - ↔ - - - ↓ - ↓ - ↓ ↓ ↓ ↔ ↓ ↔ ↓
D4T469A KI4 ↔ ↓ ↔ - ↔ - ↓ ↓ - - ↑ ↑ - ↔ ↑ ↔ ↓
D1−/− 3 ↓ - ↔ - - - ↔ - ↔ - ↔ ↔ ↓ ↔ ↔ ↔ ↔
Table 1: Comparison between different TBC1D4 mouse models Compared
body weight (BW), plasma glucose (PGlc) fasted, plasma insulin (PIns)
fasted, glucose tolerance (GT), insulin sensitivity (IS), GLUT4 content in
different tissues (adip. = adipocytes, sol. = soleus, EDL = extensor digito-
rum longus) and glucose uptake (GU) in diefferent TBC1D4 and TBC1D1
knockout models: 1[Lansey et al., 2012], 2[Wang et al., 2013], 3[Chadt et al.,
2015], 4[Chen et al., 2011]. All data points refer to their corresponding
control (wild-type) mice, ↔ = similar, ↑ = increased, ↓ = decreased, - =
not determined, ins = insulin, D4−/− = TBC1D4 knockout, ex = exon,
D4/D1 = TBC1D4/TBC1D1 double knockout, D4 T649 KI = TBC1D4
T649 knockin, D1−/− = TBC1D1 knockout
reduced in areas where these Rab GAPs are normally highly expressed (Table 1).
Further, as shown in table 1, data suggest that TBC1D1 might be important for
the regulation of body weight given how the naturally occurring loss-of-function
mutation in TBC1D1 prevents from diet-induced obesity in the diabetes-resistant
SJL mouse strain [Chadt et al., 2008]. Although the TBC1D4−/− models (1-3) all
miss the GAP enzyme, the findings were not always identical (Table 1). Discrep-
ancies may be explained for instance by strain differences, the different targeting
strategies for the generation of knockout and knockin mice, sensitivity of the ap-
plied method, age, and sex of the animals. One commonly used method to assess
the variability between different studies is to perform a meta-analysis, which com-
bines and compares the individual studies [Denker and Pollock, 1992; Matsuda and
DeFronzo, 1999]. Overall, the results are very complex and no clear statement on
TBC1D4 in vivo function can be made so far. On the one hand, TBC1D4−/− mice
appear to be glucose tolerant, but on the other hand they are insulin resistant. In
humans, both GAPs, TBC1D4 and TBC1D1, are known to interfere with glucose
metabolism and are associated with type 2 diabetes mellitus (T2DM) and obesity,
respectively [Chadt et al., 2008; Karlsson et al., 2005, 2006]. Patients with a trun-
cation of TBC1D4 (R363X) suffer from sever postprandial hyperinsulinemia [Dash
et al., 2009] and mutation of TBC1D1 (R125W) increases the risk of developing
obesity [Meyre et al., 2008; Stone et al., 2006]. However, further research is needed
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to understand the underlying molecular mechanisms and the variability between the
different models.
1.8.3 TBC1D4 expression in the kidneys
Although the kidneys are not typically considered as insulin-responsive tissues, more
and more evidence for renal TBC1D4 expression have accumulated from in vitro and
in vivo studies [Alves et al., 2010; de Baaij et al., 2013; Jung and Kwon, 2010; Kim
et al., 2011; Liang et al., 2010; Mendes et al., 2010]. In our work [Lier et al. [2012]:
see appendix Paper 1], we described the detailed expression of TBC1D4 along the
mouse nephron using immunohistochemistry (IHC) and canonical nephron segment-
specific markers (Figure 11). TBC1D4 was found in the cytosol of parietal epithelial
cells (PECs) of the Bowman’s capsule, in the thin and thick limbs, in the DCT,
and in the CNT/CD. In the latter, both, principal and intercalated cells stained for
TBC1D4. In PT cells, no TBC1D4 signal was observed.
Figure 11: Representation of TBC1D4 abundance along the nephron
TBC1D4 abundance along the nephron was analyzed by IHC using spe-
cific segmental markers and/or morphological characteristics. The Rab
GAP was found in the glomerulus, in the thin limbs (DTL/ATL), rec-
ognizable by very distinctive morphological characteristics, in the TAL
shown by co-localization with NKCC2, in the DCT1 and DCT2 with
NCC, and CNT/CD with yENaC and AQP2. Only in the PT (PCT
and PST), recognizable through f-actin staining in the brush border, no
TBC1D4 expression was found (ICC = intercalating cells) [adapted from
(Lier et al., 2012)].
The recent accumulation of in vitro findings of TBC1D4 being a possible regulator
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in the intracellular trafficking of ENaC, AQP2 and the Na+-K+-ATPase, and thus
crucial for renal ion and water homeostasis, is discussed in greater detail in 1.11.
1.9 The role of the kidneys in glucose homeostasis
The kidneys reabsorb all filtered glucose, around 180 g/day, within the first tubular
segments after glomerular filtration. In healthy individuals the urine is essentially
free from glucose. As mentioned in 1.2, the SGLTs, localized at the apical membrane,
are responsible for renal glucose uptake in an insulin-independent manner (Figure
12).
Figure 12: Transepithelial glucose uptake in the PT The Na+-glucose co-
transporter SGLT2, a low-affinity high-capacity transporter for glucose
located at the apical side takes up glucose together with Na+ in a 1:1
ratio in the S1 and S2 segments or PCT and the basolateral extrution
of glucose is mediated via GLUT2. In the later part of the PT, the S3
segment or PST, the high-affinity low-capacity SGLT1 takes up one glu-
cose molecule together with 2 Na+ ions. GLUT1 at the basolateral side
transports glucose out of the cell. [Lee and Han, 2007]
In S1 and S2 segments of the PCT, SGLT2 reabsorbs 90 % of the filtrated glucose
together with Na+ (ratio of 1:1) and with a low glucose affinity but high capacity. In
the PST/S3 segment, the remaining 10 % of glucose are reabsorbed together with
Na+ (1 glucose:2 Na+) by SGLT1, which in contrast to SGLT2 is a high-affinity low
capacity transporter [Lee and Han, 2007]. With increasing intracellular glucose con-
centrations, glucose re-enters the systemic circulation via specific facilitative glucose
transporters (GLUTs) expressed at the basolateral membrane. GLUT2 and GLUT1
facilitate glucose exit in the S1 and S3 segment, respectively. Beyond glucose filtra-
tion and reabsorption, the kidneys are able to perform gluconeogenesis. This renal
task has been underestimated for many years as the net balance technique failed to
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detect a difference between renal arterial and venous blood concentration [Bjo¨rkman
et al., 1980; Krebs and Yoshida, 1963]. This was due to the fact that the net balance
technique does not take into account the contemporaneous and distinct release and
uptake processes of glucose in the kidney. During an overnight fast, 20-25 % of the
glucose release derives from the kidneys and 75-80 % from the liver. In humans, the
kidney is, after the liver, the only organ with significant amounts of the glucose-6-
phosphatase, a rate-limiting enzyme in gluconeogenesis. This enzyme is expressed in
the renal cortex, more specifically in PT cells, which are able to produce energy by
oxidative phosphorylation. Further, PT cells rely on oxygen as they cannot perform
glycolysis, which renders them very sensitive to low oxygen levels. Thus, PT cells
are one of the first cells to be damaged under hypoxic/ischemic states. In contrast,
the renal distal tubule cells are able to perform anaerobic glycolysis. They pos-
sess glycolytic enzymes and thus can better handle a rather oxygen-poor/relatively
hypoxic environment (as e.g. in the renal medulla). Also in the S3 segment, nor-
mally involved in transepithelial glucose transport, low levels of glycolytic enzymes
have been detected, which may provide energy via the glycolytic pathway [Thorens,
1993]. Overall, the processes of oxidative phosphorylation and glycolysis in the kid-
neys account for around 10 % of glucose utilization of all ingested glucose, whereas
45 % is taken up in the liver for later glycogen formation, 30 % by the skeletal mus-
cle, 15 % by the brain and a small percentage by the adipose tissue [Meyer et al.,
2002b]. However, the molecular mechanisms underlying renal glucose utilization and
consumption are not completely understood.
1.10 GLUT4 expression in the kidney
Several GLUTs (e.g. GLUT1, 2, 3, 4 and 12) have been suggested to be expressed
in the kidneys at mRNA and protein levels [Brosius and Heilig, 2005; Linden et al.,
2006]. However, the only well established GLUTs are, as mentioned above, GLUT1
and GLUT2 involved in the transepithelial glucose uptake in the PCT (S3 segment)
and PST (S1/S2 segment), respectively. However, GLUT1 and GLUT2 in the PT
represent an exception to the rule as in most cases GLUTs facilitate glucose transport
from outside to inside the cell [Bell et al., 1990]. Next to GLUT1 and GLUT2 in the
PT, the expression patterns and the role of other glucose transporters in the kidney
are less clear. Beyond the PT, expression of GLUT1 has been found at moderate lev-
els in cells of the thin and thick ascending limbs and at high levels in the connecting
segment and the CD, with levels peaking in the intercalated cells of the CD [Thorens,
1993]. The distinct renal GLUT1 expression correlates with the glycolytic activity
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in these cells [Ross et al., 1986; Uchida and Endou, 1988]. Furthermore, GLUT1 is
present in the glomerulus; predominantely in mesangial cells, but also in podocytes,
endothelial cells and in the PECs [Brosius et al., 1992; Heilig et al., 1997, 1995]. In
podoyctes, GLUT1 has been found to be regulated by insulin [Coward et al., 2003,
2005]. Studies in other tissues have further demonstrated a regulation of GLUT1
via insulin and TBC1D4 similarly to GLUT4 [Calderhead et al., 1990; Clarke et al.,
1994; Fischer et al., 1997; Mendes et al., 2010]. It has further been documented that
GLUT4, the main insulin-responsive glucose transporter [Birnbaum, 1992] found in
adipocytes and skeletal muscle cells [Cartee and Wojtaszewski, 2007; Sano et al.,
2003], is expressed in the kidney. Similar to GLUT1, mesangial cells [Brosius and
Heilig, 2005], podocytes [Coward et al., 2003], smooth muscle cells forming the
endothelia [Brosius et al., 1992], the TAL [Chin et al., 1993] and distal tubules
[Albiston et al., 2011] express GLUT4. Anderson and coworkers verified GLUT4
expression by immunogold staining in juxtaglomerular cells (renin secreting cells).
Next to the expression, attempts were made to analyze the intracellular localization
of GLUT1 and GLUT4. Anderson and coworkers hypothesized similar trafficking
and secretory mechanisms for GLUT4 and renin [Anderson et al., 1998]. However,
they discovered that renin accumulates in secretory granula, whereas GLUT4 lo-
calizes to vesicles in close vicinity to the TGN. Moreover, Rea and James showed
basolateral membrane staining for GLUT1, and an enriched intracellular staining
for GLUT4 in MDCK cells [Rea and James, 1997]. However, there are discrepant
findings concerning GLUT1 and GLUT4 expression along the kidney, and no clear
picture about the localization along the nephron, the intracellular expression and
the function of other GLUT proteins in the kidney, apart from GLUT1 and GLUT2
in the PT, has so far been reliably drawn.
1.11 In vitro evidence for renal intracellular trafficking
regulation by TBC1D4
Recently, several in vitro analyses have suggested a role for TBC1D4 in the traf-
ficking regulation of renal water and ion channels and transporters including NCC,
ENaC, AQP and the Na+-K+-ATPase. From experiments performed in Xenopus
leavis oocytes, insulin treatment has been shown to augment NCC’s activity together
with its phosphorylation at Thr58. This effect is mediated by phosphatidylinositol 3-
kinase (PI3K), mTORC2 and Akt1 [Cha´vez-Canales et al., 2013]. Moreover, Delpire
and Gagnon identified a SPAK-binding motif (GRFEINLISP) on TBC1D4 [Delpire
and Gagnon, 2007]. Hence, TBC1D4 might modulate NCC’s action in regard to
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trafficking, activity and/or phosphorylation. As a similar cascade is present in the
TAL, this might be also true for NKCC2 regulation. From in vitro and mass spec-
trometry analysis, endogenous TBC1D4 was shown to interact with the N-terminus
of the SNAP-tagged Na+-K+-ATPase α-subunit in MDCK cells [Alves et al., 2010].
Similar to GSVs, the Na+-K+-ATPase is stored in intracellular compartments and
undergoes regulated intracellular epithelial membrane trafficking. Coexpression with
TBC1D4 in COS cells shows intracellular retention of the Na+-K+-ATPase [Alves
et al., 2010]. Furthermore, reduced activity levels of the adenosine monophosphate-
stimulated protein kinase (AMPK), a kinase especially important for contraction-
induced phosphorylation of TBC1D4, lead to an increase of Na+-K+-ATPase endo-
cytosis in MDCK cells [Alves et al., 2010]. Recently, a connection between TBC1D4
and ENaC has been suggested [Liang et al., 2010]. Liang and colleagues showed
that aldosterone promotes SGK1-mediated phosphorylation of TBC1D4, similarly
to the insulin Akt-mediated phosphorylation of TBC1D4, which hence facilitates
ENaC trafficking and insertion into the membrane in mouse cortical collecting duct
(mCCD) cells. Another example of a putative role of TBC1D4 in vivo was demon-
strated by the group of Kwon [Kim et al., 2011]. In mpkCCD cells and M1 cells,
TBC1D4 siRNA knockdown resulted in increased AQP2 expression at the plasma
membrane in the absence of dDAVP stimulation [Jung and Kwon, 2010; Kim et al.,
2011]. The V2 receptor, which regulates AQP2 expression, is a G-protein coupled
receptor acting via the cAMP and PKA signaling pathway. How TBC1D4 might be
involved in the translocation cascade of AQP2 remains to be established. However,
despite these numerous in vitro data suggesting a role for TBC1D4 in regulating
renal ion and water transporting proteins, and the fact that TBC1D4 is expressed
along the nephron, the in vivo role of TBC1D4 in the kidney is completely unknown.
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2 Objectives of the thesis
The overall objective of this thesis was to analyze the physiological relevance of
TBC1D4 in the kidney. Our immunohistochemical study revealed TBC1D4 abun-
dance in distinct parts of the nephron [Lier et al., 2012]. Based on these findings
and the in vitro data showing the involvement of TBC1D4 in the control of water
and ion transporting proteins (ENaC, AQP2, Na+-K+-ATPase), the major objective
was to define whether TBC1D4 regulates the intracellular vesicular trafficking and
activity of these proteins and/or is responsible for renal glucose homeostasis in vivo.
To this end, the following specific aims were addressed:
2.1 Investigation of the role of TBC1D4 in the kidney
by using TBC1D4−/− mice
Based on in vitro data, we analyzed the role of TBC1D4 in the regulation of renal
ion and water transporting proteins (e.g. ENaC, AQP2 and the Na+-K+-ATPase)
by using a TBC1D4−/− mouse model. In addition, we investigated the renal gene
and protein expression of GLUT4 along the nephron of wild-type (WT) mice as well
as the role of TBC1D4 in the control of renal GLUT4 trafficking and activity by
comparing the phenotype of WT and TBC1D4−/− mice.
2.2 Compensatory mechanisms in DCT cells of
TBC1D4−/− mice assessed by microarray analyses
With our findings of TBC1D4 not being involved in the regulation of renal ion and
water transporting proteins in vivo, we investigated a possible up- and/or down-
regulation of gene products, which might compensate for the loss of TBC1D4 in
renal tubules of TBC1D4−/− mice. To reach this objective, we used isolated-DCT
cells by the complex object parametric analysis and sorting technique (COPAS) and
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performed microarray analyses for the comparison of gene expression between DCT
cells of WT and TBC1D4−/− mice.
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3 Materials and Methods
3.1 Material
3.1.1 Compounds/Reagents
1,4-diazabicyclo(2,2,2)octane Sigma-Aldrich, Germany
10x blocking buffer Sigma-Aldrich, Germany
2-propanol Isopropanol Sigma-Aldrich, Germany
3H-2-deoxyglucose Perkin Elmer, USA
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) AppliChem, Germany
4’,6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich, Germany
5x FirePol Master Mix Solis BioDyne, Estonia
5x ImProm-IITM reation buffer Promega, USA
Aceton Sigma-Aldrich, Germany
Acrylamide AppliChem, Germany
Agarose Promega, USA
Albumin VWR International
Aldosterone Sigma-Aldrich, Germany
Ammonium persulfate (APS) AppliChem, Germany
Ampicillin Roche, Switzerland
Boric acid Sigma-Aldrich, Germany
Bovine serum albumin (BSA) Sigma-Aldrich, Germany
Calcium chloride (CaCl2) Riedel-de-Haen,Germany
Calyculin A LifeTechnologies, USA
Collagenase Worthington Biochemical Corp
Complete Protease Inhibitor Cocktail Tablets Roche Diagnostics GmbH
CooAssay Protein Dosage Reagent Uptima/Interchim, France
Coommassie brilliant blue G-250 Thermo Sientific, USA
Cytochalasin B Sigma-Aldrich, Germany
D-Glucose Sigma-Aldrich, Germany
Dexamethasone Sigma-Aldrich, Germany
Dimethylsulfoxid (DMSO) Fluka, Germany
Disodium hydrogen phosphate (Na2HPO4) Fluka, Germany
Dithiothreitol (DTT) AppliChem, Germany
DNase I Sigma-Aldrich, Germany
dNTPs Fermentas, Germany
Dulbecco’s modified eagle medium (DMEM) LifeTechnologies, USA
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EcoRI Fermentas, Germany
Emulsifier-SafeTM liquid scintillation cocktail Perkin Elmer, USA
Ethylenediaminetetraacetic acid (EDTA) Fluka, Germany
EZ-Link Sulfo-NHS-LC-Biotin Thermo Sientific, USA
Fetal bovine serum (FBS) Lonza, Switzerland
G-418 sulphate/Gentamycin PAA laboratories, Inc., Austria
Gel Red Nucleic acid stain Biotum, USA
GeneRulerTM 100 bp DNA Ladder Thermo Sientific, USA
Glacial acetic acid MERCK, Germany
Glycergel DakoCytomation, Denmark
Glycerol Sigma-Aldrich, Germany
Glycine Biossolve, The Netherlands
Hank’s balanced salt solution (HBSS) Lonza, Switzerland
Hyaluronidase Sigma-Aldrich, Germany
ImProm-IITM reverse transcriptase Promega, USA
Indinavir Sigma-Aldrich, Germany
Insulin Sigma-Aldrich, Germany
IsoFlo R© (isoflurane) Abbott AG, Switzerland
LB Broth Base LifeTechnologies, USA
Magnesium chloride (MgCl2) Fluka, Germany
Magnesium sulfate (MgSO4) Sigma-Aldrich, Germany
Mannitol Fluka, Germany
Metafectene Pro Biontex, Switzerland
Methanol Sigma-Aldrich, Germany
Nitrocellulose (Whatman Protran) Millipore, USA
Non-essential amino acids Gibco-BRL, The Netherlands
Normal goat serum (NGS) LifeTechnologies, USA
OdysseyTM Blocking Buffer LI-COR Biosciences, Germany
Paraformaldehyde (PFA) AppliChem, Germany
Penicillin/Streptomycin LifeTechnologies, USA
Phosphatase inhibitor (PhosStop) Roche, Switzerland
PhosStop Roche, Switzerland
Potassium chloride (KCl) Sigma-Aldrich, Germany
Potassium dihydrogen phosphate (KH2PO4) Fluka, Germany
Potassium hydroxide (KOH) Sigma-Aldrich, Germany
Quick change R© XL1-blue supercompetent E. coli Agilent Technologies, USA
Random primers Promega, USA
RiboLockTM RNase Fermentas, Germany
RIPA Buffer, 1x Thermo Sientific, USA
Select Agar LifeTechnologies, USA
SingleQuots R© BioWhittaker Lonza, Switzerland
Sodium azide (NaN3) MERCK, Germany
Sodium chloride (NaCl) Sigma-Aldrich, Germany
Sodium dodecyl sulfate (SDS) Carl Roth GmbH, Germany
Sodium hydroxyde (NaOH) Fluka, Germany
Sodium pyruvate Gibco-BRL, The Netherlands
Sodium-cacodylatetrihydrate Fluka, Germany
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Streptavidin agarose resins (beats) Thermo Sientific, USA
Sucrose Fluka, Germany
Sulfo-NHS-LC Biotin Thermo Scientific, USA
Super optimal browth base with catabolite repression (SOC) New England Biolabs, USA
Tetramethylethylenediamine (TEMED) AppliChem, Germany
Trishydroxymethylaminomethane (Tris) Biossolve, The Netherlands
Triton-X Sigma-Aldrich, Germany
Tween-20 Sigma-Aldrich, Germany
β-mercaptoethanol Sigma-Aldrich, Germany
3.1.2 Instruments/Materials
2100 Bioanalyzer Agilent Technologies, USA
850 professional IC ion chromatograph Metrohm, Switzerland
ABL800 Flex (blood gas analyzer) Radiometer, Denmark
Accu-Chek Aviva System Roche, Switzerland
BP2000 Series II (Blood Pressure Analysis System) Visitech Systems, USA
Cell culture CO2 incubator Sanyo, USA
Centrifuge 5415 R Eppendorf, Germany
Clinitubles (capillary tubes) Radiometer, Denmark
CLS150X (steromicroscope) Leica, Germany
COPAS Union Biometrica, USA
Culture plates (6, 12 wells, etc.) Nunc, Denmark
DM6000B microscope Zeiss, Germany
Glass-slides Duran Group, Germany
Housing cage (type II long IVC) Techniplast, Italy
Leica DM IL Leica Microsystems, Germany
LightCycler R© 480 II instrument Roche, Switzerland
LSM510Meta(confocal microscope) Zeiss, Germany
Metabolic cage Techniplast, Italy
Microm (cryostat) Leica Microsystems, Switzerland
Micromanipulator Narishige International, UK
Microtrainer LH (Lithium Heparin) tubes BD Diagnostics, USA
NanoDrop ND-1000 spectrophotometer Thermo Sientific, USA
Nylon sieves (250, 212, 100 and 40 µm) BD, USA
Odyssey IR-scanner detection system LI-COR Biosciences, Germany
Packard Tri-Carb 2900 Perkin Elmer, USA
Pico PriasTM vials Perkin Elmer, USA
Polytron PT 2100 homogenizer Kinematica, Switzerland
PTFE filter membranes (Transwell-COL) Corning Costar, USA
Soniplus HD2070 (ultrasound sonicator) Bandelin, Germany
Steritop 0.22 µm filter Millipore, USA
TGradient thermocycler Biometra, Germany
Thermomixer comfort Eppendorf, Germany
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3.1.3 Kits
Aldosterone EIA kit (mouse) Cayman Chemicals, USA
High pure RNA isolation kit Roche, Switzerland
Insulin ELISA kit (mouse) ALPCO Diagnostics, USA
Light Cycler R© 480 SYBR Green I Master kit Roche, Switzerland
PowerPrep HP R© Plasmid Minipred kit Origene, USA
RNAqueous-Micro RNA isolation kit LifeTechnologies, USA
SV total RNA isolation system kit Promega, USA
Ultrasensitive insulin ELISA kit (mouse) ALPCO Diagnostics, USA
ZR plasmid Minipred classic kit Zymo Research, USA
3.1.4 Buffers
Ampicillin plates 20g/l LB broth base
20g/l agarose
100 µl/ml ampicillin
ad to 1l, dH2O
High salt buffer, 1x 0.1 % Triton X-100
0.5 M NaCl
5 mM EDTA
50 mM Tris, pH 7.5
ad to 100 ml, dH2O
Laemmli buffer, 2 x 4 ml 10 % SDS (w/v)
5 mg Coomassie brilliant blue G-250
2 ml glycerol
2.4 ml 0.5 M Tris, pH 6.8
1.6 ml dH2O
100-200 mM DTT or
500 mM β-mercaptoethanol
PBS, pH 7.3, 10x 2 g KCl
2 g KH2PO4
80 g NaCl
11.5 g Na2HPO4
adjust ph to 7.3
ad to 1l, dH2O
PBS + 0.1 % Tween 1 l PBS 10x
10 ml Tween-20
ad to 10l, dH2O
4 % PFA, pH 7.4 4 % PFA
ad to 1l, PBS 1 x
heat solution to 75◦C
add 1 N NaOH (to dissolve PFA)
adjust pH to 7.4
Running & transfer buffer (RTB), 10x 144 g glycine
30.3 g Tris
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ad to 1l, dH2O
Running buffer, 1x 100 ml RTB, 10 x
890 ml dH2O
10 ml 10 % SDS (v/v)
Transfer buffer, 1x 100 ml RTB, 10 x
700 ml dH2O
200 ml MeOH
TAE buffer, 10x 48.4 g Tris
11.4 ml glacial acetic acid
20 ml 0.5 M EDTA, pH 8.0
Tris-HCl, 0.5 M, pH 6.8 6 g Tris
add dH2O (ca. 50 ml)
adjust pH to 6.8
ad to 100 ml, dH2O
Tris-HCl, 1.5 M, pH 8.8 27 g Tris
add dH2O (ca. 100 ml)
adjust pH to 8.8
ad to 150 ml, dH2O
TBE buffer, 5x 54 g Tris
27.5 g boric acid
20 ml 0.5 M EDTA
adjust pH to 8.0
ad to 1 l, dH2O
3.2 Methods
3.2.1 Mouse work
3.2.1.1 Ethical approval
All animal studies were conducted according to the Swiss animal welfare regula-
tions and after ethical approval by the local veterinarian office (Kantonales Vet-
erina¨ramt, Zu¨rich) of Zurich, Switzerland. The authorized proposal for this thesis
with the permission number 193/2010 is nominated ”Regulation des Natrium- und
Kaliumhaushaltes durch die Nieren: Zellula¨re und molekulare Mechanismen”.
3.2.1.2 Mouse housing
Mice were kept in ventilated cages (type II long IVC) in the animal facility of the
Institute of Anatomy, University of Zurich. Mice were housed under standardized
temperature- and humidity-conditions with a 12:12-h light-dark cycle (7 am-7 pm
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light phase, 7pm-7am dark phase) and had free access to standard lab chow GLP
3430 (PROVIMI KLIBA, Kaiseraugst, Switzerland) and tap water, if not differently
stated. Generally, female mice were used due to easier handling and housing and
groups were age-matched.
3.2.1.3 Generation and genotyping of TBC1D4−/− mice
TBC1D4-deficiency was generated by targeted deletion of part of exon 1 of the
TBC1D4 gene. Targeting strategy is shown in Figure 11 from Taconic’s webpage
http://www.taconic.com and has been described in Lier et al. [2012]. C57/Bl6 mice
were obtained from Harlan (Horst, The Netherlands) and TBC1D4-deficient mice
(B6129S5-TBC1D4tm1Lex) were purchased from the Texas Institute of Genomic
Medicine (Houston, Texas, USA). For our studies, 129/SvEv-C57BL/6 TBC1D4-
knockout (KO) mice were backcrossed into the C57BL6 background. Mice from the
sixth backcrossed generation on were used.
Figure 13: Targeting strategy for TBC1D4 gene deletion from Taconic
http://www.taconic.com, partial deletion of exon 1 of the TBC1D4 gene
To identify the TBC1D4 locus, a PCR on genomic DNA from a toe or ear biopsy
was performed using the 5x FIREPol R© Master Mix containing 12.5 mM MgCl2.
A 2 % agarose gel separating the wild type band of 355 bp from the band of the
TBC1D4 mutant allele of 257 bp was run in Tris-borate-EDTA (TBE, diluted 1x)
buffer. Visualization of the bands was achieved by adding Gel Red Nucleic acid
stain (Biotium, Hayward, USA). For estimation of the band size, the GeneRulerTM
100 bp DNA Ladder was used.
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Step Temp. Time
Denaturation 95 ◦C 5 min
Denaturation 94 ◦C 30 sec
40 cyclesAnnealing 60 ◦C 30 sec
Elongation 72 ◦C 2 min
Final Elongation 72 ◦C 10 min
Cooling 4 ◦C on hold
Table 2: PCR steps for TBC1D4 genotyping
Primer Sequence 5’-3’
Fwd primer AGT AGA CTC AGA GTG GTC TTG G
Rev primer WT GTC TTC CGA CTC CAT ATT TGC
Rev primer TBC1D4 KO GCA GCG CAT CGC CTT CTA TC
Table 3: Primers for TBC1D4 genotyping
3.2.1.4 Generation and genotyping of PV-EGFP and PV-EGFP-TBC1D4−/− mice
The PV-EGFP mice were generated by Meyer and coworkers [Meyer et al., 2002a].
The enhanced green fluorescence protein, EGFP, is expressed under the parvalbu-
min (PV) promoter found in e.g. DCT1, neurons, heart and skeletal muscle cells
[Cai et al., 2001; Picard et al., 2014; Wang et al., 2009]. Immunohistochemistry
analysis proved EGFP expression in NCC-positive DCT1 cells, whereas β-ENaC
positive cells in the DCT2 lacked the EGFP signal [Picard et al., 2014]. The PV-
EGFP mice were used to perform COPAS (complex object parametric analysis and
sorting). Heterozygous PV-EGFP transgenic mice were used for breeding, as one
allel was sufficient for fluorescence detection (PV-EGFP+). These transgenic mice
were bred with TBC1D4−/− and WT (TBC1D4+/+) mice to compare DCT genes
of TBC1D4+/+-PV-EGFP+ mice vs. TBC1D4−/−-PV-EGFP+mice. As PV is ex-
pressed in skeletal muscle, the transgenic EGFP+ allel was visually and postnatally
identified by illuminating hairless skin with an UV lamp. Genotyping of the TBC1D4
gene was performed as described above.
3.2.1.5 Blood pressure measurements
Murine blood pressure was determined on conscious mice using the non-invasive
computerized tail cuff method [Krege et al., 1995]. Measurements were performed
between 9 am and 12 pm. Mice were adapted for 3 days prior to the experiments
assessing 10 blood pressure measurements. During the experiment, 20 single blood
pressure measurements were recorded and the systolic blood pressure (SBP) was
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calculated by the average of a maximum of 20 corrected single measurements, but
of at least 10 single measurements, using the provided data software.
3.2.1.6 Metabolic cage experiments
For the collection of physiological data (water and food intake, body weight, urine
volumes, Na+ and K+ excretion, etc.), metabolic cage experiments were performed.
Mice were kept in single mouse metabolic cages for 4 days with the first two days
serving as adaptation. Metabolic cages allow the harvesting of urine and feces and
to strictly control nutrient and fluid uptake. Data were collected every 24 hours.
3.2.1.7 Diets
For metabolic cage experiments, powdered food was used which was moistened with
milliQ water to fit into the food porringer. The different diets used are listed in
Table 4. The low Na+/high K+ diet (LNa/HKD), with 5 % K+, was used with
the aim to maximally activate the renin-angiotensin-aldosterone system (RAAS). In
comparison, parameters of the standard lab chow/maintenance food are listed.
Name Short Comp. Cat No Na K Fat Sugar food:H2O annotation
standard diet SD ssniff E15000-00 0.19 0.97 4.2 10.8 1:1.2 -
high fat diet HFD ssniff E15186-30 0.19 0.97 30.2 13 3:1 -
high salt high HSHFD ssniff E15186-30 0.19 0.97 30.2 23 3:1 ad Na to 5 %
fat diet
low Na diet LNaD ssniff E15430-20 < 0.03 0.97 5.2 11.3 1:1 -
low Na LNa/HKD ssniff E15430-20 < 0.03 0.97 5.2 11.3 1:1 ad K to 5 %
/high K diet
standard diet - KLIBA 3430 0.2 0.78 4.5 - - -
pelleted
Table 4: Diets and diet’s composition
3.2.1.8 Glucose tolerance (GTT) and insulin tolerance test (ITT)
In order to measure glucose and insulin tolerance, mice were starved overnight and
for 3 hours, respectively. Before the experiment, mice were weighted and blood
glucose was measured from a drop of the tail tip with the Accu-Chek Aviva System
at time-point 0 min with a following intraperitoneal (i.p.) injection of 1.5 mg/g BW
glucose or 0.75 mU/g BW insulin. Blood sugar levels were measured at timepoint
15, 30, 60, 120, 150 and 180 min for glucose tolerance and in 15 min-intervals for
insulin tolerance over a total of 90 min.
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3.2.1.9 Measurement of urinary parameters
Urinary aldosterone levels were measured using the aldosterone EIA kit. Values were
normalized to urine volumes and expressed in ng/day. Urinary ion concentrations
(Na+, K+ and Mg2+) were determined using an automated 850 professional IC ion
chromatograph and creatinine levels were measured by the Jaffe method [Seaton
and Ali, 1984].
3.2.1.10 Measurement of blood parameters and mouse kidney harvesting
Mice were anesthetized with 3-4 % isoflurane under an air flow of 0.6 l/min. Blood
glucose was measured as described in 3.2.1.8 and 300 µl of blood was redrawn
from the right atrium. 100 µl of blood was immediately inserted into a blood gas
analyzer through capillary tubes to measure e.g. ion (Na+, K+, Mg2+), pH, pCO2
and hematocrit levels. The remaining blood was centrifuged at 800 g for 3 min at 4◦C
in Microtrainer LH tubes in order to obtain pure blood plasma fractions. Mice were
perfused through the heart with 1x PBS. Plasma insulin levels were determined
using the mouse insulin ELISA kit and the ultrasensitive mouse insulin ELISA
kit. Plasma aldosterone and corticosterone levels were measured at the Department
of Pharmaceutical Sciences at the University of Basel, Switzerland by Prof. A.
Odermatt (method described in more detail in Sorensen et al. [2013], supplementary
data). Kidneys were harvested, immediately put into liquid nitrogen, and stored at
-80◦C until use.
3.2.1.11 Preparation of protein samples and western blot analysis
Whole kidney homogenization was performed as described [Busque and Wagner,
2009] using 400 µl of lysis buffer (200 mM Mannitol, 80 mM HEPES, 41 mM KOH,
pH 7.5) supplemented with protease and phosphatase inhibitors. Samples were
shredded for 30 sec at maximum speed using a Polytron PT 2100 homogenizer
and centrifuged at 2’000 g for 10 min at 4◦C. The supernatant was collected and
an additional 400 µl was added to the pellet. Homogenization and centrifugation
were repeated and supernatants were pooled. For fractionation into cytosolic and
membrane enriched proteins, 400 µl of the supernatant were centrifuged at 100’000
g for 1 hour at 4◦C. The supernatant (cytosolic fraction) was transferred to a new
tube and the pellet (membrane fraction) was sonicated for 15 sec at 15 % power in
300 µl lysis buffer. Protein concentrations were assed with a Bradford assay. For
western blot analysis, proteins lysates of 25-50 µg were solubilized in 2x Laemmli
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buffer (supplemented with 500 mM β-mercaptoethanol). Lysates were separated
by 8-12 % SDS-PAGE and transferred to nitrocellulose membranes. Membranes
were blocked in OdysseyTM blocking buffer on a rolling shaker on room temperature
for 30 min and incubated with primary antibodies overnight at 4◦C. All primary
antibodies used are listed in table 5. For visualization, blots were incubated with
a species-specific secondary infrared (IR)-labeled antibody from LI-COR diluted
in 1x blocking buffer at room temperature for 2 hours and protected from light.
The Odyssey IR-scanner detection system was used. Densitometric analyses were
performed with the Odyssey v3.0 software.
Dilution
Antibody Host WB IHC Source Reference
TBC1D4 Rabbit 4000 1000 Loffing This study, Lier et al. 2012
TBC1D1 Rabbit 1000 Loffing This study
GLUT4 Rabbit 10000 1000-5000 Millipore This study
GLUT1 Rabbit 100 2000-10000 Sigma This study
pAkt S473 Rabbit 1000 Cell Signaling This study
Na+-K+-ATPase Rabbit 10000 Feraille This study
NKCC2 Rabbit 1000 10000 Loffing Wagner et al. 2008
tNCC Rabbit 10000 Loffing Sorensen et al. 2013
pT53 NCC Rabbit 5000 Loffing Sorensen et al. 2013
pT58 NCC Rabbit 5000 Loffing Sorensen et al. 2013
pS71 NCC Rabbit 5000 Loffing Sorensen et al. 2013
α-ENaC* Rabbit 1000 Loffing Sorensen et al. 2013
β-ENaC* Rabbit 7500 Loffing Sorensen et al. 2013
γ-ENaC* Rabbit 7500 20000 Loffing Lier et al. 2012, Wagner et al. 2008
AQP2 Rabbit 5000 20000 Loffing Lier et al. 2012, Wagner et al. 2008
CBP-D28k Rabbit 5000 20000 Swant Lier et al. 2012
β-actin Mouse 10000 Sigma
α-tubulin Mouse 1000 Sigma
IRDye R©800CW Rabbit 20000 LI-COR
IRDye R©680CW Mouse 20000 LI-COR
Table 5: Antibody-concentration for Western Blot and IHC proteins boiled
for 5 min at 95◦, italic = secondary antibody
3.2.1.12 RNA extraction from kidney and quantitative real-time PCR (qRT-PCR)
For total RNA extraction, whole kidneys were homogenized using the Polytron PT
2100 homogenizer in 1 ml of RNA lysis buffer of the SV total RNA isolation system
kit. Further on, 175 µl of this mix were used for RNA extraction following the
manufacturer’s instructions. DNase digestion was directly carried out on columns.
Quality, purity, and concentration of the total RNA extractions were measured us-
ing the NanoDrop ND-1000 spectrophotometer. 100-1000 ng of RNA were reverse
transcribed in a 10 µl set-up with H2O and random primers, heated up to 70
◦C for
5 min and chilled at 4◦C for 5 min. Afterwards, 5x ImProm-IITM reation buffer,
25 mM MgCl2, ImProm-II
TM reverse transcriptase, dNTPs and RiboLockTM RNase
inhibitor were added with H2O up to 20 µl for annealing at 25
◦C for 5 min, first-
strand synthesis at 42◦C for 60 min and inactivation of reverse transcriptase at
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70◦C for 15 min. Reverse transcription was performed with the TGradient ther-
mocycler. Relative mRNA expression levels were determined through quantitative
real-time PCR with the LightCycler R© 480 II instrument and the Light Cycler R©
480 SYBR Green I Master kit. 5-10 ng cDNA were used. Data were analyzed us-
ing the LightCycler R© 480 Instrument Software v1.5. Genes of interest (GOI) were
normalized to the house keeping gene (HKG) GAPDH, ratio = 2*Ct(HKG−GOI), all
reactions were run in triplicates.
3.2.1.13 Immunohistochemistry (IHC)
Mouse kidneys were fixed through the abdominal aorta with a buffer of 3 % paraform-
aldehyde (PFA) dissolved in a 0.1 M cacodylate solution (detailed description [Lier
et al., 2012; Loffing et al., 2001]). The fixative was rinsed out by perfusion with a 0.1
M cacodylate buffer for 5 min. The kidneys were removed and cut in 2-3 mm slices,
mounted on cork, frozen in liquid proprane and stored at -80◦C for later analysis.
For immunohistochemistry (IHC), 4-5 µm cryosections of fixed kidneys were cut in a
cryostat and mounted on chrom-alum gelatin coated glass-slides. Then, the sections
were blocked for 10-30 min with 10 % normal goat serum (NGS) in PBS and incu-
bated with the primary antibody in PBS/1 % BSA/0.04 % sodium azide (NaN3)
overnight in a humidified chamber at 4◦C. Primary antibodies used are listed in table
5. Thereafter, the sections were washed three times in PBS for 10 min at room tem-
perature and incubated with the species-specific fluorescent dye-labeled secondary
antibody (Table 5) for 2 hours, protected from light, and at room temperature (see
also 3.2.1.11). To counter-stain the nuclei, the blue fluorescent DNA marker, DAPI
(4’,6-diamidino-2-phenylindole; 1:1000) was added to the secondary antibody mix.
Subsequently, the slides were washed again for three times in PBS and mounted with
glycergel and added with the fading retardant 2.5 % DABCO. Immunofluorescent
pictures were taken with the DM6000B microscope and the LSM510Meta was used
for confocal microscopy. Pictures were processed using the Leica Application Suite
Advanced Fluorescence Lite (LAS AF Lite) 2.6.0 software from Leica Microsystems,
Switzerland.
3.2.1.14 Primary/ex vivo TAL cell culture
Primary TAL cells were prepared from microdissected tubules of 3-6 week-old male
mice as described previously [Glaudemans et al., 2013]. Briefly, kidneys were re-
moved and placed into ice-cold HBSS dissection solution (pH 7.4, 325 mOsm/kg
H2O). Each kidney was cut first along the midsagittal plane and then into 5-7
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square pieces. These fragments were subjected to a 35-min collagenase treatment,
which were subsequently sieved. The sieved tubular segments were collected in a
37◦C albumin solution. The TAL tubules were selected on the basis of morpho-
logical characteristics using a light microscope (Leica DM IL), and collected by a
glass pipet connected to a micromanipulator. Approximately 50 TAL segments were
placed onto 0.33 cm2 collagen-coated PTFE filter membranes (pore size 0.4 µm) in
culture medium (CM) (DMEM:F12) supplemented with 15 mM HEPES, 0.55 mM
Na+-pyruvate, 0.01 % (v/v) non-essential amino acids, 2 % (v/v) FBS and a batch
of SingleQuots R©, pH 7.4 and incubated in a humidified chamber at 5 % CO2 and
37◦C. The CM was changed every 48 h. A monolayer of TAL cells developed from
the tubular fragments after 12 to 15 days. Subsequently, the cells were cultured for
3 days in the absence of FBS to allow full differentiation.
3.2.1.15 Radioactive glucose uptake in primary TAL cells
GLUT4-specific glucose transport activity was studied in primary TAL cultures (n
= 5-8) obtained from WT and TBC1D4−/− mice (n ≤ 3, each) in the presence or ab-
sence of insulin. Working protocols were adapted from glucose uptake experiments
in fat and muscle cells [Lansey et al., 2012; Szekeres et al., 2012] as follows: cultures
were incubated overnight in a serum- and insulin-free CM. The following day, each
culture was washed 3 times using an uptake buffer (UB) (150 mM NaCl, 10 mM
HEPES, CaCl2, 5 mM KCl and 1 mM MgCl2). Next, the TAL cultures were incu-
bated for 30 minutes in UB supplemented with 100 µM D-glucose with or without
300 nM insulin. The transport function was determined by 3H-2-deoxyglucose (3H-
DOG) uptake experiments (UB buffer supplemented with 0.5 µCi/ml 3H-DOG and
100 µM glucose). After 15 minutes, the uptake was quenched with 50 µM cytocha-
lasin B-supplemented UB buffer, following 4x 5 min UB washing steps. The cells
were lysed in 1 % (v/v) SDS, added to 3 ml of Emulsifier-SafeTM liquid scintillation
cocktail in polyethylene Pico PriasTM vials and intracellular radioactivity was quan-
tified by liquid scintillation counting using the Packard Tri-Carb 2900. As a control,
10 µM indinavir [Murata et al., 2002] was used to determine the GLUT4-specific
transport in cultures from WT and TBC1D4−/− mice. All values were expressed in
pmol/h/cm2.
3.2.1.16 Cell surface biotinylation
Differentiated TAL cells on filters were washed 5 min with ice-cold 1x PBS supple-
mented with 0.1 mM CaCl2 and 1 mM MgCl2. TAL cells were incubated for 40
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min on a shaking rotor at 10 rpm/min at 4◦C in 100 mg/ml Sulfo-NHS-LC-Biotin
dissolved in 1x PBS (with 0.1 mM CaCl2 and 1 mM MgCl2) and washed two times for
5 min at 4◦C in 1x PBS containing 0.1 mM CaCl2, 1 mM MgCl2 and 0.1 M glycine,
to quench unbound biotin. The cells were lysed in 60 µl RIPA buffer (supplemented
with phosphatase and protease inhibitors) for 90 min rotating at 10 rpm/min at 4◦C
and collected from filter by pipetting. Cells from 4 filters per condition were pooled.
Afterwards, the samples were centrifuged at 10000 rpm for 10 min at 4◦C. 160
µl of streptavidin agarose beats was added to an equal amount of supernatant and
incubated overnight while rotating. The pellet and the remaining supernatant (total
proteins = TL) were stored at -80◦C. The next day, the beat-lysate samples were
quickly centrifuged and the supernatant was collected (postbiotinylated proteins =
PBP). The lysates (biotinylated proteins = BP) were washed 3x with 1x PBS and
once with a 1x high salt buffer for 5 min at 4◦C. An equal amount of 2x Laemmli
buffer was added and samples were boiled for 10 min at 75◦C. Protein fractions were
used for Western blot analysis as described in 3.2.1.11.
3.2.2 Microarray
3.2.2.1 Isolation of single tubular fragments by complex object parametric
analysis and sorting (COPAS)
For complex object parametric analysis and sorting (COPAS), 8-week old male
TBC1D4+/+-PV-EGPF+ and TBC1D4−/−-PV-EGFP+ mice were used. Prepara-
tion of single tubular fragments and COPAS were performed by Claudia Su¨nder-
mann. To isolate single tubular fragments, mice were anasthesized with isoflurane
as described before and perfused through the heart with 10 ml of ice-cold PBS
and subsequently, with 10 ml of digestion solution (1 mg/ml collagenase type-1,
1mg/ml hyaluronidase, 0.1mg/ml DNase I prepared in ice-cold KREBS buffer: 145
mM NaCl, 10 mM HEPES, 5 mM KCl, 1 mM NaH2PO4, 2.5 mM CaCl2, 1.8 mM
MgSO4, 5 mM D-glucose, pH 7.3). Renal cortex from both kidneys was dissected
under a stereomicroscope (CLS150X) and further minced and digested in 10 ml of
fresh digestion solution for 17 min at 37◦C. The tubular digest underwent several
filtrations through nylon sieves of cell strainers of 250, 212, 100 and 40 µm pore size.
The tubules retained by the 40 µm cell strainer were diluted with ice-cold KREBS to
a total volume of 50 ml. All sortings were performed with the COPAS instrument.
The full description and settings for fluorescent renal collection duct sorting can be
found in Miller et al. [2006] and Picard et al. [2014]. In an eppendorf-tubes con-
taining 1 ml of ice-cold KREBS buffer supplemented with 0.05 % BSA, 800 tubular
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green fluorescent DCT1-segments were collected. For one animal, 10-15 eppendorf-
tubes were yieled. Tubules were centrifuged at 800 g for 10 min, the supernatant
was removed and the pellet resuspendend in RNA lysis buffer (see next section).
3.2.2.2 RNA extraction of COPAS sorted DCT-segments
RNA isolation was performed using the high pure RNA isolation kit, a kit adapted
to extract RNA of small sample size with a high RNA purity yield (A260/280 and
A260/230 ± 2). 30 µl of RNA lysis buffer was added to each tube, vortexed and
pooled. In order to minimize loss of material, each tube was flushed with additional
20 µl, vortexed and added to the pool. The following steps were pursued according
to the manufacturer’s instructions with DNA digest on columns. Finally, RNA was
yielded in 35 µl elution buffer. 10 µl of RNA extracts were used for qRT-PCR after
reverse transcription (see previous sections) and 25 µl were handed to the Functional
Genomics Center Zurich (FGCZ) for microarray analysis.
Primers gene Primer sequence 5’-3’ forward Primer sequence 5’-3’ reverse
COMMd6 GTCACGGGCCAGCTTATAGA ACTTGGCCAGAGTGATCTGC
Dehydro TTCGTGACCAGGCAATTCTT CCCTTCTTGGATTTTGCCAG
Enoyl GTCAATGCCATCAGTCCAAC GGCTTCTGGTATCGCTGTAT
GAPDH CATGGCCTTCCGTGTTCC CCTGCTTCACCACCTTCT
Iqgap1 GGAGTTACTGCTGCTACGGT TCCAGGACGGAGCCATAGTG
MACA AGCCAATGATGTGTGCTTAC GGCTTTACTAGCGGGTACTT
PGC1α CGAGGACACGAGGAAAGGAA CACTGGCCTGAATCTGTGGA
PGC1β CACGGTTTTATCACCTTCCG ATGGCTTCGTACTTGCTTTT
Ptprb CACCCAGGGAGGTCCTATCA GCGGCAATGCAGGTTTTGTA
Scd1 fwd CAGGTTTCCAAGCGCAGTTC ACTGGAGATCTCTTGGAGCA
Spry2 fwd CCGATTGCTTGGAAGTTGGAC GAACACATCTGAACTCCGTGA
TBC1D10a TCGTCTTCGATGCCAGAAGG GTCCAGCTCATCAAACTTCCC
TBC1D4 GCGCCAACGAATCTCTGGTGGAT GCATGGGGCAGGTCTCGCAC
Table 6: Primers used for qRT-PCR
3.2.2.3 Transcriptomic comparison between TBC1D4−/− and WT DCTs using
Affymetrix Microarray analysis
Affymetrix microarray analysis was used to investigate for differentially regulated
mRNAs in the DCT, a segment with high TBC1D4 expression [Lier et al., 2012], be-
tween WT and TBC1D4-deficient mice. 4 mice per group (TBC1D4+/+-PV-EGFP+
vs. TBC1D4−/−-PV-EGFP+) were used under standard conditions. All steps af-
ter RNA-lysates handover were performed by the FGCZ: quality analysis of each
total RNA sample with the 2100 Bioanalyzer and NanoDrop ND-1000, generation
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of labeled cDNA from 100 ng of total RNA, running the Affymetrix GeneAtlas mi-
croarray and the analysis of hybridization-images from cDNA on the gene chips.
The microarray experiment compared 4 TBC1D4−/− samples versus 4 WT sam-
ples on Affymetrix 1.1 Mouse Gene Array. The resulting values of expression have
been summarized on the gene level using RMA algorithm [Irizarry et al., 2003].
The analyses have been performed with Bioconductor libraries [Gentleman et al.,
2004] encapsulated in the b-fabric system of the FGCZ. The pairwise comparison
between TBC1D4−/− and WT was based on log2 expression ratios and p-values of
the (unpaired, two-group, two-tailed) t-test. The significant genes were confirmed
to have high absolute log2 fold change and low p-values. The detection filtering
condition was also set to find the genes that have the expression above standardized
background for this type of chip (Exp >10; log2 Exp > 3.322).
3.2.3 Cell culture
Human embryonic kidney 293 (HEK293) cells were cultivated in DMEM supple-
mented with 10 % heat-inactivated FBS and 1 % penicillin/streptomycin (100
U/ml). Starvation medium consisted of DMEM without supplements. Both me-
dia were filtered through a 0.22 µm filter before use. HEK293 cells were cultivated
in T75 flasks in a cell incubator with an air atmosphere of 5 % CO2 and 37
◦C.
Medium was changed every two to three days and cells were splitted twice per week.
3.2.3.1 Transformation of bacteria
20 µl of Quick change R©XL1-blue supercompetent E. coli cells together with 2 µl of
pcDNA-3.1(+)-hNCC were heat shocked for 30 sec at 42◦C and afterwards put on
ice for 5 min. Thereafter, 400 µl of SOC medium was added to the bacteria mix
and incubated for 1 h at 400 rpm at 37◦C. Then, the mixture was centrifuged at
5000 rpm for 1 min and the pellet was resuspended in 1 ml SOC medium. 100 µl
of supernatant was plated on ampicillin-agarose plates and incubated overnight at
37◦C. The next day, 3 ml LB medium supplemented with ampicillin (50-100 µg/ml)
was inoculated with a single bacterial colony picked from the plate. The infected
LB medium was incubated overnight in a shaker at 300 rpm at 37◦C, and DNA
was extracted after 16-24 h using the ZR plasmid Minipred classic kit. For higher
DNA yield, 100 ml LB medium with ampicillin was inocculated with 2 ml baterial
solution and again, incubated for 16-24 h. DNA was extracted using the Power prep
HP Plasmid Minipred kit.
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3.2.3.2 Stable transfection of HEK293 cells
For transfection, 8*105 cells were seeded into one well of a 6 well culture plate
and grown until reaching 50-60 % confluency. Transfection was performed using
Metafectene Pro and linearized (Eco RI) or circular pcDNA-3.1(+)-hNCC plasmid
in a ratio of 6:1 (Metafectene:plasmid) by following manifacture’s instruction. To
achieve stable transfection, 1000 µl/ml G-418 sulphate was added after 48 h to select
for only those cells who inserted the gentamycin-cassette from the pcDNA-3.1(+)-
hNCC plasmid. The selection medium was changed every second day and cells were
split at 80 % confluence. Non-transfected/control HEK293 cells were cultivated in
parallel with approximately the same number of passages.
3.2.3.3 RNA and protein extraction
HEK293 cells grown on 6 well plates were scratched from plastic with 1 ml of PBS
and collected in an eppendorf tube. Cells were quickly centrifuged and the pellet
was used for either RNA or protein extraction. For RNA extraction, the pellet
was resuspended in RNA lysis buffer from the RNAqueous-Micro RNA isolation kit
with DNase I treatment and following the kit’s protocol. The RNA concentration
was measured using NanoDrop (see above). For protein extraction, the pellet was
resuspended in RIPA buffer supplemented with 50 x protease inhibitor cocktail and
20x phosphatase inhibitor and incubated for 30 min on ice. Afterwards, the mix was
centrifuged at 5000 rpm for 10 min at 4◦C to pellet cell debris. Protein concentration
of the supernatant was assessed by Bradford assay and 25-50 µg of total protein were
used for western blot analysis as described before.
3.2.3.4 Immunofluorescence/Immunocytochemistry
HEK293 and HEK293-hNCC cells were grown on sterilized and collagen-coated 22-
mm coverslips out in each well of a 6-well plate and up to a confluence of 60-80 %.
The cells were washed two times with ice-cold PBS containing 1 mM MgCl2 and
0.1 mM CaCl2 and fixed in a methanol-acetone solution (1:1, v/v) for 5 min at 4
◦C.
Further on, cells were fixed with 4 % PFA in 0.1 M phosphate buffer for 20 min
at room temperature. Subsequently, cells were washed three times in ice-cold PBS
and then put in blocking solution containing 0.04 % Triton X-100 to permeabilize
the cells. Primary antibodies were added to the fixed cells in blocking solution
(withouth Triton X-100) and incubated overnight at 4◦C. Again, cells were washed
three times in ice-cold PBS and secondary antibody as well as DAPI (1:1000) were
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added. After 2-4 h of incubation at room temperature, cells were quickly washed
with PBS. The following steps were performed as described under IHC (3.2.1.13).
3.2.3.5 In cell western (ICW)
5-10*103 HEK293-hNCC cells were seeded into each well of a 96 well plate. After
reaching approximately 80 % confluency, treatment with 50 nM Calyculin A (CA)
for 30 min was performed. Afterwards, cells were washed once with PBS and fixed
with 4 % PFA in PBS for 20 min at 4◦C. Cells were then washed three times in 0.1 %
Triton X-100 in PBS on a shaker for 5 min and blocked using LI-COR blocking buffer
for 30 min. Primary antibodies dissolved in LI-COR blocking buffer were incubated
overnight at 4◦C. The following washing and incubation steps were performed as
described in 3.2.1.11. The secondary antibody concentration was adjusted to a
much higher concentration of 1:100-1:200, and in the LI-COR scanner the focus was
set accordingly to the height of the plate (+ 0.5 cm).
3.2.4 Statistical analysis
Statistical analyses were performed with the GraphPad Prism Software, Inc. (San
Diego, California, USA). Data are represented as means ± SEM and were tested
for significance using one- or two-way ANOVA analyses followed by unpaired stu-
dent’s t-test and Bonferroni multiple comparisons where appropriate. P < 0.05 was
considered statistically significant.
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4 Results
4.1 Project 1, part I: TBC1D4-deficiency and renal salt
and water handling
4.1.1 No sign of hyper- or hypotension in TBC1D4−/− mice
From previous in vitro studies, we suggested TBC1D4−/− mice to show i) a PHAI-
salt losing phenotype in case of TBC1D4 being a stabilizer of ENaC as described
by data of our group and Liang and coworkers [Gresko, 2011; Liang et al., 2010].
Hence, TBC1D4 deficiency would lead to an impairment of ENaC membrane in-
sertion, abundance and function with consequently decreased total body volume
causing hypotension or ii) as demonstrated by Liang et al., lead to hypertension
through increased ENaC activity by the removal of the negative trafficking regula-
tor TBC1D4. Therefore, using the tail-cuff method, we measured the systolic blood
pressure (SBP) of TBC1D4-deficient female and male mice and their corresponding
wild-type (WT) littermates. Overall, the SBP did not change between WT and
TBC1D4−/− mice independently of the gender (Figure 14 A and B). Solely, the
SBP of male TBC1D4+/− vs. TBC1D4−/− mice was reduced under standard diet
(SD) (Figure 14 B). To investigate whether TBC1D4−/− mice manifest a change in
blood pressure under challenging dietary conditions, female TBC1D4−/− mice were
kept for four months on a high fat diet (HFD, 30 % fat, Figure 14 C). After one
additional month on a high salt high fat diet (HSHFD, 5 % Na+, Figure 14 D),
blood pressure measurement was repeated. Under neither condition, differences in
mmHg between knockout and wild-type littermates could be observed.
4.1.2 TBC1D4−/− mice show no Liddle’s syndrome- or PHAI-like
phenotype
In order to gain more insights into the renal physiological role of TBC1D4, especially
in regard to ion and water homeostasis, we performed metabolic studies, blood gas
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Figure 14: TBC1D4−/− mice show no difference in SBP under different di-
etary conditions A Systolic blood pressure (SPB) was measured using
the tail-cuff method in wild-type (WT), TBC1D4+/− (HETERO) and
TBC1D4−/− (KO) mice under standard diet (SD) (0.19 % Na+, 4.2 %
fat). No statistical difference was observed between WT and KO litter-
mates. B Only in male HETERO vs. KO mice, SBP was reduced (114.8
± 2.69 mmHg TBC1D4+/− vs. 102.83 ± 3.82 mmHg TBC1D4−/−, p <
0.05). C SBP measured in female mice under SD and high fat diet (HFD)
(0.19 % Na+, 30 % fat) for four months. D SBP measured in female
mice under SD, HFD and high salt-high fat-diet (HSHFD) (5 % Na+,
30 % fat) in the same mice as in B after one month. No rise or drop in
blood pressure was detectable in KO compared to WT littermates. Each
bar depicts the average values of 3 days. Values are ± S.E.M. Statistical
significance was calculated with the two-tailed and unpaired student’s
t-test (# vs. HETERO, p < 0.05).
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Standard diet (SD)
WT n KO n p-value
Bodyweight [g] 31.94 ± 2.18 8 30.88 ± 0.66 7 0.067
Food intake [mg/g BW//24 h] 109.929 ± 20.542 4 113.724 ± 26.837 4 0.913
Water intake [µl/g BW/24 h] 151.69 ± 39.2 4 138.079 ± 9.164 3 0.784
Urine excretion [µl/24 h] 23.266 ± 10.083 4 27.007 ± 13.976 3 0971
UOsmolarity [mOsm] 296.25 ± 56.092 4 412.0 ± 92.43 3 0.277
UNa+ (norm. to Creat.) 8.988 ± 1.385 4 8.929 ± 1.137 4 0.975
UK+ (norm. to Creat.) 32.999 ± 5.66 4 41.934 ± 5.970 4 0.312
URatio N+/K+ 0.276 ± 0.026 4 0.221 ± 0.031 4 0.225
UAldosterone [ng/24 h] 13.36 ± 4.31 7 13.30 ± 4.46 6 0.957
pH 7.42 ± 0.03 4 7.41 ± 0.01 4 0.837
pCO2[mmHg] 29.5 ± 2.54 5 26.43 ± 2.09 4 0.400
Haematocrit (%) 45.86 ± 1.24 5 44.03 ± 1.89 4 0.426
Na+ [mM] 147.5 ± 0.65 4 146.25 ± 0.48 4 0.171
K+ [mM] 4.30 ± 0.15 4 3.98 ± 0.29 4 0.359
Cl− [mM] 112.75 ± 0.75 4 112.5 ± 0.50 4 0.791
Ca2+ [mM] 1.268 ± 0.02 4 1.295 ± 0.006 4 0.234
Corticosterone [nM] 658.71 ± 91.25 7 811.55 ± 76.52 6 0.235
Aldosterone [nM] 0.64 ± 0.13 7 0.86 ± 0.17 6 0.328
Table 7: Metabolic and physiological parameters as well as blood gas and
hormonal level of TBC1D4−/− (KO) and wild-type (WT) litter-
mates on standard diet Values are S.E.M., n = number, norm. to creat.
= normalized to creatinine. Statistical significance was calculated using
student’s t test.
analyses and determined hormonal levels (e.g. aldosterone, corticosterone) in WT
and TBC1D4−/− mice. Bodyweight, food and water intake were similar between
WT and TBC1D4-deficient littermates on SD (Table 7). Although slightly higher
levels were presented in TBC1D4−/− mice, urine volumes and osmolarity were not
statistically different. We further wanted to investigate whether urinary ion excre-
tion is changed, which is a common characteristic of Liddle’s syndrome (e.g. higher
K+ excretion) or PHAI (e.g. increased Na+ excretion). Neither fractional urinary
Na+ nor K+ excretion was different between the genotypes. To exclude the possi-
bility of counter-acting effects of altered aldosterone level, which might mask the
effect of TBC1D4 for example on ENaC activity, we measured urinary and plasma
aldosterone levels. However, despite our assumption of a regulatory compensation
by altered aldosterone levels, TBC1D4−/− mice displayed similar aldosterone lev-
els in both, urine and plasma, when compared to their WT littermates (Table 7).
Moreover, blood gas analyses of important physiological parameters (pH, pCO2,
hematocrit) showed no alterations. Plasma electrolytes levels (Na+, K+, Cl−, Ca2+)
were similar in both genotypes. Plasma corticosterone levels were slightly but not
significantly elevated in TBC1D4−/− compared to WT mice (Table 7).
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4.1.3 Similar protein levels of important water and salt
transporters and channels in TBC1D4−/− mice on standard
diet
Despite the strong in vitro effect of TBC1D4 deficiency in renal cells, TBC1D4−/−
mice did not show any signs of hyper- or hypertension and of a dysregulation in
plasma as well as urinary ion levels and volumes on SD when compared with their
wild-type littermates. Compensation via altered aldosterone levels as shown by the
analysis of urinary and plasma aldosterone did not occur. Potentially, other compen-
satory mechanisms might explain the rather normal phenotype of TBC1D4−/− mice.
Therefore, we performed immunoblot analyses of various proteins involved in sodium
and water transport along the nephron. In the TAL, which does not belong to the
ASDN, protein abundance of the NKCC2 transporter was not altered in TBC1D4−/−
mice. Furthermore, total NCC and its phosphorylation sites pT53, pT58 and pS89
in the DCT did not show significant changes between WT and TBC1D4−/− ani-
mals. Likewise, in the ASDN, all three subunits of ENaC (α, β, γ) as well as AQP2
were not different in protein abundance between the genotypes. In addition, protein
levels of the Na+-K+-ATPase showed no alteration between TBC1D4−/− and WT
littermates (Figure 15). Thus, in kidney lysates on SD of TBC1D4−/− compared to
WT mice, no major difference in the abundance of pivotal proteins known to handle
Na+ and H2O reabsorption was observed.
4.1.4 No change in physiological parameters in TBC1D4−/− mice
when maximally stimulating the RAA-system with a low
Na+/high K+ diet
Although under SD no abnormal renal phenotype was observed in TBC1D4-deficient
mice, other mice with gene deletions (e.g. for the E3-ubiquitin ligase Nedd4-2,
SGK1) have been demonstrated to reveal renal impairments only after metabolic
challenges [Faresse et al., 2012; Ronzaud et al., 2013]. Therefore, mice were fed a
diet containing low Na+ (< 0.03 %) and high K+ (5 %) levels (low Na+/high K+
diet; LNa/HKD) to maximally stimulate the RAA-system, a multi-organ hormonal
system that is crucial for blood pressure regulation. Juxtaglomerular cells lining
next to the afferent arterioles of the glomerulus secrete renin into the blood stream,
when blood volume levels are low. In the blood, renin catalyzes the cleavage of
liver angiotensinogen into angiotensin I, which is further cleaved by the angiotensin-
converting enzyme to angiotensin II. Angiotensin II stimulates the aldosterone secre-
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Figure 15: Western blot analysis of important salt and water transporting
proteins of WT and TBC1D4−/− mice under SD Left: Western blot
analysis (WT and TBC1D4−/−, n = 7), right: densitometric anaylses,
values are ± SEM. Statistical significance was calculated using two-tailed
and unpaired student’s t test.
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Low Na+/high K+-diet (LNa/HKD)
WT KO p-value
Bodyweight [g] 22.0 ± 0.38 22.24 ± 0.73 0.778
Food intake [mg/g BW//24 h] 234.942 ± 24.842 217.766 ± 15.026 0.570
Water intake [µl/g BW/24 h] 348.662 ± 43.426 298.110 ± 18.705 0.316
Urine excretion [µl/24 h] 159.097 ± 36.666 118.455 ± 19.576 0.357
UOsmolarity [mOsm] 309.0 ± 49.13 327.4 ± 30.53 0.759
UNa+ (norm. to Creat.) 5.284 ± 0.736 5.609 ± 0.433 0.903
UK+ (norm. to Creat.) 894.308 ± 68.635 909.041 ± 94.252 0.903
Ratio N+/K+ 0.006 ± 0.001 0.007 ± 0.001 0.622
UAldosterone [ng/24 h] 373.09 ± 51.29 353.88 ± 64.80 0.819
Corticosterone [nM] 304.41 ± 26.70 416.15 ± 59.98 0.127
Aldosterone [nM] 5.24 ± 1.05 5.15 ± 1.45 0.960
Table 8: Metabolic and physiological parameters as well as blood gas and
hormonal level of TBC1D4−/− (KO) and wild-type (WT) litter-
mates on low Na+/high K+-diet Values are S.E.M., WT and KO mice
n = 5, norm. to creat. = normalized to creatinine. Statistical significance
was calculated using student’s t test.
tion from adrenal glands. Aldosterone mainly increases Na+-retention by activation
of ENaC, thus regulating circulating volumes and blood pressure. Also under these
conditions, metabolic parameters such as bodyweight, water and food intake were
not different between WT and TBC1D4−/− mice. Urine excretion and osmolarity
as well as urinary Na+ and K+ levels were not significantly altered in TBC1D4−/−
mice on LNa/HKD compared to wild-type mice. Renin mRNA levels of whole kid-
ney lysates were measured, but neither renin mRNA (Figure 16) nor plasma and
urinary aldosterone levels differed between the genotypes. Remarkably, plasma and
urinary aldosterone levels were highly elevated in TBC1D4-deficient and WT mice,
confirming the dietary effect of maximally stimulating the RAA-system (plasma SD
vs. LNa/HKD aldosterone; WT p < 0.005 and TBC1D4−/− mice p < 0.05, urine
SD vs. LNa/HKD aldosterone; WT p < 0.005 and TBC1D4−/− mice p < 0.005)
(values shown in table 7 SD and table 8 LNa/HKD). Plasma corticosterone levels
were slightly but not significantly increase in TBC1D4−/− animals compared to WT
animals.
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Figure 16: Renin mRNA levels Similar renin mRNA levels in whole kidney lysates
of TBC1D4-deficient (KO) mice compared to WT mice. Values are ±
S.E.M and normalized to GAPDH expression, n ≥ 3. Statistical signifi-
cance was calculated using student’s t test.
4.1.5 Similar proteins levels of important water and salt
transporters and channels in TBC1D4−/− mice on low
Na+/high K+ diet
Analogously to the studies on SD, we investigated the protein abundance of NKCC2,
NCC, ENaC, AQP2 and the Na+-K+-ATPase in TBC1D4−/− mice under the chal-
lenging LNa/HKD. Again, neither the transporter abundance of NKCC2 and NCC
nor the phosphorylation of NCC (pT53, pT58 and pS89) was different between
KO and WT animals. The abundance of ENaC with its three subunits α, β, γ
and the proteolytically cleaved bands of the α- (35 kDa) and γ-subunit (70 kDa)
were unchanged in TBC1D4-deficient mice compared to WT mice. Furthermore,
TBC1D4−/− mice showed similar protein abundance to WT mice for the 25 and
35 kDa band of AQP2, and the Na+-K+-ATPase (Figure 17). Overall, the chal-
lenging conditions did not reveal any differential regulation on renal water and salt
transporters and channels between WT and TBC1D4−/− mice.
4.1.6 No apparent disturbances in the vasopressin-signaling
pathway of TBC1D4−/− littermates
To investigate whether TBC1D4−/− mice might have a different urine concentrating
ability caused by impairments in AQP2-transport as suggested by TBC1D4 deple-
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Figure 17: Western blot analysis of important salt and water transporting
proteins of WT and TBC1D4−/− mice under LNa/HKD Left:
Western blot analysis (WT and TBC1D4−/−, n = 5), right: densitometric
anaylses, values are ± SEM. Statistical significance was calculated using
two-tailed and unpaired student’s t test.
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tion in vitro [Jung and Kwon, 2010; Kim et al., 2011], we challenged the mice with
a mild 24 h water restriction (WR). A mild WR was performed in order to prevent
a maximal stimulation of the vasopressin and renal collecting system, which could
allow full compensation and mask subtle differences in the urinary concentrating
mechanism. The relevance of this caveat has been demonstrated in previous studies
[Zuber et al., 2007]. Therefore, the drinking bottle was removed, but the food was
moisturized with 50 % of milliQ-water. When compared with the previous 48 h
ad libitum food and water access, food intake slightly increased during 24 h WR in
both genotypes but was not different between TBC1D4−/− and WT mice (Figure
18 A). WT as well as TBC1D4−/− littermates significantly reduced urine volumes
during WR compared to the previous 48 h period (p = 0.024 and p = 0.04, re-
spectively) (Figure 18 A). Furthermore, urine osmolarity was increased in the WT
group (p = 0.027) and TBC1D4−/− mice showed a similar increase, although the
increase did not reach statistical significance (p = 0.14) (Figure 18 A). Total water
intake, calculated from drinking water and water content of the food, was slightly
decreased confirming our aim to mildly deprive the mice from water (Figure 18 B).
The urinary ion (Na+, K+, Mg2+) excretion during WR was not different between
WT and KO mice (Figure 18 C). Likewise, urinary aldosterone excretion was similar
for WT and KO mice (Figure 18 D).
4.1.7 Similar protein levels of water and salt transporters and
channels in TBC1D4−/− mice on high fat diet
In addition, we analyzed the abundance of renal Na+-transporting proteins in kid-
neys of WT and TBC1D4−/− mice, when fed a high caloric fat-enriched diet. The
Na+-transporters present in the PT, NaPiIIa and NHE3, showed no dysregulation, as
well as the Na+-transporting proteins NKCC2, NCC, and ENaC in the distal tubule
and the collecting system. Also the Na+-K+-ATPase was not differently abundant
between WT and TBC1D4−/− mice, when compared to their WT littermates under
a HFD (Figure 19).
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Figure 18: Metabolic parameters of WT and TBC1D4−/− mice under water
restriction (WR) A Mice were restricted from water for 24 h. Food
intake increased slightly but not significantly during WR in both groups.
Urine volumes and osmolarity were similar before and after WR between
the genotypes, but urine volumes were significantly reduced (WT, 48 h
ad. lib. vs. 24 h WR, 40.3 ± 5.6 vs. 18.2 ± 5.6 µl/24 h/g BW, p =
0.024, TBC1D4−/− 49.6 ± 7.4 vs. 27.8 ± 4.9 µl/24 h/g BW, p = 0.04)
and urine osmolarity increased in both groups (WT, 48 h ad. lib. vs.
24 h WR, 22.4 ± 3.6 vs. 51.7 ± 10.2 mOsm/24 h/g BW, p = 0.027,
TBC1D4−/− 22.5 ± 3.0. vs. 49.2 ± 16.0 mOsm/24 h/g BW, p = 0.14).
B Total water intake (calculated from water intake and water content in
the food) was lowered as intended C Measurements of urinary cations
did not show any difference in Na+, K+ and Mg2+ excretion D Urinary
aldosterone levels were similar under WR between WT and TBC1D4−/−
mice. White bars WT (TBC1D4+/+), black bars TBC1D4−/− mice, n =
5, mean ± SEM, student’s t test, *p ≤ 0.05
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Figure 19: Western blot analysis of important salt and water transporting
proteins of WT and TBC1D4−/− mice under HFD Left: Western
blot analysis (WT and TBC1D4−/− n ≥ 6), right: densitometric anaylses,
values are ± SEM. Statistical significance was calculated using two-tailed
and unpaired student’s t test.
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4.2 Project 1, part II: TBC1D4-deficiency and systemic
and renal glucose handling
4.2.1 TBC1D4−/− mice gain less body weight under HFD
compared to WT littermates
The body weights (BW) of TBC1D4−/− and WT mice were monitored over 6 month
on SD and HFD (Figure 20). Under SD, BWs increased significantly over a 6 month
period (WT begin vs. after 6 months p < 0.0005 and KO begin vs. end p < 0.0005),
but were not different between the genotypes (begin WT 19.94 g ± 0.43 g, n = 8
and TBC1D4−/− 21.11 g ± 1.52 g, n = 7, p > 0.05, after 6 months WT 31.94 ± 2.16
g, n = 8 and KO 30.89 ± 0.59 g, n = 7, p > 0.05). Interestingly, after 6 months on
a HFD, TBC1D4−/− mice gained less BW in comparison to WT mice (begin WT
25.02 ± 2.5 g, n = 11 and KO 21.96 ± 1.18 g, n = 8, p > 0.05, after 6 months WT
41.44 ± 2.5 g, n = 11 and KO 32.89 ± 2.20 g, n = 8, p < 0.05). BW also increased
with time in both genotypes under HFD (WT begin vs. after 6 months p < 0.0001
and KO begin vs. after 6 months p < 0.0005) (Figure 20 D).
4.2.2 TBC1D4−/− mice have an improved glucose tolerance under
HFD compared to WT mice
As TBC1D4 is highly expressed in muscle and fat cells and is known to regulate
glucose uptake into skeletal muscle and fat cells, we analyzed whole body glucose
homeostasis in WT and TBC1D4−/− mice. Therefore, we performed a glucose tol-
erance test (GTT) (1.75 mg glucose/g BW) after an overnight fast (16 h). Inter-
estingly, TBC1D4−/− mice had reduced blood glucose levels at the beginning of the
GTT under SD and HFD (Figure 21). In general, TBC1D4−/− seemed to have
an improved glucose tolerance shown by a faster glucose disposal over the 180 min
measured, which was more pronounced under a HFD [area under the curve (AUC);
SD WT 1347.19 ± 84.48, n = 8 vs. KO 1197.97 ± 54.11, n = 7, p = 0.17; HFD
WT 1745.70 ± 60.25, n = 19 vs. KO 1420.36 ± 46.67, n = 16, p < 0.0003, only
female mice were used]. These results are similar to what was shown by Wang et al.
[2013], who used male mice, but contrast to the results of Lansey et al. [2012], in
which glucose tolerance was impaired in female TBC1D4−/− mice, but normal in
male mice (Table 1, 1.8.2).
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Figure 20: Body weights of WT and TBC1D4−/− mice over 6 months on
SD and HFD A + B bar blots comparing start of the experiment
and after 6 months A on SD, body weight was not different between the
genotypes B on HFD, BW gain was significantly lower in TBC1D4−/−
vs. WT mice C + D Line plots. BWs were not different over time under
SD, but significantly changed over time on HFD between TBC1D4−/−
vs. WT mice. Values are means ± SEM. BW was measured twice a
week, two-way ANOVA with Bonferroni’s Multiple Comparison Test, *p
< 0.05
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Figure 21: Interperitonal glucose tolerance test (GTT) TBC1D4−/− mice have
an improved glucose tolerance under a HFD. The area under the curve
(AUC) shows significantly decreased values for TBC1D4−/− (KO) mice.
under HFD (***p < 0.0005) over 90 min compared to WT littermates.
Values are ± SEM, student’s t test, *p < 0.05, **p < 0.005, ****p <
0.0001.
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4.2.3 TBC1D4−/− mice are insulin resistent
To determine whether the improved glucose tolerance was due to a higher insulin
sensitivity, an insulin tolerance test (ITT) was performed. Mice were synchronized
by starvation 3 h prior the i.p. insulin injection (0.75 mU/g BW). Unexpectedly,
TBC1D4-deficient mice presented insulin resistance (Figure 22) [area under the curve
(AUC); SD WT 230.98 ± 27.41, n = 6 vs. KO 303.8 ± 9.0, n = 6, p < 0.03; HFD
WT 295.75 ± 32.13, n = 10 vs. KO 362.84 ± 20.80, n = 10, p < 0.1, over 90 min,
only female mice]. The effect was even more pronounced, when only the period
after insulin injection (15-90 min) was compared. (SD WT 162.85 ± 25.63, n = 6
vs. KO 244.82 ± 7.38, n = 6, p = 0.012; HFD WT 207.77 ± 27.94, n = 10 vs.
KO 287.22 ± 16.61, n = 10, p = 0.025). Likewise, Lansey et al. [2012], and Wang
et al. [2013], found insulin resistance in male and female TBC1D4−/− mice and in
male TBC1D4−/− mice tested at different age. Again, in all our experiments, basal
glucose levels were much lower in TBC1D4−/− mice compared to WT mice (see
Table 9, 4.2.4, and Table 1, 1.8.2).
Figure 22: Interperitonal insulin tolerance test (ITT) TBC1D4−/− mice show
an insulin resistance over a period of 90 min under SD and a tendency
under HFD (p = 0.0967) compared to WT mice.
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4.2.4 TBC1D4−/− mice are normoinsulemic but hypoglycemic
under fasted conditions
From the results obtained from the ITT, the next question to address was whether
the impaired insulin tolerance was due to an increased insulin secretion (Table 9).
Under all three tested dietary conditions (SD, HFD, LNa/HKD) and under feeding
ad lib., TBC1D4-deficient mice did not show any increased plasma insulin values
when compared to WT mice. Nevertheless, TBC1D4−/− animals exhibited a slight
hypoglycemia on SD and LNa/HKD and a strong hypoglycemia under starved con-
ditions under SD and HFD compared to WT animals (Table 9). Thus, TBC1D4−/−
mice compared to WT mice are not hyperinsulemic, but have constantly lowered
blood glucose levels.
SD LNa/HKD HFD
WT n KO n WT n KO n WT n KO n
PInsulin 0.4 7 0.35 7 0.66 5 0.55 5 0.39 7 0.53 7
(random fed) ± 0.04 ±0.01 ±0.07 ±0.06 ±0.01 ±0.12
PGlucose 8.72 5 7.43 3 7.08 5 5.3 5 8.54 5 8.17 5
(random fed) ±0.46 ±0.32$ ±0.56 ±0.34* ±0.21 ±0.49
PGlucose 3.56 8 2.4 7 3.72 5 3.6 5 4.61 19 3.33 16
(starved GTT) ±0.19 ±0.2* ±0.39 ±0.35 ±0.14 ±0.19****
PGlucose 6.03 6 4 6 n.d. n.d. 7.65 10 5.62 10
(starved ITT) ±0.23 ±0.21**** ±0.38 ±0.28***
Table 9: Plasma insulin and glucose levels under random fed and starved
conditions of TBC1D4−/− (KO) and wild-type (WT) littermates on
different diets Values are± SEM, student’s t test, *p < 0.05, ***p < 0.0005,
****p < 0.0001, $p < 0.1, GTT = glucose tolerance test, ITT = insulin
tolerance test, PInsulin = plasma insulin, PGlucose = plasma glucose, n.d.
not determined
4.3 GLUT4 gene and protein expression analysis in
kidney of WT mice
4.3.1 Analysis of GLUT4 gene expression in microdissected
tubules of WT mice
The previous studies did not provide any evidence that TBC1D4 is involved in
the regulation of renal ion and water transporting proteins. Therefore, we next
tested the hypothesis that TBC1D4 might be involved in the regulation of renal
glucose transporters, in particular GLUT4. Thus, it was first crucial to determine
i) whether GLUT4 is expressed in the kidney and ii) where exactly the transporter
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is found (cell type, intracellular localization). To approach this aim, we used free-
hand renal tubule microdissection and subsequent mRNA expression analysis. qRT-
PCR analysis revealed high GLUT4 gene levels in the TAL, which was therefore
determined as reference segment for which expression levels were set to 100 %.
GLUT4 expression in the glomerulus was 20 ± 4 %, but was very low in PCT and
PST (≤ 7 ± 1 %). Furthermore, the transporter was highly expressed in the DCT
(74 ± 12 %) and modestly in CNT/CD (41 ± 5 %). This expression pattern nicely
matched with the TBC1D4 expression levels along the nephron (Figure 23). Only
the mRNA expression levels for TBC1D4 were slightly higher in the glomerulus
compared to GLUT4 gene levels in this site (TBC1D4 mRNA 35 ± 10 % vs. WT
mRNA 20 ± 4 %, p = 0.17). The qRT-PCR data were further confirmed by IHC
(see next section).
Figure 23: TBC1D4 and GLUT4 mRNA expression along the nephron A +
B GLUT4 mRNA expression overlaps with TBC1D4 mRNA expression
along the nephron (n ≥ 3 for each segment, mean ± SEM, normalized to
GAPDH) of microdissected tubules from WT mice. A TBC1D4: Glom
35 ± 10 %, PCT 8 ± 1 %, PST 7 ± 2 %, TAL 100 ± 19 %, DCT 88 ±
7 %, CNT/CD 34 ± 1 % B GLUT4: Glom 20 ± 4 %, PCT 6 ± 1 %,
PST 7 ± 1 %, TAL 100 ± 18 %, DCT 74 ± 12 %, CNT/CD 41 ± 5 %
4.3.2 Analysis of GLUT4 protein expression along the nephron
via IHC in WT mice
We used two commercially available antibodies against GLUT4 (from Sigma Aldrich R©
and MilliporeTM for immunohistochemistry on fixed kidney cryosections. GLUT4-
immunostaining was detectable in the medullary and cortical TAL as shown by
co-localization with the TAL specific NKCC2. Moreover, GLUT4 was shown by co-
staining for with NCC (DCT-marker) and AQP2 (CNT/CD-marker) to be present
at high levels in DCT, CNT and CD (Figure 24). In the latter two segments, GLUT4
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protein expression levels were higher in intercalated cells than in the segment-specific
CNT and CD cells. In the glomerulus, despite mRNA-results, no GLUT4-staining
could be found. Instead, the close family member, GLUT1 stained parietal epithelial
cells (PECs) in the glomerulus. One possible explanation might be that GLUT4-
antibodies were not sensitive enough to stain for GLUT4 in the glomerulus, or that
GLUT1 replaces GLUT4 in these cells, which might also be regulated by TBC1D4.
Figure 24: Immunohistochemistry of GLUT4 protein expression along the
nephron GLUT4 is seen in NKCC2-positive TALs, NCC-positive DCTs,
and AQP2 positive CNTs and CDs. The bar indicates the transition
from TAL to DCT. GLUT4 is absent from the GLUT1-positive parietal
epithelial cells (PECs, arrow). Consecutive sections, n ≥ 3.
4.3.3 Intracellular distribution of renal GLUT4 in WT mice
The intracellular localization of renal GLUT4 was analyzed by using IHC and con-
focal microscopy. In TAL and DCT, GLUT4 appeared to be localized below the
apical membrane and in a perinuclear region (Figure 25). The latter possibly re-
spresenting the GLUT4-storage vesicles (GSV). In the CNT/CD, especially in the
intercalated cells, the staining for GLUT4 appeared to be most prominent at the
cell basis. However, neither in TAL, DCT nor CNT/CD a clear apical or basolateral
membrane staining was visible.
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Figure 25: Intracellular localization of GLUT4 GLUT4 seems to be localized
below the apical membrane at perinuclear regions in the TAL/DCT. In
the CNT, especially in the intercalated cells GLUT4 appears more pro-
nounced at the basolateral cell side. CALB D28K (green); cytoplasmic
Ca2+ binding protein, GLUT4 (red), DAPI (blue)
4.4 Renal GLUT4 protein levels are reduced in
TBC1D4−/−mice
When we analyzed by western blotting GLUT4 levels in the kidneys of WT vs.
TBC1D4−/− mice, we found decreased GLUT4 expression in TBC1D4−/− mice,
independent from the diet on which the mice were kept (Figure 26). Membrane-
enriched GLUT4 as well as total GLUT4 protein levels were diminished by around
30 - 40 %. Both antibodies (S = from Sigma Aldrich R© and M = from MilliporeTM)
showed the same effect (Figure 27). This data indicates that the Rab GAP TBC1D4
may regulate GLUT4 not only in the previously shown fat and muscle tissue, but
also in the kidney. Interestingly, also GLUT1 protein levels were found to be re-
duced in kidneys of TBC1D4−/− mice compared to TBC1D4 WT mice (Figure 27).
To further analyze the effect of TBC1D4 on GLUT4, the distribution, localization
and abundance of GLUT4 was also studied in kidneys of WT and TBC1D4−/− mice
by IHC. Using an antibody dilution series, it was possible to clearly show that the
GLUT4 signal vanished earlier and more in TBC1D4−/− mice than in WT litter-
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mates (Figure 28). Although the protein abundance was clearly different between
the genotypes, higher magnifications of TBC1D4-positive tubule segments did not
reveal any differences in the subcellular localization of GLUT4 between renal tubules
of WT and TBC1D4-deficient mice.
Figure 26: Western blot analysis of renal GLUT4 of WT and TBC1D4−/−
mice under different diets SD, LNa/HKD and HFD show all a de-
crease of GLUT4 abundance of renal membrane enriched protein fractions
(WT vs. KO: SD 100 ± 8.45 vs. 71.4 ± 7.18, p = 0.024; LNa/HKD 100
± 12.45 vs. 63.38 ± 7.17, p = 0.034; HFD 100 ± 13.61 vs. 59.37 ±
7.81, p = 0.027). Normalized to β-actin. Densitometric analysis in bar
graph, values are ± SEM, student’s t test, *p < 0.05. GLUT4 Sigma (S)
antibody
4.4.1 Upstream proteins and TBC1D1 proteins are not changed in
TBC1D4−/− mice
To investigate whether upstream proteins of the insulin-TBC1D4-GLUT4 pathway
were differentially regulated, immunoblotting was performed of kidney lysates from
mice on SD and LNa/HKD. The phosphorylation level of the Akt kinase, which
itself is activated through phosphorylation by the PI3K at Ser473 (pS473) after
insulin binding, was analyzed (Figure 29). Under SD, Akt pS473 levels were not
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Figure 27: Western blot analysis of renal GLUT4 and GLUT1 of WT and
TBC1D4−/− mice under SD GLUT4 levels of renal membrane en-
riched protein fractions were analyzed with two commercially availably
antibodies (S = Sigma, M = Millipore). GLUT1 (M = Millipore) was
further analyzed. Protein levels were all decreased [WT vs. KO: GLUT4
(S) 100 ± 8.45 vs. 71.4 ± 7.18, p = 0.024; GLUT4 (M) 100 ± 10.13 vs.
70.23 ± 6.48, p = 0.03; GLUT1 (M) 100 ± 6.58 vs. 72.74 ± 4.26, p =
0.004]. Densitometric analysis in bar graph, values are ± SEM, student’s
t test, *p < 0.05
different between WT and KO mice and slightly up-regulated under LNa/HKD in
TBC1D4−/− mice (p = 0.083) (Figure 29). For the close homologue of TBC1D4,
TBC1D1, no differential expression was observed in the kidneys of TBC1D4−/− mice
under SD and LNa/HKD (p = 0.76 and p = 0.260, respectively) (Figure 29), sug-
gesting that altered expression of TBC1D1 does not contribute to the compensation
of the loss of TBC1D4 in knockout mice.
4.4.2 Increased basal glucose uptake in primary TAL cells of
TBC1D4−/− mice
The data presented above suggests that GLUT4 protein abundance is reduced in the
kidneys of TBC1D4−/− mice when compared to WT mice. To investigate the func-
tional impact of altered GLUT4 abundance, an adequate assay system to measure
GLUT4 function was needed. For this, we used the recently established primary
TAL cell culture method [Glaudemans et al., 2013]. qRT-PCR of known genes in
the insulin-signaling cascade of microdissected TAL tubules was performed, which
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Figure 28: GLUT4 IHC/antibody dilution series using two commercially
available antibodies GLUT4 staining disappears earlier in TBC1D4−/−
compared to WT mice on higher antibody dilutions, tested with the
antibody from Sigma and Millipore, n ≥ 3
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Figure 29: Western blot analysis of TBC1D1 and Akt pS473 of WT and
TBC1D4−/− (KO) mice under SD and LNa/HKD Left: Western
blot analysis (n = 5- 7), right: densitometric anaylsis, ± SEM, student’s
t test.
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confirmed the presents of essential genes such as TBC1D4 and GLUT4 as well as
the insulin receptor (IR), the Rab GAP TBC1D1 and the Rab GEF DENND4C
(Table 10).
TAL genes CT ± SEM
GLUT4 28.22 ± 0.085
TBC1D4 24.37 ± 0.22
TBC1D1 22.22 ± 0.035
IR 25.49 ± 0.064
Rab8A 23.49 ± 0.092
DENND4C 24.20 ± 0.085
Table 10: qRT-PCR analysis of genes involved in the insulin-signaling
pathway in lysates of microdissected TALs Values are ± SEM. Trip-
licates were run.
Primary TAL cells were grown on permeable support for a proper differentiation
and polarization (apical vs. basolateral) of the cells. After 14 days in primary
culture, TAL cells taken from WT and TBC1D4−/− mice were analyzed for insulin-
dependent glucose uptake measured by 3H-deoxyglucose uptake. Glucose uptake un-
der unstimulated conditions was significantly higher in TAL cells from TBC1D4−/−
mice compared to TAL cells of WT mice (128.2 %, p = 0.018) (Figure 30 C). Insulin
treatment (300 nM) increased glucose uptake to values seen in unstimulated TAL
cells of TBC1D4−/− mice, when compared to unstimulated basal condition. In TAL
cells of TBC1D4−/− mice, insulin did not stimulate glucose uptake at all (basal vs.
insulin-stimulated: 128.2 % vs. 125.8 % p = 0.82). Indinavir, a reversible blocker
of GLUT4 [Murata et al., 2002], lowered glucose uptake similarly in TAL cells of
both, WT and TBC1D4−/− mice (WT: 101 %, p = 0.004, TBC1D4−/−: 97 %, p =
0.027), suggesting that the insulin-mediated increase in glucose uptake is mediated,
at least in part, by GLUT4. Cytochalasin B, an irreversible blocker of GLUT1-4
[Blodgett et al., 2011], reduced glucose uptake to over 99 % (Figure 30 B).
We also tried to determine the cell surface abundance of GLUT4 in TAL cells. To
reach this aim, the apical and basolateral membrane of primary TAL cells grown
on permeable supports were biotinylated. Subsequently, biotinylated proteins were
purified by streptavidin-beats and then used for immunoblotting. While biotiny-
lated Na+-K+-ATPase was well detectable, biotinylated NKCC2 and GLUT4 were
not detectable, suggesting that their cell surface abundance is below the detection
threshold (Figure 31). Detection of NKCC2 and GLUT4 in total kidneys and total
TAL-cell protein samples served as positive controls. The intracellular β-actin was
only detectable in total kidney and total TAL fractions, but not in the biotinylated
fraction, confirming that only plasma membrane but not intracellular proteins had
been biotinylated (Figure 31).
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Figure 30: Glucose uptake in primary TAL cells A Top and tanslateral view
of TAL cells grown on permeable supports. B Block with the irreversible
GLUT1-4 blocker Cytochalasin B inhibited > 99 % of the glucose uptake
in primary TAL cells. C Basal glucose uptake was increased in TAL cells
of TBC1D4−/− mice and insulin response (300 nM insulin, 15 min) was
abrogated in these cells compared to cells from WT mice. Block with
the specific GLUT4 inhibitor indinavir (10 µM, 15 min) reduced glucose
uptake levels to basal levels of TAL cells from WT mice in both genotypes.
Ins = insulin, ind = indiniavir, * vs. WT basal *p < 0.05, ***p < 0.001,
**p < 0.005, #vs. KO ins, #p < 0.05, n ≥ 3, mean ± SEM.
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Figure 31: Cell surface biotinylation of TAL cells Apical No detection of the
NKCC2 and GLUT4 in the biotinylated protein (BP) fraction. Baso-
lateral The Na+-K+-ATPase was detectable in the BP fraction, but not
GLUT4. The intracellular β-actin was not stained in the BP fraction. TP
= total proteins, PBP = post-biotinylated proteins, BP = biotinylated
proteins
4.5 Project 2: Microarray analysis to examine for
compensatory mechanisms of TBC1D4-deficiency
in COPAS-sorted DCT cells
The intensive phenotyping including various physiological challenges in project 1, did
not reveal a severe impairment in renal water and salt handling, but rather showed
a renal electrolyte handling that is not different between WT and TBC1D4-deficient
mice. Therefore, we speculated a compensatory regulation of other genes (e.g. up-
regulation of alternative RAB GAPs or down-regulation of counter-regulatory RAB
GEFs) may explain the rather normal phenotype. To test this hypothesis, we used
microarray analysis in order to investigate differently regulated mRNAs in COPAS-
isolated DCTs of WT and TBC1D4-deficient mice. The DCT was chosen, because
this tubule segment is one of the segments with the highest TBC1D4 expression
levels. Moreover, it is rather short and composed by only one cell type, eliminating
the risk of high variability between samples.
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4.5.1 Confirmation of microarray analysis of TBC1D4 deficiency
and the NF-κB inhibitor COMMD6 down-regulation by
qRT-PCR
Microarray and qRT-PCR analysis confirmed loss of the TBC1D4 gene in DCT cells
of TBC1D4 knockout mice (Figure 32 A). Interestingly, microarray analysis revealed
also a loss of COMMD6 expression. COMMD6 is an inhibitor of tumor necrosis
factor (TNF)-induced NF-κB. Remarkably, the gene is localized on the same chro-
mosome as the TBC1D4 gene and both genes are directly adjacent (Figure 32 B).
Therefore, we speculated that the loss of COMMD6 is due to an extended fusion
transcript deletion of TBC1D4 and thus an artefact of the knockout technique. In-
deed, when analyzing genomic DNA (gDNA), COMMD6 expression was not absent
(Figure 32 C).
Figure 32: Microarray analysis: Confirmation of TBC1D4 and COMMD6
knockdown in DCT lysate by qRT-PCR A mRNA levels TBC1D4
and COMMD6 are significantly down-regulated in TBC1D4−/− vs. WT
mice.B Adjacent localization of TBC1D4 and COMMD6 (green under-
lined) on chromosome 14 in mice (www.ensembl.org) C Expression of
COMMD6 in genomic DNA.
4.5.2 qRT-PCR analysis of microarray data of possible genes
interfering with TBC1D4-signaling
The microarray analysis revealed, in addition to COMMD6, a few other differently
regulated genes (Table 11). Those that were most significantly regulated and/or
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could be likely involved in compensation of the TBC1D4 loss were further ana-
lyzed by qRT-PCR. Reduced levels of Sprouty 2 (Spry2), which is able to inhibit
Ras activity similarly to TBC1D4 and is involved in the endothelial growth factor
(EGF) signaling, could not be confirmed by qRT-PCR to be differentially regulated
between WT of TBC1D4−/− mice. Likewise, the mRNA levels of the protein ty-
rosine phosphatase 1 β, PTP-1B, or protein tyrosine phosphatase receptor type B
(Ptpb1; Ptprb), being regulated by Spry2 and known to regulate IGF-1 signaling,
were slightly but not significantly reduced in knockout mice compared to WT mice
(Figure 33). Moreover, the TBC1 protein family member, TBC1D10a, and the Ras
GTPase-activating like protein IQGAP1 were not differentially expressed between
WT and TBC1D4-deficient mice as shown by qRT-PCR (Figure 34).
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Gene Chr Ratio p-value ØWT ØKO KO1 WT1 KO2 WT2 KO3 WT3 KO4 WT4
Tbc1d4 TBC1 domain family, member 4 chr14 0.05129 6.60E-012 6.752 2.467 2.509 6.695 2.724 6.807 2.455 6.582 2.178 6.924
Commd6 COMM domain containing 6 chr14 1.285 0.0001085 7.403 7.765 7.851 7.424 7.806 7.402 7.733 7.366 7.67 7.42
Ptprb protein tyrosine phosphatase, chr10 0.6894 0.002328 4.104 3.567 3.262 4.216 3.784 3.977 3.86 4.12 3.364 4.103
receptor type B
Spry2 sprouty homolog 2 (Drosophila) chr14 1.217 0.007187 4.367 4.65 4.834 4.446 4.634 4.431 4.565 4.187 4.566 4.402
Itpripl1 inositol 1,4,5-triphosphate receptor chr2 0.7876 0.007899 4.219 3.874 3.799 3.911 3.939 4.194 3.835 4.37 3.925 4.401
interacting protein-like 1
Scd1 stearoyl-Coenzyme A desaturase 1 chr19 0.4913 0.02288 4.962 3.937 4.133 5.347 4.6 3.796 3.571 5.613 3.443 5.093
Hbegf heparin-binding EGF-like growth factor chr18 0.7806 0.02747 4.804 4.447 4.522 5.16 4.52 4.951 4.244 4.535 4.501 4.592
Iqgap1 IQ motif containing GTPase activating protein 1 chr7 1.112 0.01762 7.889 8.041 8.041 7.926 8.102 7.895 8.044 7.884 7.978 7.85
Tbc1d10a TBC1 domain family, member 10a chr11 1.142 0.05076 4.674 4.865 5.023 4.634 4.938 4.778 4.752 4.759 4.746 4.524
Acadm acyl-Coenzyme A dehydrogenase, chr3 1.011 0.8038 9.628 9.644 9.658 9.534 9.545 9.655 9.726 9.629 9.646 9.694
medium chain
Ehhadh enoyl-Coenzyme A, hydratase/3-hydroxyacyl chr16 1.005 0.9725 6.907 6.914 6.526 6.619 7.4 6.656 6.966 7.109 6.763 7.244
Coenzyme A dehydrogenase
Hadh hydroxyacyl-Coenzyme A dehydrogenase chr3 1.001 0.9876 10.52 10.52 10.66 10.46 10.48 10.49 10.5 10.56 10.45 10.58
Ppargc1a peroxisome proliferative activated receptor, chr5 1.055 0.4514 9.402 9.479 9.482 9.465 9.586 9.617 9.557 9.302 9.291 9.222
gamma, coactivator 1 alpha
Ppargc1a peroxisome proliferative activated receptor, chr5 1.033 0.5558 8.476 8.524 8.572 8.513 8.608 8.551 8.602 8.419 8.313 8.422
gamma, coactivator 1 alpha
Ppargc1b peroxisome proliferative activated receptor, chr18 1.04 0.6976 5.604 5.661 5.768 5.772 6.063 5.501 5.453 5.603 5.36 5.542
gamma, coactivator 1 beta
Insr insulin receptor chr8 1.042 0.4396 7.181 7.241 7.23 7.274 7.178 7.21 7.338 7 7.217 7.242
Rab8a RAB8A, member RAS oncogene family chr8 0.9975 0.9514 8.277 8.273 8.305 8.264 8.222 8.268 8.205 8.261 8.36 8.315
Dennd4c DENN/MADD domain containing 4C chr4 1.003 0.9505 7.168 7.172 7.237 7.176 7.281 7.207 7.152 7.085 7.018 7.202
Slc2a4 solute carrier family 2 chr11 1.001 0.9801 7.71 7.712 7.706 7.801 7.694 7.746 7.649 7.766 7.798 7.527
(facilitated glucose transporter), member 4
Slc12a1 solute carrier family 12, member 1 chr2 0.9341 0.4817 7.541 7.443 7.223 7.675 7.709 7.511 7.57 7.734 7.269 7.244
Scnn1a sodium channel, nonvoltage-gated 1 alpha chr6 1.103 0.06993 9.901 10.04 9.989 9.851 10 10.07 10.11 9.83 10.06 9.849
Scnn1b sodium channel, nonvoltage-gated 1 beta chr7 0.8982 0.1281 7.604 7.449 7.519 7.722 7.633 7.499 7.202 7.601 7.444 7.596
Scnn1g sodium channel, nonvoltage-gated 1 gamma chr7 0.9541 0.6009 7.378 7.31 7.485 7.336 7.531 7.324 6.941 7.564 7.285 7.288
Table 11: Microarray analysis: list of genes of DCT cells from WT and TBC1D4 −/− mice
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Figure 33: Microarray analysis: Analysis of Spry2 and Ptprb in DCT
lysates by qRT-PCR Left: Schematic depiction of the Spry2 and Ptprb
(also named PTPB1) pathways (www.biocarta.com). Right: Differential
regulation of the Spry2 and Ptprb gene could not be confirmed by qRT-
PCR.
Figure 34: Microarray analysis: Analysis of TBC1D10A and IQGAP1 in
DCT lysates by qRT-PCR The TBC1D10a and IQGAP1 genes were
not differentially expressed between WT and TBC1D4−/− (KO) mice in
DCT lysates as shown by qRT-PCR.
In contrast, the stearoyl-CoA desaturase 1 (Scd1), which is a rate-limiting enzyme
in the biosynthesis of mono-unsaturated fatty acids, was confirmed to be reduced
by over 50 % (Figure 35). Dobrzyn and coworkers have shown that Scd1 knockout
mice have increased energy expenditure, reduced adiposity, and increased insulin
sensitivity. Furthermore, Scd1-deficiency decreases the activity of PTP-1B, which
leads to an increase in phosphorylation of IR and IRS-1 and -2 with subsequent
augmentation of Akt activity and finally increased GLUT4 membrane translocation
and enhanced glucose transport. Likewise, Scd1-KO mice showed increase in the
expression of enzymes involved in fatty acid oxidation [Dobrzyn and Ntambi, 2005;
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Dobrzyn et al., 2010]. Additionally, Chadt et al. showed an increased basal palmi-
tate oxidation in EDL muscle of TBC1D4−/− mice [Chadt et al., 2015]. However,
when we analyzed mRNA levels of genes involved in fatty acid oxidation, such as
the acyl-Coenzyme A dehydrogenase medium chain (MCAD; Acadm), the enoyl-
Coenzyme A hydratase/3-hydroxylacyl Coenzyme A dehydrogenase (HD; Ehhadh),
and the 3-hydroxyacyl-Coenzyme A dehydrogenase (HCDH; Hadh) as well as the
transcriptional activators PGC-1α and PGC1β (peroxisome proliferative activated
receptor gamma, coactivator 1; Ppargc1a and Ppargc1b), we found no evidence for
any differential regulation of these genes at the transcriptional level in renal DCT
cells of WT and TBC1D4−/− mice (Figure 36). Therefore, the functional impact of
the deregulated Scd1 expression for fatty acid oxidation in particular and metabolism
in general remains elusive.
Figure 35: Microarray analysis: Confirmation of reduced Scd1 gene ex-
pression in TBC1D4−/− (KO) mouse qRT-PCR Left: The Scd1
gene expression was decreased in DCT cell lysates of TBC1D4−/− com-
pared to WT mice. student’s t test, n =4, *p < 0.05. Right: impact of
Scd1 deletion on multiple intracellular pathways [Dobrzyn and Ntambi,
2005].
4.6 Establishing a cell culture system with functional
NCC expression as a tool to study the role of
TBC1D4 in NCC regulation
The aim of this subproject was to establish an in vitro system with stable NCC
expression in which by co-expression the role of TBC1D4 on NCC regulation could
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Figure 36: Microarray analysis: Genes of the fatty acid (FA)-β oxi-
dation Gene levels of the acyl-Coenzyme A dehydrogenase medium
chain (Acadm), enoyl-Coenzyme A hydratase/3-hydroxylacyl Coenzyme
A dehydrogenase (Ehhadh), 3-hydroxyacyl-Coenzyme A dehydrogenase
(Hadh), and the peroxisome proliferative activated receptor gamma, coac-
tivator 1 β and α (Ppargc1a and Ppargc1b) were similar. qRT-PCR of
DCT lysates of WT and TBC1D4−/− (KO) mice, student’s t test
be studied. To date, no ex vivo/in vitro system has been found suitable to study
the molecular regulation of NCC. The only two available DCT cell line so far, the
mpkDCT [Gesek and Friedman, 1992; Diepens et al., 2004] and native mDCT cells
[Gesek and Friedman, 1995; Dai et al., 1997a,b, 1998], both form a polarized ep-
ithelium, yet have either a very low NCC expression or lose their NCC expression
rapidly with time in cell culture.
4.6.1 HEK293 cells with stably inserted hNCC
Human embryonic kidney (HEK293) cells were transfected with either the linearized
pcDNA3.1-hNCC plasmid or with the pEGFP-C3-NCC plasmid for monitoring
transfection efficiency (Figure 37). Only cell cultures showing a transfection ef-
ficiency > 50 % were kept for antibiotic selection (gentamycin; G-418) of stably
transfected cells (Figure 37). Further on, cell lines with NCC expression maintained
for more than 2 passages under antibiotic selections were considered to stably express
NCC and were used for further experiments.
We tested mRNA expression of transfected HEK cells, which were starved for 24 h
or 48 h prior to RNA extraction, with two different primer pairs, amplifying the ini-
tial region (N-terminus) and the end region (C-terminus) of NCC. The latter primer
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Figure 37: Transfection of HEK293 with pEGFP-C3-NCC HEK293 cells were
transfected with the pEGFP-C3-NCC in order to estimate transfection
efficiency, cell cultures with > 50 % transfection rate were used.
pair was used in order to confirm complete integration of the linearized plasmid in
the cells’ genome and thus intact NCC-expression (Figure 38 A). With both primer
sets, strong NCC expression could be detected in transfected HEK293 cells, but not
in untransfected HEK293 and mCCD cells, confirming successful stable expression
of full-length NCC in the transfected HEK293 cells. These results were reflected on
the protein level (Figure 38 B). Untransfected HEK293 cells and mCCD cells showed
no NCC expression. The total kidney lysate showed a slight smear at around 130
kDa, which is well known to represent glycosylated NCC and a band at around 110
kDa representing core-glycosylated NCC [de Jong et al., 2003; Hoorn et al., 2011].
Transfected HEK293 cells strongly expressed the 110 kDa-NCC band. Next to tran-
scriptional and proteomic studies, immunofluorescence of transfected HEK293 cells
revealed a strong NCC-staining, whereas untransfected HEK293 cells only showed
background staining. The arrow points to possible membrane localization of NCC
(Figure 38 C). The amount of transfected NCC-cells was around 40-50 %.
4.6.2 Analyzing the phosphorylation levels of hNCC in stably
transfected HEK cells using in cell western
NCC function critically depends on phosphorylation of NCC at several serine and
threonine residues in the N-terminal tail of NCC [Richardson et al., 2008]. To assess
if NCC phosphorylation can be modulated in stably transfected NCC cells, cells
were treated with calyculin A (CA), a strong serine/threonine protein phosphatase
inhibitor, in an in cell western (ICW). Total NCC abundance, using an antibody
recognizing the C-terminus of NCC (total NCC = tNCC), was similar compared
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Figure 38: Stable transfection of HEK293 with pcDNA3.1-hNCC A Anal-
ysis of NCC gene expression in total kidney (TK), mCCD cells, un-
transfected HEK293 and HEK293 transfected and starved for 24 h/48 h
(HEKtr 1/HEKtr 2), with two primer pairs, N-terminal (N-Term) and C-
terminal (C-Term). B NCC protein expression (HEKunt = HEK293 un-
transfected). C Immunocytochemistry of untransfected and transfected
HEK293 with the pcDNA3.1-hNCC with NCC (red). Detection of nuclei
with DAPI (blue), of cytoskeleton with α-tubulin (green). Arrow points
to a possible membrane staining of NCC.
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to control and vehicle treated HEK293-hNCC-cells (Figure 39). Total NCC abun-
dance, using an antibody recognizing an extracellular loop of NCC (extracellular
total NCC = etNCC), was strongly reduced after CA treatment compared to con-
trol and vehicle cells. All 4 phosphorylation sites (pT53, pT58, pS71 and pS89)
were highly phosphorylated. In conclusion, the phosphatase-inhibitor CA is able to
modulate phosphorylation of hNCC in transfected HEK293 cells. Further charac-
terization of the HEK-hNCC-cell line (e.g. NCC sequencing, NCC trafficking, NCC
cell surface expression, Na+ and Cl− uptake) was the objective of the master thesis
of Dario Ruppli [Ruppli, 2012], that I oversaw under the supervision of Prof. Jo-
hannes Loffing and Dr. Urs Ziegler. The thesis showed that HEK293 cells, though
expressing significant levels of NCC, do not export NCC to the cell surface and hence
show no measurable NCC cell surface abundance and activity. Likewise, other re-
search groups were not able to achieve significant cell surface activity in transfected
HEK293 cells (O. Staub and D. Ellison, personal communication). Therefore, this
approach was abandoned.
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Figure 39: NCC phosphorylation by ICW HEK293-hNCC cells were treated
for 30 min with either 50 nM CA or vehicle. An additional control
without any treatment was used, n = 4. CA-treatment increased NCC-
phosphorylation at pT53, pT58, pS71 and pS89, extracellular NCC was
decreased (etNCC). tNCC = total NCC, student’s t test, ** p < 0.005,
*** p < 0.0005
82
5 Discussion
By using a complete knockout mouse model, this thesis investigated the role of the
Rab GAP TBC1D4 with a special focus on the role of TBC1D4 on renal electrolyte
and fluid homeostasis. By immunohistochemistry analyses, TBC1D4 expression was
found in distinct nephron segments; the parietal epithelial cells (PECs) of Bowman’s
capscule, the thin and thick limbs of Henle’s loop, the DCT, CNT and CD, but its
function in these segments remained elusive. Based on in vitro studies showing mod-
ulation by TBC1D4 of ENaC, AQP2 and Na+-K+-ATPase abundance, cell surface
localization and function, we hypothesized that TBC1D4 might be involved in the
regulation of these salt and water transporting proteins in the kidney and thus that
TBC1D4 controls renal ion and water handling and hence extracellular fluid home-
ostasis. The experiments presented in this thesis showed that a loss of TBC1D4 in
the kidney in vivo does not impair renal ion and water handling but reduces the
abundance of the glucose transporter GLUT4 in the renal distal tubule. The latter
may affect glucose uptake into these renal epithelia and hence interfere with their
glycolytic capacity. Microarray analysis of COPAS-isolated DCTs from WT and
TBC1D4−/− mice did not provide any conclusive proof regarding the differential
expression of other gene products compensating for the loss of TBC1D4. However,
Scd1, an enzyme involved in fatty acid metabolism was significantly down-regulated
in TBC1D4−/− mice on transcriptional levels. The functional relevance of Scd1 in
the kidney remains to be analyzed.
5.1 TBC1D4 and the control of renal salt and water
reabsorption in vivo
One of the most pivotal tasks of the kidneys is to adjust ion and water balance and
hence blood volume and blood pressure. To fulfill this task, the nephron is equipped
with specific ion transporters and ion and water channels such as NKCC2, NCC,
ENaC, AQP2 and the Na+-K+-ATPase. Recent in vitro studies suggested that the
Rab GAP TBC1D4 is a key protein regulating the trafficking of the Na+-K+-ATPase
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[Alves et al., 2010], ENaC [Liang et al., 2010], and AQP2 [Jung and Kwon, 2010;
Kim et al., 2011]. In MDCK and COS cells, Alves and coworkers demonstrated
that TBC1D4 promotes intercellular retention of the Na+-K+-ATPase [Alves et al.,
2010]. Likewise, Liang and coworkers showed that knockdown of TBC1D4 in mp-
kCCD cells increases apical ENaC abundance and amiloride-sensitive Na+ transport
[Liang et al., 2010]. Thus, these in vitro studies suggested that TBC1D4 retains the
Na+-K+-ATPase and ENaC inside the cell and reduces transepithelial Na+ trans-
port. Conversely, we found in another mouse CCD cell line (mCCD cells), that a
TBC1D4 knockdown reduced both, baseline as well as aldosterone-stimulated ENaC
cell surface abundance and activity [Gresko, 2011], suggesting that TBC1D4 is a
positive regulator of Na+ transport in the renal collecting system. Based on the
results of Liang, we expected that TBC1D4−/− mice would have a sodium retaining
phenotype with arterial hypertension, hypokalemia and suppressed plasma aldos-
terone levels (Liddle’s syndrome-like phenotype), while based on our results, we
expected the opposite phenotype with arterial hypotension, hyperkalemia, and in-
creased plasma aldosterone levels (pseudohypoaldosteronism type I-like phenotype).
5.1.1 Effects of renal TBC1D4 loss on salt homeostasis under
standard conditions
In contrast to the profound effects of TBC1D4 on ENaC and the Na+-K+-ATPase
in vitro, TBC1D4−/− mice were neither hyper- nor hypotensive, independent of
any dietary challenge (high-fat diet or high salt-high fat diet). For blood pressure
recordings, we used the non-invasive tail cuff method, which has a lower sensitiv-
ity in detecting blood pressure differences compared to the invasive, more costly
radiotelemetry. The disadvantage of the tail cuff method compared with the ra-
diotelemetry is, that it does not allow monitoring of blood pressure over 24 hours.
Hence, we lack blood pressure-measurements during the active night period, where
differences between mouse lines may become more pronounced as shown for exam-
ple in Ronzaud et al. [2013]. Nevertheless, we did not find any evidence by further
analyzes, that TBC1D4−/− mice display a dysfunction of ENaC. The TBC1D4−/−
mice did not show any abnormalities in plasma aldosterone and renin levels, plasma
ion levels (Na+, K+), acid-base status, urinary ion excretion (Na+, K+), and uri-
nary aldosterone excretion. Moreover, the protein abundance of the most important
distal tubule Na+ proteins (NKCC2, NCC, ENaC, AQP2 and the Na+-K+-ATPase)
were not different between the genotypes. Likewise, no difference in the phospho-
rylation level of NCC was observed. Taken together, these results strongly suggest
that TBC1D4−/− mice do not have any dysregulation in renal Na+ transporting
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proteins and renal Na+ handling, which does also likely explain the normal blood
pressure in the knockout mice.
5.1.2 Effects of renal TBC1D4 loss on salt homeostasis under
challenging conditions
Gene knockout mice do often show no or a rather mild renal phenotype under
standard conditions, but reveal severe adaptive impairments when challenged, e.g.
by dietary ion restriction or loading. Only on a high Na+ diet, mice with a nephron-
specific deletion of the E3-ubiquitin protein ligase Nedd4-2 reveal increased blood
pressure and elevated ENaC (β and γ), ROMK, total and phosphorylated NCC levels
[Ronzaud et al., 2013]. Similarly, in nephron-specific SGK1−/− mice reduced blood
pressure, lowered Nedd4-2 phosphorylation, decreased NCC levels and Na+ loss only
became apparent under a low Na+ diet [Faresse et al., 2012]. Likewise, NCC−/−
mice developed hypokalemia, a common feature of Gitelman’s syndrome, only after
exposure to a low K+ diet only [Morris et al., 2006]. A main task of the TBC1D4-
positive distal tubule is to adapt renal Na+ and K+ excretion to the dietary intake. A
maximal stimulation of the distal tubule can be achieved by a low Na+ and high K+
diet, that also profoundly stimulates the aldosterone system [Kaissling and Le Hir,
1982; Le Hir et al., 1982]. Therefore, WT and TBC1D4−/− mice were given a low
Na+/high K+ diet (LNa/HKD) for 14 days. This diet drastically increased urinary
and plasma aldosterone levels in both genotypes, confirming the efficacy of the diet.
However, plasma aldosterone levels were not different between the genotypes and
also other metabolic parameters, blood values, renal renin mRNA levels and the
renal protein abundance of NKCC2, NCC, ENaC, AQP2 or the Na+-K+-ATPase
were not different between WT and TBC1D4−/−mice (4.1.4 and 4.1.5). Thus, even
under conditions of a maximally challenged aldosterone system, we could find no
evidence for a disturbed regulation of one of the tested Na+ and water transporting
proteins and renal Na+ and K+ handling. Hence, despite the strong role of TBC1D4
for the regulation of ENaC and the Na+-K+-ATPase in vitro [Alves et al., 2010; Liang
et al., 2010], we did not find any evidence for a similar role of TBC1D4 in vivo.
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5.2 TBC1D4 and the control of renal water
reabsorption in vivo
Based on in vitro experiments showing how TBC1D4 siRNA knockdown is asso-
ciated with increased AQP2 cell surface abundance in mpkCCD cells [Kim et al.,
2011], we wanted to investigate whether the vasopressin-dependent regulation of
AQP2 abundance and trafficking and thus water balance (i.e. urine volumes and
urine osmolarity) is disturbed in TBC1D4−/− mice. Therefore, mice were challenged
by a mild water restriction in order to stimulate vasopressin release, but to avoid
an over-compensatory response induced by maximum water depletion [Zuber et al.,
2007]. To do so, mice had ad libitum access to moisturized food (50 %), but not
to a water bottle for 24 hours. In response to water restriction, both WT and
knockout mice were able to decrease urinary output significantly (4.1.6, Figure 18
A). The urine osmolarity was also increased in WT and KO mice. Likewise, uri-
nary ion (Na+, K+, Mg2+) excretion remained similar in both genotypes, suggesting
normal vasopressin-dependent regulation of renal water handling. The final effector
for vasopressin-dependent regulation of renal water handling is the water channel
AQP2 localized in the apical membrane of the segment-specific cells of the CNT
and CD. Vasopressin was shown to stimulate via binding to vasopressin V2 recep-
tors intracellular cAMP levels, which activate protein kinase A (PKA) and finally
increase the phosphorylation of AQP2 at multiple sites [Fenton et al., 2013; Hoffert
et al., 2008, 2006; Katsura et al., 1997; Rice et al., 2012]. The phosphorylation level
of AQP2 is eventually decisive for the trafficking of AQP2 to the cell surface and
hence for the activity of AQP2 and water transport [Katsura et al., 1997; Rice et al.,
2012]. In our study, we did not analyze AQP2 phosphorylation levels, as TBC1D4
is supposed to interfere with AQP2 trafficking, but not with vasopressin-signaling
and AQP2-phosphorylation. Using immunoblotting and immunohistochemistry, we
did not obtain any evidence that AQP2 regulation is disturbed, even not under
challenging conditions such as water restriction. Together with the unaffected uri-
nary concentration ability in TBC1D4−/− mice, our data suggest that the loss of
TBC1D4 does not affect renal AQP2 activity in vivo, which contrasts to the strong
effect seen in in vitro-experiments [Jung and Kwon, 2010; Kim et al., 2011].
5.3 Discrepancy between in vitro and in vivo data
Our renal phenotyping experiments did not reveal any striking renal disturbance (es-
pecially in regard to Na+ handling, blood pressure control and water homeostasis)
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in mice lacking the Rab GAP TBC1D4 (whole section 4.1). This contrasts to several
in vitro studies, which consistently reported that TBC1D4 regulates salt and water
transporting proteins in renal cells. Kwon and colleagues observed i) decreased phos-
phorylation of TBC1D4 in Akt1-siRNA M1 cells with or without dDAVP stimulation
and ii) in the absence of dDAVP, increased plasma membrane expression of AQP2
in both TBC1D4 knockdown-M1 cells [Jung and Kwon, 2010] and -mpkCCDc14
cells [Kim et al., 2011] by semi-quantitative immunocytochemistry. Furthermore,
cell surface biotinylation assays also showed increased AQP2 expression in trans-
fected TBC1D4-siRNA compared with non-targeting control-siRNA mpkCCDc14
cells. Notably, the experiments were performed on non-polarized M1 and mpkC-
CDc14 cells, which do not resemble the situation found in vivo, in which cells are
well differentiated and polarized. The mechanism of regulation of membrane pro-
teins may differ between non-polarized and polarized cells [Lavialle et al., 2000].
On the other hand, Liang and coworkers used polarized mCCD cells, which better
resemble the normal physiological properties of tubular cells in vivo. They observed,
that the knockdown of TBC1D4 resulted in increased ENaC activity [Liang et al.,
2010]. In the same year, Alves et al. showed intracellular retention of the Na+-
K+-ATPase in COS cells, a monkey kidney-derived cell line, when co-transfected
with the Na+-K+-ATPase and TBC1D4 [Alves et al., 2010]. However, also these
cells do not form a polarized epithelium, questioning the relevance of this model
for the in vivo situation. In experiments with polarized MDCK cells, Alves and
coworkers found that silencing of TBC1D4 mediated Na+-K+-ATPase endocytosis,
when treated with compound C, an inhibitor of AMPK. This led to the suggestion
that phosphorylation of TBC1D4 might be important for Na+-K+-ATPase traffick-
ing and retention at the cell surface. Overall, the discrepancy between the profound
role of TBC1D4 on ENaC, the Na+-K+-ATPase and AQP2 seen in vitro and the
lack of any clear effect seen in vivo might be related to:
1. The cell culture systems. Cell physiology as well as cell culture environment
might lack or differ in important cellular and systemic features (e.g. hormonal
composition, free fatty acids content, gene expression, and level of cell differ-
entiation).
2. Compensatory mechanisms. As a consequence of the congenital deletion of
TBC1D4, compensation may occur, whereby essential renal functions are taken
over by other, yet to be determined, mechanisms leading to no overt renal phe-
notype.
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3. Indirect stimulation. The effects seen in vitro might reflect an indirect stimula-
tion leading to an unspecific increased or decreased trafficking and/or activity
of membrane transporters and channels.
To 3): the effect seen by the knockdown of TBC1D4 in vitro might reflect an in-
direct stimulation, e.g. by the lack of GLUT4-storage vesicles, which are typically
regulated by TBC1D4, other cargo-vesicles containing e.g. ENaC, AQP2 or the Na+-
K+-ATPase might be transported in a more unspecific way via Rab proteins to the
cell membrane. One other possibility might be, that by interfering with the insulin-
signaling cascade, for instance by repressing TBC1D4 in these cells, the trafficking
of GLUT4 and thus glucose uptake and energy availability is increased leading to a
(secondary/indirect) increase in trafficking and activity of membrane proteins such
as ENaC, APQ2 and the Na+-K+-ATPase. Indeed, several group have suggested
that insulin is thought to regulate ENaC, AQP2, the Na+-K+-ATPase as well as
NCC not only in vitro but also in vivo. However, the molecular mechanisms and
whether this regulation occurs via GLUT4 are still unexplored. Song and cowork-
ers observed increased activity of NCC (most likely via WNK4) and ENaC during
chronic insulin infusion in rats [Song et al., 2006]. Several studies have demonstrated
that insulin induces the phosphorylation of NCC in heterologous expression systems
[Cha´vez-Canales et al., 2013], in mpkDCT cells [Sohara et al., 2011] as well as in
vivo, in Zucker obese (ZO) rats [Komers et al., 2012] and in mice [Sohara et al., 2011].
Interestingly, this specific NCC phosphorylation is associated with a concomitant
increase in the phosphorylation of SPAK and OSR1 [Cha´vez-Canales et al., 2013;
Komers et al., 2012; Sohara et al., 2011]. Furthermore, insulin is known to increase
renal salt reabsorption in the distal nephron and hyperinsulemia is proposed to
cause hypertension [Song et al., 2006]. In mammals (men, dogs and mice), insulin
leads to the reduction of fractional Na+ excretion [DeFronzo et al., 1975, 1976] re-
lated to increased ENaC abundance, trafficking and activity [Tiwari et al., 2007].
Furthermore, the Na+-K+-ATPase is activated, phosphorylated, and trafficked from
intracellular vesicles to the cell surface by insulin stimulation [Comellas et al., 2010;
McGill and Guidotti, 1991]. This insulin-dependent Na+-K+-ATPase regulation has
been demonstrated in adipocytes [McGill, 1991], human [Al-Khalili et al., 2004] and
rat skeletal muscle cells [Al-Khalili et al., 2003], and in lungs [Comellas et al., 2010]
and is linked to ERK1/2 and PI3K signaling ([Al-Khalili et al., 2004; Comellas et al.,
2010]. Likewise, insulin has been shown to increase AQP2 expression via MAPK,
PI3K, and ERK1/2 in mouse mpkCCD [Bustamante et al., 2005] and rat native
IMCD cells [Pisitkun et al., 2008]. However, it seems in this case that the loss of
TBC1D4 is redundant in vivo as no effect on renal ion and water handling as well
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as in the abundance, subcellular localization and activity of renal Na+ and water
transporting proteins was seen with mice fed different diets like the high fat diet
known to affect insulin signaling. However, when interfering more upstream in the
insulin-signaling cascade, e.g. knockout of the insulin receptor (IR), effects on ENaC
trafficking and regulation were observed in vivo (Li et al., 2013; Pavlov et al., 2013)
(further discussed in 5.5).
5.4 TBC1D4 and whole body glucose homeostasis
5.4.1 Loss of TBC1D4 and body weight regulation
As mentioned previously, TBC1D4 was linked to the insulin-dependent regulation of
glucose homeostasis. Moreover, members of the TBC1 domain family were related
to the control of body weight. Chadt and coworkers reported for example a pro-
tection against diet-induced obesity in mice bearing a naturally-occurring mutation
in TBC1D1 [Chadt et al., 2008]. A lower BW was also seen in TBC1D1/TBC1D4
double knockout mice, even when fed an ad libitum standard diet [Chadt et al.,
2015]. Likewise, a reduced gain in BW gain was observed in the TBC1D4-Thr649Ala
knockin mice [Chen et al., 2011]. Overall, these examples are in line with our findings
that TBC1D4−/− mice increase their body weight (BW) less than their WT litter-
mates following a 6-month period on a HFD. Interestingly, this weakened increase in
BW was not driven by food intake, which was similar in both mice genotypes [data
not shown, but see [Wang et al., 2013]]. In addition, TBC1D1−/− and TBC1D4−/−
mice had increased fatty acid uptake and oxidation, reflected by a lower respiratory
quotient, which implies a higher energy supply from fatty acids [Chadt et al., 2015,
2008]. Wang and coworker could further demonstrate that TBC1D4−/− mice have a
normal physical activity, but a lower energy expenditure rate, evident from a lower
oxygen consumption and heat production [Wang et al., 2013]. Chadt and coworkers
suggested that the lower BW in TBC1D1−/− and TBC1D4−/− mice results from a
higher lipid oxidation and hence from a lowered adipose tissue mass [Chadt et al.,
2015]. Conclusively, our finding of a reduced body weight gain further confirms that
also TBC1D4 might control body weight.
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5.4.2 Effects on glucose tolerance and insulin sensitivity in
TBC1D4−/− mice
We found a normal to a slightly improved glucose tolerance and impaired insulin
sensitivity in TBC1D4−/− mice. These effects may appear surprising, given that an
impaired insulin sensitivity and an improved glucose tolerance are usually opposing
effects. However, similar observations were made by others; in TBC1D4 knockout
mouse models, which are different from ours [Lansey et al., 2012; Wang et al., 2013],
and in the Thr649Ala knockin mouse model [Chen et al., 2011]. In contrast to the
knockout models, the TBC1D4 Thr649Ala model has an impaired glucose tolerance,
whereas the knockout models show either a normal or slightly improved glucose tol-
erance [Wang et al., 2013]. Interestingly, all knockout models did not show any
hyperinsulemia during the glucose tolerance test [Chadt et al., 2015; Chen et al.,
2011; Wang et al., 2013]. Our TBC1D4−/− mice had constantly lower blood glucose
levels under non-starved conditions and significantly lower levels after starvation
(see 4.2.4). Remarkably, the TBC1D4−/− mice had also lower plasma insulin levels,
which could be the consequence of the slight hypoglycemia (see section 4.2.4 and
[Wang et al., 2013]). The cellular and molecular mechanisms underlying these find-
ings deserve further elucidation. This thesis focused on the renal role of TBC1D4.
Underlying mechanisms for the metabolic phenotype are currently being addressed
elsewhere. The discrepancies observed between the different TBC1D4-knockout and
-knockin models regarding glucose metabolism (Table 1, 1.8.2) may dependent on
several factors, such as strain differences, targeting strategy for knockout/knockin
generation, age and sex of the animals, etc. These discrepancies also warrant further
investigations, as they might be informative about the role of TBC1D4 in different
genetic backgrounds and may offer explanations for gender differences.
5.5 GLUT4 expression in the kidney
As mentioned above, TBC1D4 was previously demonstrated to regulate the intra-
cellular trafficking of the glucose transporters GLUT4 [Kane et al., 2002; Sano et al.,
2003; Treebak et al., 2010] and GLUT1 [Ngo et al., 2009] in fat and skeletal mus-
cles cells. Both transporters were also shown to be expressed in the human and
rat kidney, though slightly discrepant results on the precise intracellular localiza-
tion were reported. Now, we analyzed mouse kidneys of WT mice and found by
qRT-PCR analysis of free-hand microdissected nephron segments GLUT4 mRNA
expression in the glomerulus, the TAL, DCT and CNT/CD (see 4.3.1). Using two
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different GLUT4 antibodies, immunohistochemistry confirmed the high abundance
of GLUT4 in distal tubules and the collecting system (4.3.2). However, in the
glomerulus, GLUT4 protein could not be detected by IHC. This divergence to the
mRNA data could be explained by several not mutually exclusive reasons:
1. The sensitivity of qRT-PCR is usually higher than the sensitivity of IHC.
Thus, it is possible that the protein abundance of GLUT4 in the glomerulus is
below the detection limit of IHC, while the mRNA is already well detectable
by qRT-PCR. In fact, the glomerular GLUT4 mRNA expression was lower
than in distal tubules and collecting ducts.
2. mRNA and protein abundance do not necessarily correlate, due to posttran-
scriptional and posttranslational mechanisms, which control protein abun-
dance independent from altered transcription [Gygi et al., 1999].
3. The detection of GLUT4 in the glomerular preparation could be due to a con-
tamination with distal tubular epithelia cells. In fact, the macula densa of the
TAL is firmly attached to the vascular pole of the glomerulus (see 1.1). How-
ever, previous studies using the detection of tubule marker genes confirmed
that contaminations are negligible [Glaudemans et al., 2013].
While there was a close correlation between GLUT4 and TBC1D4 expression through-
out the renal tubular system, GLUT4 mRNA expression in the glomerulus was rather
weak compared with the prominent TBC1D4 expression at this site. This sug-
gests, that there might be an additional target protein for TBC1D4 expressed in the
glomerulus. In fact, IHC demonstrated that the parietal epithelial cells (PECs) of
the mouse glomerulus, previously shown by us to be the glomerular site of TBC1D4
expression [Lier et al., 2012], do also express GLUT1. Similarly, Heilig and cowork-
ers found GLUT1 staining in PECs by using immunogold staining [Heilig et al.,
1995]. Moreover, Clarke and collaborators suggested an insulin-regulated transport
of GLUT1 similar to GLUT4 [Clarke et al., 1994], which was reinforced by the
finding of Mendes et al., who showed GLUT1 cell surface expression in response to
WNK1-phosphorylation of TBC1D4 in HEK293 cells [Mendes et al., 2010]. There
is increasing evidence that cells of the glomerulus and the distal tubule are insulin-
sensitive, as shown by the presence of proteins of the insulin-signaling cascade,
including the insulin receptor (IR) [Butlen et al., 1988; Hale and Coward, 2013] and
PKB/Akt [Chabarde`s-Garonne et al., 2003; Pradervand et al., 2010]. As mentioned
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in 5.3, previous studies suggested that insulin regulates distal tubule ion transport-
ing proteins including NCC, ENaC and the Na+-K+-ATPase [Fe´raille et al., 1995;
Sohara et al., 2011; Tiwari et al., 2007]. Consistently, recent studies demonstrated
the localization of the IR on the basolateral plasma membrane of the distal tubule
and collecting duct of WT mice [Li et al., 2013; Pavlov et al., 2013]. Mice with a CD-
specific deletion of the IR have a reduced apical ENaC activity and an abated blood
pressure [Li et al., 2013]. These observations were interpreted to further support a
direct regulation of ENaC by insulin. However, given the striking high abundance
of GLUT4 in the distal tubule and collecting duct another link between the IR and
ENaC activity is conceivable. Insulin may regulate GLUT4-dependent glucose up-
take into the distal tubular and collecting duct epithelial cells, which could be used
for glycolytic ATP production, which drives the activity of the Na+-K+-ATPase
and hence indirectly also ENaC activity. Indeed, the distal tubules require a lot of
energy, especially the TAL and the DCT, which do also have the highest expres-
sion of GLUT4 and TBC1D4. Furthermore, these nephron segments do have the
highest density of mitochondria and basolateral membrane infoldings bearing the
Na+-K+-ATPase, which drives active transport processes [Giebisch and Stanton,
1979; Jorgensen, 1985]. In contrast to the proximal tubule cells, the distal tubule
cells possess glycolytic enzymes, which are capable to oxidize glucose and produce
ATP in response to insulin during high energy requirements [Mitrakou, 2011]. The
GLUT4-mediated glucose uptake and the glycolytic capacity of these cells might
contribute to their more pronounced hypoxic/ischemic tolerance compared to the
strictly aerobic proximal tubule cells [Bastin et al., 1987; Gamboa et al., 2011; Sun
et al., 1994]. Nevertheless, GLUT4 localization at the basolateral side, where the
glucose is hypothesized to enter the renal cells, has yet to be confirmed. From our
IHC-pictures, GLUT4 appears to be localized in a perinuclear, cytoplasmic region
(4.3.2 and 4.3.3), which is consistent to previous reports by Heilig [Heilig et al., 1995].
Only in intercalated cells (ICCs), where GLUT4 as well as TBC1D4 [Lier et al.,
2012] are highly abundant, GLUT4 appears to be preferentially localized towards
the basolateral plasma membrane. Further experiments and specialized methods
are needed (e.g. cell-impermeable GLUT4 photolabeled-biotin ATB-BMPA, high-
resolution microscopy, etc.), to reveal the precise localization of GLUT4 expression
in kidney cells.
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5.6 GLUT4 expression in kidneys and glucose uptake
in TAL cells of TBC1D4−/− mice
By western blot analysis and by performing IHC, GLUT4 levels in the kidney were
found to be decrease in TBC1D4−/− mice (4.4). Since TBC1D4 down-regulates
GLUT4 activity, we expected that the loss of TBC1D4 would increase (and not
decrease) GLUT4 abundance, trafficking and membrane insertion. However, also
in adipocytes and skeletal muscle cells of TBC1D4−/− mice, GLUT4 levels were
reported to be reduced [Lansey et al., 2012; Wang et al., 2013]. A surprising in-
consistency was observed when comparing adipocytes with soleus muscle cells in
TBC1D4−/− mice. Specifically, basal glucose uptake and the GLUT4-ratio (the ra-
tio between cell surface GLUT4 versus total GLUT4) was increased in adipocytes,
whereas is soleus muscle these values were unaltered and decreased, respectively, in
TBC1D4−/− versus WT mice [Lansey et al., 2012]. Therefore, global predictions of
GLUT4-ratios and glucose uptake cannot be reliably made. Given the fact that re-
nal GLUT4 mRNA levels were not different between our TBC1D4−/− and WT mice,
posttranslational effects (e.g. reduced translocation, increased degradation) likely
explain the reduced GLUT4 abundance in TBC1D4−/− mice. Moreover, due to the
possibility of a higher intrinsic activity of cell surface GLUT4, abundance might be
reduced as a compensatory effect in TBC1D4−/− mice. Since GLUT4 abundance
and GLUT4 (transport) activity do not necessary correlate, we tried to set-up an ex
vivo assay system to measure glucose uptake into renal epithelia of TBC1D4-WT
and -deficient mice. For this purpose, we took advantage of the previously developed
technique of primary culture of TAL cells from mouse kidneys [Glaudemans et al.,
2013]. A further advantage of TAL cells was the high expression of TBC1D4 and
GLUT4 and genes involved in the insulin-signaling cascade (see 4.4.2). Using dif-
ferent inhibitors, we confirmed the reliability of our ex vivo assay and to the best of
our knowledge, this assay is the first cell culture assay for GLUT4-mediated glucose
uptake in polarized renal cells. In these ex vivo-experiments using TAL cells derived
from WT and TBC1D4-deficient mice, we found an increased basal glucose uptake
in TAL cells of TBC1D4−/− mice. Upon stimulation of TAL cells with insulin,
glucose uptake was increased in TAL cells of WT but not in KO mice, suggesting
that in TBC1D4-deficient TAL cells glucose uptake was already maximally stimu-
lated (see 4.4.2). Interestingly, the increased basal glucose uptake and the lack of
any response to insulin in TAL cells matches well with the hypoglycemic status of
TBC1D4−/− mice on basal conditions and the abrogated response to insulin in the
insulin tolerance test (ITT). Nevertheless, the observed changes to whole-body glu-
cose homeostasis are unlikely to be related solely to the kidneys. They are most likely
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a consequence of the whole body deletion of TBC1D4, but especially in adipocytes
and muscle cells. It is however conceivable that the kidneys contribute to the ob-
served systemic effect. Insulin-dependent uptake of glucose into renal distal tubule
epithelia may suit the requirements of the cells: provide substrates (e.g. glucose),
replenish energy and cover metabolic needs for the increasing workload in e.g. post-
prandial states. Western blot analysis did also reveal reduced GLUT1 protein levels
in kidneys of TBC1D4−/− mice, which further underlines, that GLUT1 might be
also regulated by TBC1D4. Similar to the previous results of other research groups
[Lansey et al., 2012; Wang et al., 2013] on adipocytes and skeletal muscle cells of
TBC1D4−/− mice, we did not find any evidence for any consistent dysregulation of
PKB/Akt, suggesting that the observed effects on GLUT4 abundance and activity
are independent from or down-stream of Akt.
5.7 Microarray analysis of differentially regulated
genes in DCT1 cell of TBC1D4−/− mice
Given the rather mild renal phenotype of the TBC1D4−/− mice (see 4.1), we ad-
dressed the question whether the up- or down-regulation of other genes may com-
pensate for the loss of TBC1D4. Therefore, we performed a microarray analysis
to seek differentially expressed genes in COPAS-isolated DCT cells from WT and
TBC1D4−/− mice. The DCT was chosen, because previous data established that
the DCT expresses very high levels of TBC1D4 (our data and Lier et al. [2012]).
Moreover, the DCT is, in contrast to the CNT and CD, composed by only one
single cell type, reducing the risk of high variability of these results due to cellu-
lar heterogeneity in the isolated preparation. The microarray mRNA analysis of
COPAS-sorted DCTs corroborated the loss of TBC1D4. Moreover, microarray data
showed an almost complete loss of the expression of COMMD6, an inhibitor of
NF-κB-dependent immunity and inflammation [Bartuzi et al., 2013]. COMMD6 is
localized directly adjacent and down-stream of the TBC1D4 gene on chromosome
14. Although the analyzes of genomic DNA indicated that the COMMD6 gene locus
is intact in TBC1D4−/− mice, it is possible that the almost complete decrease of
COMMD6 mRNA levels might reflect the loss of an extended fusion transcript with
TBC1D4 and/or an artefact by the applied knockout technique. In as much the
concomitant loss of COMMD6 interfered with the effect of the loss of TBC1D4 is
unclear and a caveat that needs to be considered for the interpretation of the pre-
sented data in this thesis. In addition, several other genes (e.g. Spry2, Ptpb1, Scd1,
TBC1D10a, IQGAP1) were found to be differently regulated between DCTs of WT
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and TBC1D4-deficient mice in the microarray data. However, only dysregulation
the stearoylCoA-desaturase-1 (Scd1) could be confirmed by qRT-PCR. Scd1 is a
key enzyme in fatty acid metabolism. Interestingly, DCT-Scd1 mRNA levels were
decreased in TBC1D4−/− mice. Scd1-KO mice show enhanced insulin-signaling
with increased insulin sensitivity together with higher phosphorylation of down-
stream proteins, such as the IR, insulin receptor substrate (IRS) 1 and 2, and Akt.
Consequently, Scd1-deficiency leads to enhanced glucose transport [Dobrzyn and
Ntambi, 2005; Rahman et al., 2003]. The loss of TBC1D4 might favor an increase
of Scd1 protein levels in order to avoid uncontrolled glucose uptake, thus decreas-
ing Scd1-mRNA levels as a feedback mechanism. Indeed, similarly to TBC1D4−/−
mice, which are insulin-resistant, increased Scd1 protein levels have been related to
insulin-resistance in humans and animals (reviewed in Dobrzyn et al. [2010]). In
addition, Scd1 has been shown to modulate membrane fluidity by the production of
oleate, a major monounsaturated fatty acid. By the knockdown of Scd1, the ratio
between oleate and membrane phospholipids might change, leading to alterations in
the membrane fluidity [Dobrzyn et al., 2010]. The DCT segment is highly plastic
and Scd1 loss might influence membrane integrity, having implications on absorptive
and secretory transport mechanisms of the DCT. However, a clear role for Scd1 in
the DCT and in the kidneys in general is not known. Overall, Scd1 seems promis-
ing in unravel further mechanisms in the complex regulation of glucose homeostasis
through a putative interference with the TBC1D4-signaling pathway, what could
be investigated in a double knockout mouse model. Furthermore, Scd1 has been
demonstrated to modulate enzymes involved in fatty acid β-oxidation and Chadt
and coworkers showed increased palmitate oxidation in the Rab GAP-deficient mice
[Chadt et al., 2008]. We therefore analyzed additional genes, especially involved in
fatty acid β-oxidation, although a priori microarray data did not show any specific
changes. None of five genes (Acadm, Ehhadh, Hadh, Ppargc1a, Ppargc1b)
tested by qRT-PCR was either up- or downregulated. Although microarray analysis
revealed some contamination of isolated DCTs by NKCC2 (Slc12a1 )-positive TALs
and ENaC (Scnn1 )-positive late DCTs/CNTs, the expression did not differ between
samples from TBC1D4 WT and KO mice. As TBC1D4 as well as GLUT4 (Slc2a4 )
are highly expressed in these adjacent segments, the contamination through mRNAs
of these segments was not believed to interfere with the regulatory mechanisms on
gene levels in DCTs. However, if genes of the TAL and late DCT/CNT segment
would have an impact, the compensatory regulation would most probably be similar
in the GLUT4/TBC1D4-positive adjacent segments as in the DCT.
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6 General Conclusion/Perspectives
With the finding of TBC1D4 expression in specific segments of the nephron [Lier
et al., 2012], this study was devoted to unravel the physiological role of TBC1D4
in the kidneys. In vitro observations suggested a role of TBC1D4 in the control
of the ENaC, AQP2 and Na+-K+-ATPase. However, this thesis shows that in the
kidney in vivo, the regulation of these sodium and water transporting proteins is
not affected by a constitutive TBC1D4 deletion. Instead, this thesis provides con-
clusive evidence from in vivo and in vitro experiments that TBC1D4 controls the
glucose transporter GLUT4 in renal distal tubule cells. RT-PCR and immunohisto-
chemistry demonstrated a prominent co-expression of TBC1D4 and GLUT4 along
the distal tubule and the collecting system. Loss of TBC1D4 reduces total protein
abundance of renal GLUT4, but increases glucose uptake into distal tubules cells
to such extent that it cannot be further stimulated by insulin. As such, the data
are consistent with the role of TBC1D4 in adipocytes and skeletal muscle cells and
suggest that renal TBC1D4 mainly controls renal GLUT4 and glucose metabolism,
but not directly renal ion and water handling. Future studies will have to further
determine the precise function of TBC1D4 and in particular GLUT4 in the kidney.
The distinct localization of TBC1D4 and GLUT4 in the distal tubule is striking. In
contrast to proximal tubules, distal tubules do not only rely on aerobic metabolism,
but are also enabled for anaerobic glycolysis, which however requires the uptake of
large quantities of substrates such as glucose. Given the fact that the tubular fluid in
distal tubules is glucose-free, glucose uptake can be only achieved via the basolateral
cell side, where it is likely facilitated by GLUT4. The ability for GLUT4-mediated
glucose uptake may explain the lower vulnerability to ischemic damage of distal
tubules compared with proximal tubules. In line with this, we would expect that
the kidneys of TBC1D4-deficient mice may better tolerate ischemia than kidneys of
wild-type mice. In fact, preliminary data of collaborators in Yale point in this di-
rection. Moreover, in WT mice insulin-dependent phosphorylation of TBC1D4 may
release GLUT4 from intracellular retention in order to provide glucose and energy
via glycolysis at times of high requirements/working load (e.g. in the postprandial
state) (Figure 40). Moreover, the higher glucose and hence energy supply may indi-
rectly improve energy consuming transepithelial ion and water transport, driven by
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the Na+-K+-ATPase and mediated by ENaC and AQP2, respectively (Figure 40).
Future studies using wild-type, TBC1D4-, and kidney-specific GLUT4-deficient mice
will have to further address these hypothesis.
Figure 40: Hypothetical role of TBC1D4 in renal epithelial cells A In its non-
phosphorylated state, TBC1D4 might inhibit GLUT4-trafficking to the
basolateral membrane, as well as indirectly inhibit trafficking of ENaC,
AQP2 and the Na+-K+-ATPase. B After binding of insulin to the ba-
solateral insulin receptor (IR), e.g. at postprandial states, the intracel-
lular phosphorylation cascade might phosphorylate TBC1D4, leading to
GLUT4-transport to the membrane and increased glucose uptake. Via
(aerobic or anaerobic) glycolysis, the energy in the cell rises favoring the
transport of other vesicles containing renal transporters and channels
(e.g. ENaC, AQP2 and the Na+-K+-ATPase) to the membrane.
In summary, TBC1D4 is not directly crucial for the regulation of renal electrolyte
and water transport, but may play a role as part of the renal insulin-signaling cascade
in which GLUT4-mediated basolateral glucose uptake may improve the anaerobic
glycolytic capacity of distal tubules cells relevant during renal hypoxia and/or during
enhanced workload in e.g. postprandial states.
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